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Zusammenfassung 
 
dmyc, das Drosophila-Homolog der myc-Proto-Onkogene in Säugetieren, spielt eine wichtige Rolle in 
der Kontrolle des Wachstums auf zellulärer und organismischer Ebene. Zusammen mit den 
antagonistisch agierenden Proteinen der Mad/Mnt-Familie (dMnt in Drosophila) und dem zentralen 
Kofaktor Max (dMax in Drosophila) bilden die Myc-Proteine ein Transkriptionsfaktor-Netzwerk: das 
Max-Netzwerk.  
Im Gegensatz zu dmyc- und dmnt-Mutanten sind dmax-Mutanten bis jetzt noch nicht studiert worden. 
In dieser Arbeit präsentieren wir ein RNAi-System, mit dem wir in vivo die Expression von dmax 
stark erniedrigen können, und wir haben dmax-Nullmutanten erzeugt. Diese experimentellen 
Werkzeuge erlaubten uns, eine detaillierte Analyse der Funktionen von dmax durchzuführen, die 
zeigte, dass dmax sowohl im larvalen, als auch im imaginalen Wachstum benötigt wird. Bei Verlust 
von dmax-Funktionen stellten sich Phänotypen ein, die ähnlich derer in dmyc-hypomorphen Mutanten 
waren. Ausserdem konnten wir positive genetische Interaktionen mit dmyc und zwei dmyc-Kofaktoren 
(reptin und pontin) zeigen. Zusammen mit den bereits beschriebenen dmyc- und dmnt-Nullmutanten 
erlaubte die Erzeugung von dmax-Nullmutanten eine gründliche genetische Analyse des Max-
Netzwerks in Drosophila. Indem wir Wachstum und Überleben der verschiedenen null-mutanten 
Kombinationen von dmyc, dmnt und dmax verglichen, konnten wir zeigen, dass dmnt einen direkten 
antagonistischen Effekt auf das dmyc-abhängige Wachstum und Überleben hat. Des weiteren 
entdeckten wir, dass ein wichtiger Teil der Funktionen von dmyc nicht von dmax abhängt, ein 
Resultat, das den etablierten Vorstellungen widerspricht.  
Wir charakterisierten das Wesen dieser dmax-unabhängigen Funkionen dmycs in einer ausgedehnten 
loss-of-function-Analyse, mittels derer wir zeigten, dass diese Funktionen wichtig sind für die RNA-
Akkumulation in jungen L1-Larven, für das Wachstum und die Endoreplikation der polyploiden 
larvalen Gewebe, aber auch für das Wachstum in imaginalen Geweben sowie für die Zell-
Kompetition. Ausserdem fanden wir in verschiedenen dmyc-Überexpressions-Situationen Evidenz für 
dmax-unabhängige Funktionen von dmyc: Wir konnten nachweisen, dass die Überexpression von 
dmyc im Drosophila-Auge dmax-unabhängige Effekte zeitigte, die in Verbindung zu Apoptose stehen. 
In dmax-null-mutanten Flügel-Imaginalscheiben konnte dmyc immer noch Zell-Kompetition 
induzieren. In dmax-null-mutanten Larven fanden wir, dass konditionale Überexpression von dmyc zu 
Häutungs-Defekten führt und die Verpuppung verhindert, indem dmyc mit dem Ecdyson-System 
interferiert - möglicherweise ein Hinweis auf bisher unbekannte Zusammenhänge zwischen dmyc und 
der zeitlichen Regulation der Larvenstadien und der Metamorphose. 
Die diesen dmax-unabhängigen Funktionen von dmyc zugrundeliegenden molekularen Mechanismen 
harren einer Erklärung. Ein Hinweis auf eine mögliche Erklärung, wie dmyc auch ohne dmax einen 
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positiven Einfluss auf das Zell-Wachstum hat, mag in der Entdeckung zu sehen sein, dass die 
Überexpression von dmyc in dmax-mutanten Larven die Expression von 5sRNA, tRNA(Leu) und von 
zwei snoRNAs stimuliert.  
4
  
Summary 
 
dmyc, the Drosophila homolog of the mammalian myc proto-oncogenes, plays an important role in the 
control of cellular and organismal growth. Myc proteins, along with their antagonists of the Mad/Mnt 
protein family (dMnt in Drosophila), have been shown to function in a transcription factor network in 
which the activity of the network members depends on the binding to the central cofactor Max (dMax 
in Drosophila).  
While dmyc and dmnt mutants have been studied, dmax mutants have not been available so far. In this 
study, we present a conditional gene silencing system that allows to create situations of low dmax 
levels and we report the generation of dmax null mutants. Using both these tools, we conducted a 
detailed functional analysis of dmax, showing that dmax is required for both the growth of polyploid 
larval and diploid imaginal cells. Loss of dmax produced phenotypes that were reminiscent of dmyc 
hypomorphic phenotypes. Positive genetic interactions with dmyc and two cofactors, reptin and pontin 
could be shown. Together with the already available null mutants of dmyc and dmnt, the dmax null 
mutants allowed for a rigorous genetic analysis of the Drosophila Max network: By comparing the 
growth and survival of different null mutant combinations of the Max network members, we could 
show that dmnt directly antagonizes dmyc-dependent growth and survival. Furthermore, we discovered 
that an important part of the functions of dmyc do not require dmax, in contradiction to the current 
model of dmyc function.  
We performed a detailed loss of function analysis of the nature of these dmax-independent functions 
of dmyc, showing that these functions are important for the accumulation of total RNA in young L1 
larvae, for the growth and endoreplication of the polyploid larval tissues, but also for the growth of 
imaginal tissues and in cell competition. Moreover, we found several lines of evidence for dmax-
independent functions in situations where dmyc was overexpressed. In the Drosophila eye, 
overexpression of dmyc could be shown to have dmax-independent effects that are associated with 
apoptosis. In dmax null imaginal wing discs, dmyc could still induce cell competition. In dmax null 
larvae, conditional overexpression of dmyc interfered with ecdysone signaling, resulting in molting 
phenotypes and a block of pupariation, pointing to a previously unknown connection between dmyc 
and the regulation of developmental timing.  
The molecular mechanisms underlying these dmax-independent functions of dmyc remain to be 
elucidated. However, the discovery that overexpression of dmyc in dmax null larvae resulted in the 
upregulation of 5sRNA, tRNA(Leu) and of two snoRNAs might at least partially explain how dmyc can 
have a positive influence on growth in the absence of dmax. 
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Introduction 
 
1. The proto-oncogene myc 
myc is one of the most intensively studied proto-oncogenes. As one of the most frequently activated 
oncogenes, myc is estimated to be mutated in 20% of all human cancers (Nesbit et al., 1999). More 
than two decades ago, myc was found as the transforming principle of avian myelocytomatosis virus, 
deriving its name from this avian retrovirus (Sheiness et al., 1978). The viral version, termed v-myc, 
was shown to be the retrovirally captured homolog of a mammalian gene, termed c-myc (Vennstrom et 
al., 1982). The discovery that Burkitt's lymphoma is caused by a chromosomal translocation of c-myc 
in B cells has established myc's role as a prototypical oncogene (Hollis et al., 1984) that was later 
found to be involved in many human cancers. Besides c-myc, further paralogs are known in humans: 
N-myc, which is frequently found mutated in neuroblastomas and retinoblastomas (Kohl et al., 1983), 
and L-myc, first found in lung carcinomas (Nau et al., 1985). S-myc and B-myc have also been 
described, the latter gene only in rodents. These paralogs lack neoplastic potential (Henriksson and 
Luscher, 1996). 
 
1.1. Biological functions of myc    
myc genes encode transcription factors that play an important role in growth control, regulating 
proliferation, cell growth, differentiation and apoptosis (amongst others). Myc expression, both on the 
transcriptional and post-transcriptional level, is controlled by a wide range of growth factors, 
cytokines and mitogens (Kelly et al., 1983; Shibuya et al., 1992) and Myc activity links mitogenic 
signaling and the cell cycle. Myc and Ras have been shown to collaborate in inducing accumulation of 
active cyclin E/Cdk2 and E2F, thus inducing cell-cycle entry (Leone et al., 1997). Lack of Myc 
expression prevents quiescent cells from entering the cell cycle upon exposure to mitogenic signals 
(Roussel et al., 1991; Barone and Courtneidge, 1995). Conversely, overexpression of Myc can drive 
quiescent cells into the cell cycle and has been shown to promote S-phase entry and shorten G1-phase 
in cycling cells (Karn et al., 1989). Ectopic expression of c-Myc in the absence of survival factors does 
not only promote proliferation, but also leads to apoptosis in an, at least partly, Arf-Mdm2-p53-
pathway-dependent manner (Askew et al., 1991; Evan et al., 1992; Zindy et al., 1998). Myc expression 
rapidly decreases during the terminal differentiation of many cell types and it has been shown that 
Myc overexpression can prevent cells from undergoing terminal differentiation, reviewed in 
(Henriksson and Luscher, 1996).  
The functions of c-Myc and N-Myc are essential for development: c-myc null mice die before 10.5 
days of gestation (Davis et al., 1993), N-myc null mice at 11.5 days of gestation (Sawai et al., 1991; 
Sawai et al., 1993), while L-myc null mice have a wild type phenotype (Hatton et al., 1996). 
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From the findings above, a picture of Myc as an important regulator of proliferation had emerged. 
However, more recent studies have shown that Myc has an at least as important role in the regulation 
of cell growth (defined as the increase in cellular mass). This was compellingly shown in Drosophila, 
where Myc primarily regulates cell size (Johnston et al., 1999), and also in mammalian systems 
(Iritani and Eisenman, 1999; Schuhmacher et al., 1999). Transcriptome profiling techniques (such as 
SAGE and microarrays) made it possible to show that the most distinctive target genes downstream of 
Myc are the genes involved in ribosome biosynthesis and protein biosynthesis, e.g. Boon et al. (2001); 
Hulf et al. (2005), see also Zeller et al. (2003). Myc does not only regulate RNA polymerase II-
transcribed protein-coding genes, it has also been shown that Myc controls the transcription of RNA 
polymerase III-dependent small RNA genes (Gomez-Roman et al., 2003) in mammals and of RNA 
polymerase I-dependent ribosomal RNA (Grandori et al., 2005; Grewal et al., 2005) in mammals and 
in Drosophila. 
 
1.2. Molecular function of myc 
Myc proteins are members of the basic region/helix-loop-helix/leucine zipper (bHLHzip) superfamily 
of transcriptional regulators and have been shown to function as transcription factors. Myc possesses 
an N-terminal transactivation domain (Kato et al., 1990) and the C-terminal bHLHzip domain that is 
required for heterodimerization and DNA binding. Key to understanding Myc's function as a 
transcription factor was the discovery of its heterodimerization partner, the small bHLHzip protein 
Max (Blackwood and Eisenman, 1991; Prendergast et al., 1991). Myc/Max heterodimers have been 
shown to bind to DNA sequences called E-boxes (canonical sequence: CACGTG) (Blackwood and 
Eisenman, 1991) and variants thereof (Blackwell et al., 1993; Grandori et al., 1996). 
Heterodimerization of Myc with Max and subsequent binding to E-boxes is required for the 
transactivation effects of Myc (Amati et al., 1992; Crouch et al., 1993) and has been shown to be 
required for the cell cycle progression, apoptotic and oncogenic effects of the overexpression of Myc 
in cell culture systems (Amati et al., 1993a; Amati et al., 1993b). However, overexpression of Myc has 
been shown to induce apoptosis in PC12 cells (Wert et al., 2001), a cell line that does not express a 
functional Max transcript (Hopewell and Ziff, 1995).  
More recent studies have provided evidence that transactivation by Myc may be mediated by 
chromatin modifying (histone modification) and chromatin remodeling (nucleosome 
movement/displacement) systems. The Myc transactivation domain binds to the TRRAP protein, a 
factor that is part of the SAGA and Tip60 histone acetyltransferase (HAT) complexes and that is also 
found in a complex containing the Swi/Snf-related p400 protein (Cowling and Cole, 2006). TRRAP 
function was shown to be required for Myc-mediated transformation (McMahon et al., 1998). Besides 
HAT-containing complexes, chromatin remodeling systems are likely to be involved in Myc-mediated 
transactivation, since overexpression of dominant-negative forms of BRG1, a Swi/Snf complex 
7
  
member, blocks c-Myc-mediated transactivation (Cheng et al., 1999). Furthermore, Myc has been 
shown to bind to Tip48 and Tip49, two DNA-helicase/ATPases found in the Tip60 HAT complex, but 
also in chromatin remodeling complexes (Shen et al., 2000; Wood et al., 2000), and homologs of 
Tip48 and Tip49 (Reptin and Pontin) have been shown to interact genetically with Myc both in 
Drosophila (Bellosta et al., 2005) and in Xenopus (Etard et al., 2005). 
Myc has also the potential to repress certain target genes, many of which contain TATA-less 
promoters featuring a specific initiator element (Inr) that is recognized by the activating transcription 
factor Miz-1. Myc has been shown to bind Miz-1 and is believed to be recruited to the Inr promoters 
through this interaction (and not by direct binding to the DNA), leading to a repression of the target 
gene (Wanzel et al., 2003). Miz-1 binds to Myc's bHLHzip domain, but does not preclude binding to 
Max, because binding occurs on opposite sides of the domain, and indeed it has been shown that the 
presence of Max is required for Myc-mediated repression (Mao et al., 2003). The exact mechanism of 
Myc-mediated repression remains unclear, but presumably involves disruption of the binding of p300 
to Miz-1 (Staller et al., 2001).  
  
2. max 
The small protein Max has no transactivation domain of its own, consisting mainly of a bHLHzip 
domain, and it was shown to be transcriptionally inert in reporter assays (Kato et al., 1992; Min and 
Taparowsky, 1992). Besides Max's important ability to form heterodimers with Myc, Max has also 
been shown to form homodimers which bind to the same E-boxes that are recognized by Myc/Max 
heterodimers (Blackwood and Eisenman, 1991; Prendergast et al., 1991). While it has been reported 
that Max homodimers repress the transcription of E-box reporters (Kretzner et al., 1992), the 
biological relevance of this finding is unclear, since DNA binding by Max homodimers is inhibited by 
constitutive CKII-mediated phosphorylation (Berberich and Cole, 1992) and Max homodimers did not 
repress Myc-responsive genes in vivo (Yin et al., 1998). 
CKII-mediated phosphorylation of Max is also relevant in the recently described caspase-mediated 
degradation of Max during Fas-mediated apoptosis (Krippner-Heidenreich et al., 2001). At present it is 
not clear whether this degradation process is just a part of the general apoptotic dismantling of a cell, 
or whether it has a dedicated regulatory purpose that might be important in the context of Myc-
induced apoptosis. 
Several splice forms of max exist in mammals (Blackwood and Eisenman, 1991; Makela et al., 1992; 
Vastrik et al., 1993; Arsura et al., 1995). The high degree of conservation of the max gene structure - 
the exon-intron boundaries are identical in insect max (Gallant, 2006), theoretically allowing the 
formation of the same splice forms that exist in vertebrates - might imply that alternative splice forms 
of max have biological importance.  
8
  
Consistent with Max's essential role as a cofactor of Myc, max null mice are not viable. max null mice 
die at much earlier stages (4.5 - 7.25 days of gestation) than c-myc or N-myc null mice (Shen-Li et al., 
2000). The longer survival of c-myc or N-myc null mutants might be due to redundant functions of c-
myc and N-myc.  
The only max mutant cell line that has been studied so far is the rodent PC12 cell line. In these cells, a 
mutation in the max locus precludes the formation of functional max transcript. Overexpression of 
Myc has been reported to induce apoptosis in PC12 cells, suggesting that at least a part of the role of 
Myc in apoptosis is dMax-independent. 
  
3. myc, max, mad, and more: the Max network 
Max has important functions beyond its role as a cofactor of Myc. The identification of a set of Myc-
related bHLHzip proteins that heterodimerize with Max and function as transcriptional repressors has 
placed Max at the centre of a transcription factor network, called the Max network. Expression cloning 
and yeast two hybrid assays led to the discovery of the four closely related bHLHzip proteins Mad1, 
Mxi1, Mad3 and Mad4 (also called MXD1-4) and later of the proteins Mnt (also called Rox) and Mga 
(Ayer et al., 1993; Zervos et al., 1993; Hurlin et al., 1995; Hurlin et al., 1997b; Hurlin et al., 1999).  
Five of these proteins, Mad1, Mxi1, Mad3, Mad4 (also called MXD1-4) and Mnt possess N-terminal 
SID domains (Sin3-interaction domains) that mediate interaction with Sin3 corepressors and they have 
been shown to function as transcriptional repressors that can block Myc-dependent cell transformation 
in cell culture assays (Ayer et al., 1993; Hurlin et al., 1995; Koskinen et al., 1995; Schreiber-Agus et 
al., 1995; Hurlin et al., 1997a). Transcription assays showed that Mad proteins and Mnt repress the 
expression of synthetic reporters in an E-box-dependent manner (Ayer et al., 1993; Hurlin et al., 
1997a). The Mad proteins, and also Mnt, therefore appear to function as direct antagonists of Myc 
(Figure I). Consistent with such a model, increased expression of several Mad proteins is associated 
with cellular differentiation and growth arrest (Ayer and Eisenman, 1993; Chin et al., 1995), and Mxi1 
as well as Mnt proteins act as tumor suppressors (reviewed in Hurlin and Huang, 2006). Knock-out 
mice mutant for mad1, mxi1, mad3 and mnt have been generated (Foley et al., 1998; Schreiber-Agus et 
al., 1998; Queva et al., 2001; Hurlin et al., 2003). While mad1, mxi1 and mad3 mice were viable and 
displayed rather subtle phenotypes, mnt null mice die at or soon after birth. 
Recent studies have shown that mnt plays a central role in antagonizing Myc function: Cells that are 
mutant for mnt show many of the hallmark aspects of Myc overexpression. Deletion of mnt leads to 
disrupted cell cycle control, transformation and enhanced levels of apoptosis (Hurlin et al., 2003; 
Nilsson et al., 2004). Conditional deletion of mnt in breast epithelial cells, T-cells and B-cells in 
transgenic mice leads to tumorigenesis (Hurlin et al., 2003; Dezfouli et al., 2006; Hurlin and Huang, 
2006; Toyo-oka et al., 2006). Importantly, each of these cell types has been shown to be prone to 
tumorigenesis by Myc overexpression in transgenic mice (Nesbit et al., 1999). Furthermore, Myc and 
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Mnt have been shown to regulate a similar set of target genes (Toyo-oka et al., 2006). Taken together, 
these data indicate that Mnt operates in the same cells and at the same times like Myc, directly 
antagonizing Myc function. 
Less is known about the biological functions of Mga, a large protein that possesses two DNA binding 
domains: the bHLHzip domain and a T-domain (Hurlin et al., 1999). However, Mga was shown to 
inhibit Myc-dependent cell transformation (Hurlin et al., 1999) and Mga/Max complexes were 
identified as part of an E2F6 repression complex (Ogawa et al., 2002), making it possible that also 
Mga acts as Myc antagonist. 
 
 
 
 
Figure I 
The diagram depicts the association of Max with either Myc or Mad/Mnt proteins. The heterodimeric 
transcription factors are shown to regulate transcription of a hypothetical target gene through the E 
box element, 5'-CACGTG-3'. The Myc/Max heterodimer binds E-boxes and activates transcription 
possibly through histone acetylation and direct interaction of the Myc transregulatory domain with the 
transcriptional machinery. Mad/Max complexes recruit Sin3 corepressors and histone deacetylases to 
the Sin3-interacting domain (SID) to repress E-box-driven transcription. The Myc, Mad and Max 
functional domains are shown, with all three proteins containing the basic helix-loop-helix leucine 
zipper (bHLHZip). NTS is the nuclear targeting signal. TRD is the Myc transactivation domain, 
containing the Myc box I (MBI) and Myc Box II (MBII) regions. (modified from Dang et al., (1999) 
Experimental Cell Research 253:63-77) 
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4. The Max network in Drosophila 
 
4.1. Drosophila orthologs 
The identification of dMyc, the sole Myc ortholog in Drosophila, in yeast two-hybrid screens, using 
human Max protein as bait, has made it possible to study Myc in a genetically tractable animal model 
(Gallant et al., 1996; Schreiber-Agus et al., 1997). The gene that encodes dMyc turned out to be 
identical to the diminutive gene (dm), a gene that had been described based on a mutation (dm1) in the 
1930s (Bridges, 1935). While "dm" is the official designation, the synonym "dmyc" is widely used in 
the literature. After its identification, dMyc was then used to identify the Drosophila ortholog of Max 
(dMax). As in vertebrates, dMyc and dMax form heterodimers and these bind to the canonical E-box 
sequence (Gallant et al., 1996). More recently, dMnt has been described as the sole Drosophila 
ortholog of the vertebrate Mad/Mnt protein family (Loo et al., 2005). Thus, the Max network is 
conserved in Drosophila, but much simpler than in vertebrates, featuring one member of each protein 
class. 
 
4.2. dmyc 
The bHLHzip domain of dMyc is highly conserved, and also the domains important for transactivation 
(MBI, MBII) and the acidic region are conserved, albeit to a lesser degree (Gallant, 2006). dMyc and 
c-Myc can functionally substitute for each other surprisingly well: dMyc can transform rat embryo 
fibroblast upon coexpression of oncogenic Ras (Schreiber-Agus et al., 1997), functionally substitutes 
for c-Myc in transactivation assays (Gallant et al., 1996) and rescues growth defects of mouse embryo 
fibroblasts derived from c-myc conditional knock-outs (Trumpp et al., 2001). Conversely, two c-Myc 
isoforms (c-Myc2 and MycS) can rescue the otherwise complete lethality of a strong hypomorphic 
dmyc mutant, allowing these flies to develop into fertile adults (Benassayag et al., 2005). Taken 
together, these findings show a high degree of functional conservation between vertebrate and 
Drosophila Myc. 
Loss of dMyc function is associated with growth defects. Mutants hypomorphic for dMyc can reach 
adulthood, but show a developmental delay, smaller body size, reduced weight and a thin bristle 
phenotype. The small size of these mutants is due to smaller cell size (Johnston et al., 1999). Strong 
hypomorphic mutants and null mutants die as larvae (Maines et al., 2004; Pierce et al., 2004). dmyc 
mutant clones show growth defects both in diploid and polyploid (endoreplicating) tissues (Johnston et 
al., 1999; Maines et al., 2004; Pierce et al., 2004). Conversely, dMyc overexpression leads to bigger 
diploid cells and to a tremendous increase in the size of endoreplicating cells.  
dMyc has an effect on both the cell cycle and on cellular growth (defined as the increase in cell mass 
over time). While dmyc hypomorphic mutant imaginal wing disc cells show a slight accumulation in 
G1 phase and smaller size, overexpression of dMyc strongly accelerates G1-S transition. However, the 
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overall duration of the cell cycle cannot be shortened by the overexpression of dMyc, since the 
observed shorter G1 phases go along with longer S and G2 phases. Since dMyc does not increase the 
cycling rates of these cells, but increases cellular growth, cell size but not cell number is increased 
(Johnston et al., 1999). 
How does dMyc regulate cellular growth? Several lines of evidence point to an important role of 
dMyc in the control of protein biosynthesis. Firstly, the developmental delay and thin bristle 
phenotypes of dmyc hypomorphic mutants are reminiscent of the phenotypes of Minute mutants. 
Minute genes encode ribosomal proteins - Minute mutations result in impaired protein biosynthesis. 
Secondly, overexpression of dMyc strongly increases nucleolar size, indicating higher rates in the 
production of ribosomes (Grewal et al., 2005). Thirdly, a large number of dMyc target genes is 
involved in nucleolar function, rRNA processing and ribosome biosynthesis (Orian et al., 2003; Hulf 
et al., 2005), and dMyc has been shown to regulate RNA polymerase I-dependent transcription 
(Grewal et al., 2005). 
The role of dMyc in the regulation of protein biosynthesis is probably linked to another phenomenon 
that can be observed both in the context of dmyc and Minute mutant situations: cell competition in 
imaginal disc tissues. When Minute+ clones are generated in Minute+/Minute- imaginal wing discs, 
normally sized wings result, but a large part of the heterozygous tissue is found to be replaced by 
Minute+ tissue, implying the elimination of the Minute+/Minute- cells. Conversely, Minute-/+ clones 
are eliminated from wild type imaginal disc tissue, but survive well when surrounded by tissue that is 
heterozygous mutant for another Minute gene (Simpson and Morata, 1981). This phenomenon was 
termed cell competition. This process has also been observed in dmyc mutant situations. Clones 
mutant for the weak hypomorphic allele dmP0 are eliminated from dmP0/+ imaginal wing disc tissue by 
cell competition (Johnston et al., 1999). Recently, this process has been studied more closely, and it 
has been shown that in situations, where cells with differing dmyc levels are juxtaposed, apoptosis is 
induced in the cells with lower dmyc levels (De La Cova et al., 2004; Moreno and Basler, 2004). 
Strikingly, cells which moderately overexpress dmyc have a competitive advantage over wild type 
cells. Presently, it is not clear whether cell competition exists in mammalian systems. If it exists, it 
might play an important role in tumorigenesis. 
 
4.3. dmnt 
The sole Drosophila ortholog of the mad/mxi/mnt gene family has been termed dmnt, because it is 
most similar to mnt in size and overall organization (Loo et al., 2005). Like its mammalian 
counterparts, dMnt acts as a transcriptional repressor. dMnt forms heterodimers with dMax, binds to 
canonical E-box sequences and represses transcription via the Sin3 corepressor and recruitment of 
HDAC. Three splice variants occur: full length dMnt, dMntΔSID (a form lacking the Sin3-interaction 
domain) and dMntΔZip (a form lacking the leucine zipper) (Loo et al., 2005).  
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dmnt mutant flies are fully viable, unlike the mnt mutant mice which die at birth. These flies have 
larger cells than wild type animals and a larger total body weight. Conversely, overexpression of dmnt 
in cell clones in the imaginal wing discs results in a strongly reduced size of the clones (and of the 
individual mutant cells) (Loo et al., 2005). 
 
4.4. dmax 
Prior to this study (and the diploma thesis preceding it (Steiger, 2002)), no genetic analysis of dmax 
had been undertaken and no dmax mutants had been described. Therefore, not much was known about 
the biological functions of dMax. Like its mammalian counterpart, dMax is required for the regulation 
of transcription by the other members of the network, forming positively acting dMyc/dMax 
heterodimers and repressive dMnt/dMax heterodimers that bind to E-box sequences (Gallant et al., 
1996; Loo et al., 2005). In embryos, the 1.2 kb dmax transcript is expressed ubiquitously, being less 
restricted in the expression pattern than dmyc, but at lower levels than the dmyc transcript, especially 
in earlier stages (Gallant et al., 1996).  
 
5. Project overview 
In mammalian systems, a large amount of knowledge about the molecular and biological functions of 
the Max network has been accumulated. Yet, a rigorous analysis of the functions of the Max network 
has proved difficult due to functional redundancy among the network members and due to the 
complexity and diversity of the network's functions. In Drosophila, the Max network is conserved in a 
greatly simpler form, with one ortholog of myc, mnt and max present. Nevertheless, at least a large 
part of the fundamental functions of both myc and mnt are conserved. Taken together with the 
sophisticated genetic tools available, Drosophila is therefore an ideal system for a thorough genetic 
epistasis analysis. While null mutants for both dmyc and dmnt have been described (Pierce et al., 2004; 
Loo et al., 2005), mutants for dmax have been lacking so far.  
With the dmax-RNAi system and the dmax null mutant presented in this study, a functional analysis of 
dmax and a detailed epistatic analysis of the whole Max network became possible. While the analysis 
showed that loss of dmax recapitulates the loss of dmyc to a certain extent, striking differences 
between the phenotypes of dmyc and dmax mutants were revealed. A detailed analysis of mutant 
combinations of the Max network members clearly showed that dMyc has important growth functions 
that do not require dMax, both in diploid an polyploid tissues. Furthermore, the analysis showed that 
cell competition is partly dmax-independent. Experiments in which dmyc was overexpressed both in 
wild type and dmax mutant situations provided further evidence for dmax-independent functions of 
dmyc: Overexpression of dmyc in the eye resulted in dmax-independent growth and apoptosis. 
Strikingly, ubiquitous overexpression of dmyc in dmax null larvae revealed a connection to the 
ecdysone system and to the control of the developmental timing. Finally, dmyc was shown to 
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upregulate the levels of transcription of certain small RNA genes (among them 2 snoRNA genes) in 
the absence of dmax, providing a potential molecular basis for the observed dmax-independent growth 
functions of dmyc. 
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Results 
 
1. dmax-RNAi 
 
In the first part of this study, a system based on transgenic RNAi was used to monitor the 
consequences of reduced dmax levels. 
 
1.1. Tools: dmax- and lacZ-dsRNA constructs 
In the diploma thesis that preceded this work, transgenic flies were created that carry constructs that 
allow a regulated expression of dmax or lacZ double stranded RNA (Steiger, 2002). In these flies, 
dmax or lacZ mRNA is silenced upon expression of dmax or lacZ double stranded RNA (dsRNA) by 
RNA interference (RNAi). The transgenes consist of inverted repeats of dmax or lacZ cDNA that were 
cloned into the expression cassette of the pUAST P element vector (Figure 1). Expression of the 
inverted repeat cDNA under the control of the yeast transcriptional activator GAL4 leads to the 
formation of RNA hairpins that provoke RNA interference. The inverted repeats are directly 
juxtaposed and only separated by an SfiI restriction site containing 5 nonpalindromic nucleotides that 
help to prevent recombination events during the cloning process. The 784 bp dmax repeats correspond 
to nucleotides 132-915 of the 1011 bp dmax transcript. The lacZ repeats have a length of 769 bp and 
contain nucleotides 1847-2615 of the total 3113 bp lacZ cDNA.  
The lacZ-dsRNA construct has been generated for control purposes: we intended to demonstrate that 
the chosen type of dsRNA construct is capable of strongly and specifically silencing the target gene. 
The lacZ-dsRNA construct also serves as a control in experiments with the dmax-dsRNA construct to 
exclude general consequences of the overexpression of double stranded RNA. 
Figure 2 depicts the dmax genomic locus. As indicated, the dmax cDNA included in the inverted 
repeat constructs covers almost the whole dmax transcript. Contrary to our intentions, a small part of 
the repeat also covers the first exon of a neighboring gene (CG9666). This exon has been added to the 
gene prediction in genome version 3. The prediction is supported by two cDNA clones (clones 
RE16168 5 and RE39930 5). As we show in this work, CG9666 is not downregulated by dmax-RNAi 
and moreover, CG9666 is nonessential. 
Several independent transgenic fly lines have been generated with both of the constructs and an initial 
characterization of the fly lines has been performed (Steiger, 2002). In this work, the following 
naming convention will be used: Fly lines carrying the dmax dsRNA construct are called dmax-IR 
(inverted repeat) lines, fly lines carrying the lacZ dsRNA construct are correspondingly called lacZ-IR 
lines. Independent transgenic lines are labeled with stock numbers (e.g. dmax-IR 2-7). 
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Figure 1 
Structure of the dmax- and lacZ-RNAi constructs.  
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Figure 2 
dmax genomic locus. The arrows indicate transcription start sites and the direction of transcription. 
Grey boxes indicate transcribed DNA, blue boxes indicate open reading frames. Red boxes indicate 
regions covered by the dmax inverted repeats. 
16
  
1.2. Effects of dmax-RNAi on viability 
 
1.2.1. dmax-RNAi causes pupal lethality in a background of reduced dmax dosis 
In Steiger (2002), an initial characterization of the established lacZ-IR and dmax-IR lines has been 
performed. This section gives a brief summary of the performed experiments. Based on the larval and 
pupal lethal phenotype of strong hypomorphic dm mutants like dmPG45 or dmPL35 (Bourbon et al., 
2002), we tested whether we could produce a similar phenotype by overexpressing dmax dsRNA with 
the strong and ubiquitous drivers actin-GAL4 and daughterless-GAL4. Surprisingly, strong ubiquitous 
overexpression of dmax dsRNA did not lead to a noticeable decrease in viability of the flies in most of 
the experiments. Next, we examined if we would see a stronger effect in flies that carry only one copy 
of dmax. For this purpose, flies were used that are heterozygous for Df(3L)fz2, a large deficiency that 
uncovers the dmax locus. Expression of dmax dsRNA under control of actin-GAL4 in this context led 
to almost complete lethality in 6 out of 10 independent dmax-IR lines (0 - 10 % escapers). These lines 
(dmax-IR 2-7, 5-1, 5-2, 6-1, 7-3, 8-1) were chosen for further investigation. The effect is specific for 
dmax RNAi, since the presence of Df(3L)fz2 did not significantly alter the viability of flies in which 
lacZ dsRNA was expressed. The tested lacZ-IR lines (lacZ-IR 1-1, 3-1, 6-1) have been shown to 
strongly silence lacZ expression (Steiger, 2002). 
Df(3L)fz2/+ animals in which dmax dsRNA is expressed died as pharate imagines. The morphology of 
these imagines was normal, except that they frequently showed necrosis of thoracal and postocular air 
sacs. Less frequently, necrotic lesions of abdominal tissue were observed. The few eclosing escapers 
had a mostly normal appearance. Infrequently, small necrotic lesions were present. Both uneclosed 
pharate animals and eclosed escapers had a wild type body size, but thin bristles. Thus, dmax is 
essential for viability and for bristle growth, as is dmyc.  
 
1.2.2. dmax-RNAi causes pupal lethality also in a dmax1 background 
The surprisingly strong reduction in viability from complete lack of lethality to almost full lethality in 
a Df(3L)fz2/+ background can by explained by the assumption that dmax levels in this situation fall 
short of a critical threshold that is necessary for continuation of development. However, Df(3L)fz2 is a 
large deficiency that also uncovers reptin, a gene that has been shown to positively interact with dmyc 
(Bellosta et al., 2005). Hence it was possible that the effect seen (even though dependent on RNAi) is 
based on the combined reduction of dmax and reptin levels. We tested therefore whether the observed 
strong loss of viability could also be caused by the removal of one copy of dmax. Indeed, expression 
of dmax dsRNA with actin-GAL4 in a dmax1/+ background had the same effect as in a Df(3L)fz2/+ 
situation (Figure 3, A-C and D-F), confirming that a strong enough reduction of dmax levels alone is 
sufficient to cause lethality. 
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1.2.3. The pupal lethality caused by dmax-RNAi in a Df(3L)fz2/+ background can be fully 
rescued by coexpression of a UAS-dmax rescue construct 
The observed pupal lethality is due to specific silencing of dmax and not a consequence of unspecific 
effects of dmax-RNAi, since coexpression of a UAS-dmax cDNA rescue construct fully restores wild 
type viability (Figure 3, G-K). This finding also rules out the possibility that the observed effects are 
due to a reduction of CG9666 mRNA levels by dmax-RNAi. 
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Figure 3 
Viability of flies that strongly and ubiquitously express dmax dsRNA, in combination with Df(3L)fz-2 
and with a UAS-dmax rescue construct. Viability rates of the genotypes B and C are calculated relative 
to genotype A (the viability of A was set to 100%). Viability rates of the genotypes E and F are 
calculated relative to genotype D (the viability of D was set to 100%). The viability rate of the 
genotypes H, I, K is indicated relative to genotype G (the viability of G was set to 100%). For a more 
detailed explanation of the viability calculations, see Materials and Methods. 
 
Label:  Genotypes:        Eclosed flies: 
 
A  y w; UAS-dmax-IR(2-7)/CyO, y+     199 
B  y w; actin-GAL4/CyO       173 
C  y w; UAS-dmax-IR(2-7)/actin-GAL4     191 
D  y w; UAS-dmax-IR(2-7)/CyO, y+; dmax1/+    114 
E  y w; actin-GAL4/CyO; dmax1/+     123 
F  y w; UAS-dmax-IR(2-7)/actin-GAL4; dmax1/+   4 
G  y w; actin-GAL4/UAS-dmax; UAS-dmax-IR(6-1)/Df(3L)fz2  100 
H  y w; actin-GAL4/+; UAS-dmax-IR(6-1)/Df(3L)fz2   1 
I  y w; [UAS-dmax; UAS-dmax-IR(6-1)]/SM5-TM6B   73 
K  y w; [+; UAS-dmax-IR(6-1)]/SM5-TM6B    71 
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1.2.4. Combinations of dmax dsRNA constructs cause pupal lethality in a wild type background 
Since strong expression of the dmax dsRNA constructs led to no reduction of viability in a wild type 
background (dmax-IR 2-7: Figure 3, for the other dmax-IR lines see Steiger, 2002), we generated fly 
lines that carry combinations of dmax dsRNA constructs. All combinations that were tested (2-7 + 5-2, 
5-2 + 6-1, 5-2 + 7-1 and 2-7 + 5-2 + 6-1) caused almost complete pupal lethality. The effect that was 
observed was as strong as the effect of expressing single copies of the dmax dsRNA constructs in a 
Df(3L)fz2/+ or dmax1/+ background. We concluded that combinations of the dmax dsRNA transgenes 
sufficiently lower dmax mRNA levels to cause pupal lethality in a wild type background.  
The flies fail to eclose and die as pharate animals. Dissection of such pupal cases revealed normally 
developed animals with a thin bristle phenotype. Frequently, necrosis of thoracal air sacs, of air sacs in 
the head and of abdominal trachea was observed (Figure 4). Diffuse patterns of necrosis were 
observed on the abdomen. It is not clear whether the observed necrosis is an unspecific consequence 
of the failure of the flies to eclose. 
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Figure 4 
Genotypes: A y w; UAS-dmax-IR(2-7)/+; UAS-dmax-IR(5-2) UAS-dmax-IR (6-1)/da-GAL4 
  B y w; UAS-dmax-IR(2-7)/+; UAS-dmax-IR(5-2) UAS-dmax-IR (6-1)/da-GAL4 
  C y w; UAS-dmax-IR(2-7)/actin-GAL4; UAS-dmax-IR(5-2) UAS-dmax-IR (6-1)/+ 
  D y w; UAS-dmax-IR(2-7)/actin-GAL4; UAS-dmax-IR(5-2) UAS-dmax-IR (6-1)/+ 
 
Pharate animals were taken out of their pupal case. The animals have thin bristles. Necrotic spots are 
visible on the abdomens (A, B [higher magnification], C). Thoracal air sacs and air sacs in the head 
show widespread necrosis (A, C, D). Arrows indicate necrotic regions. 
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1.3. dmax-RNAi strongly decreases dmax mRNA levels 
Having identified strong dmax-IR lines based on the pupal lethality of animals expressing dmax 
dsRNA in a Df(3L)fz2/+ background, we examined the extent of reduction of dmax mRNA levels in 
flies that express dmax dsRNA under control of actin-GAL4. For this purpose, we extracted total RNA 
from wandering larvae that carried the actin-GAL4 driver and one or three copies of the dmax dsRNA 
transgene. As a control, total RNA was extracted from flies that carried only actin-GAL4. 
Additionally, total RNA was extracted from larvae that carried a P element insertion (EY02775) in the 
second exon of CG9666 (flies of this genotype were used to create the dmax1 null mutant). The total 
RNAs were retrotranscribed and qRTPCR was performed with primers specific for the dmax and 
CG9666 3' UTRs; the amplified sequence did not overlap with the sequence included in the inverted 
repeat RNA. mRNA levels were calculated relative to reference qRTPCR reactions with primers 
specific for the Act42A or Rpl32 gene (Figure 5). 
The results show that dmax mRNA levels in the dmax-IR larvae were strongly reduced, even though a 
full silencing is clearly not achieved. Surprisingly, we could not show that dmax mRNA levels are 
more strongly reduced in the flies carrying three copies of the dmax-IR construct. We had expected to 
find lower mRNA levels in this genotype based on the stronger phenotypes that are created by 
expressing three copies of the dmax dsRNA transgene instead of one copy. Possibly, the additional 
decrease in dmax mRNA levels is too weak to be detected given the experimental errors in qRTPCR 
experiments, or it affects only a subset of tissues. 
dmax RNA levels in the y w; P{y+ w+}CG9666EY02775 genotype were - if at all - only slightly reduced. 
The EY02775 P element insertion is only 400 bp from the start of the dmax transcript, but the finding 
is compatible with the observation that y w; P{y+ w+}CG9666EY02775 as well as y w; P{y+ 
w+}CG9666EY02775/Df(3L)fz2 flies are fully viable. 
According to annotation 3.0 of the Drosophila genome, the first exon of CG9666 overlaps with the 
first and the second exon of dmax and thus with a short region of the dmax dsRNA constructs (Figure 
2). Nevertheless, CG9666 levels seem not to be affected by dmax-RNAi. This might be due to the 
shortness of the overlap of the inverted repeat sequence with the CG9666 transcript or due to the fact 
that the annotation of CG9666 in the Drosophila genome version three is wrong. y w; P{y+ 
w+}CG9666EY02775 flies, which are fully viable, show clearly reduced levels of CG9666. The fact that 
there is substantial expression of CG9666 in this genotype is still surprising, since the P element is 
inserted in the second exon of the gene. This might hint to an alternative transcription start site 
upstream of the CG9666 ORF, but downstream of the P element insertion.  
CG9666 mRNA levels are clearly lower in y w; P{y+ w+}CG9666EY02775 flies than in flies that express 
dmax dsRNA, but this reduction obviously does not reduce viability (nor does it have any other 
phenotypic consequences). It is therefore clear that the observed strong pupal lethality caused by 
dmax-RNAi is independent of CG9666. 
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Taken together, these findings indicate that dmax-RNAi specifically decreases dmax mRNA levels, 
thus phenocopying a dmax hypomorphic mutant. 
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Figure 5 
mRNA levels of dmax and CG9666 relative to the reference genes Act42A and RpL32. Quantitative 
real time PCR was performed on cDNA from wandering third instar larvae. Values with error bars are 
based on 2 biological replicates, whereas values without error bars are based on a single RNA sample. 
The error bars indicate standard deviations.  
 
Genotypes: 
A y w; +/actin-GAL4 
B y w; UAS-dmax-IR(2-7)/actin-GAL4; TM6B/+ 
C y w; UAS-dmax-IR(2-7)/actin-GAL4; UAS-dmax-IR(5-2) UAS-dmax-IR(6-1)/+ 
D y w; P{y+ w+}CG9666EY02775 
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1.4. GAL4 drivers which do not cause mutant phenotypes with the dmax dsRNA constructs 
The single insertion line dmax-IR 2-7 and the recombined line dmax-IR 2-7 5-2 6-1 were crossed to 
the following GAL4 driver lines: eyeless-GAL4 (eye and head capsule specific), pumpless-GAL4 (fat 
body specific), engrailed-GAL4 (specific for the posterior compartments), ELAV-GAL4 (pan-neural) 
and forkhead(81.0)-GAL4 (salivary gland specific). At 25° C, expression of dmax dsRNA with these 
drivers did not result in a mutant phenotype. We repeated the experiments at a temperature of 29° C, 
since GAL4 activity is temperature-dependent and more active at higher temperatures. Experiments 
above 29° C are not possible, since higher temperatures are not well tolerated by Drosophila at 
extended lengths of time. Also at 29° C, none of the drivers did result in a mutant phenotype.  
 
1.5. dmax-RNAi reduces body weight 
Strong expression of single copies of a dmax dsRNA construct that lowers dmax mRNA levels to 20% 
(Figure 5) did generally not lower the viability of the flies, even though there was a certain extent of 
variability in the survival of male flies whose viability was decreased in some experiments. However, 
Figure 6 shows that expression of dmax dsRNA decreases the weight of females by 19% and of males 
by 15% relative to the weight of females and males that express lacZ dsRNA. The effect is due to the 
expression of the construct, since both transgenes do not reduce body weights in absence of actin-
GAL. Thus, dmax behaves as expected for an essential partner of dmyc, since hypomorphic mutants of 
dmyc are smaller than wild type animals (Johnston et al., 1999). 
 
1.6. dmax-RNAi causes a thin bristle phenotype 
One of the hallmarks of dmyc hypomorphic mutants is a thin bristle phenotype (macrochaetae that are 
smaller in relation to overall body size than in wild type animals). This phenotype occurs in mutants 
that have defects in protein biosynthesis and is typical for Minute mutants (Lambertsson, 1998). When 
dmax dsRNA is strongly expressed under control of actin-GAL4 in a Df(3L)fz2/+ background, pupal 
lethality resulted and pharate animals that did not eclose as well as the few escapers showed a thin 
bristle phenotype. To confirm this phenotype, we expressed dmax dsRNA with scabrous-GAL4 (sca-
GAL4), a GAL4 driver that is expressed in bristle progenitor cells. This did not compromise the 
viability of the flies, but resulted in a thin bristle phenotype. We measured the bristle sizes of the 
posterior scutellar macrochaetae. In comparison to control flies that expressed lacZ dsRNA, the size of 
the posterior scutellar bristles was reduced by 30% in both males and females that expressed dmax 
dsRNA (Figure 7). One copy of the dmax dsRNA construct was sufficient for this decrease; bristle 
size could not be further reduced in flies that carried three copies of the dmax dsRNA construct. 
A strong reduction in thoracal bristle size could also be achieved with the driver decapentaplegic-
GAL4 (dpp-GAL4). Whereas expression of dmax dsRNA with dpp-GAL4 did not cause a mutant wing 
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phenotype and did not cause lethality, it reduced the size of the anterior and posterior bristles by more 
than 50% (Figure 8). 
These results show that also in its effect on bristle size, reduction of dmax has similar consequences as 
a reduction of dmyc has. 
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Figure 6 
dmax-RNAi decreases the body weight of adult females and males, whereas lacZ-RNAi has no such 
effect. The error bars indicate standard deviations. 
 
 
 
Label:  Genotypes:      Number of measured flies: 
 
Females: 
A  y w; UAS-lacZ-IR(3-1)/CyO, y+   109 
B  y w; UAS-dmax-IR(2-7)/CyO, y+     90 
C  y w; UAS-lacZ-IR(3-1)/actin-GAL4   104 
D  y w; UAS-dmax-IR(2-7)/actin-GAL4     46 
Males: 
E  y w/Y; UAS-lacZ-IR(3-1)/CyO, y+   104 
F  y w/Y; UAS-dmax-IR(2-7)/CyO, y+   108 
G  y w/Y; UAS-lacZ-IR(3-1)/actin-GAL4    39 
H  y w/Y; UAS-dmax-IR(2-7)/actin-GAL4      9 
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Figure 7 
dmax-RNAi reduces bristle size. The pictures above show the posterior scutellar bristles (and partly 
the anterior scutellar bristles (arrowheads)) of flies that express lacZ dsRNA (A) and dmax dsRNA (B, 
C) under control of sca-GAL4. The chart below depicts the calculated bristle area of the posterior 
scutellar bristles for females (A, B, C) and males (A', B', C') of the indicated genotypes. For every 
genotype, the area of both posterior scutellar bristles of 8-10 individual flies was determined. The 
error bars indicate standard deviations.  
 
Genotypes: 
 
A y w/w; UAS-lacZ-IR(1-1)/sca-GAL4 
A' y w/Y; UAS-lacZ-IR(1-1)/sca-GAL4 
B y w/w; UAS-dmax-IR(2-7)/sca-GAL4 
B' y w/Y; UAS-dmax-IR(2-7)/sca-GAL4 
C y w/w; UAS-dmax-IR(2-7)/sca-GAL4; UAS-dmax-IR(5-2) UAS-dmax-IR(6-1)/+ 
C' y w/Y; UAS-dmax-IR(2-7)/sca-GAL4; UAS-dmax-IR(5-2) UAS-dmax-IR(6-1)/+ 
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Figure 8 
Expression of dmax dsRNA under control of dpp-GAL4 strongly reduces the size of the anterior and 
posterior scutellar bristles. For every genotype, the area of both anterior and posterior scutellar bristle 
pairs of 9-11 individual flies was determined. The error bars indicate standard deviations. 
 
Genotypes: 
 
A y w/Y; UAS-lacZ-IR(1-1)/Sp dpp-GAL4 
B y w/Y; UAS-dmax-IR(2-7)/Sp dpp-GAL4; UAS-dmax-IR(5-2) UAS-dmax-IR(6-1)/+ 
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1.7. dmax-RNAi has a only a weak effect on wing area and wing cell size 
Slight discrepancies in the sizes of the dorsal and ventral wing epithelia lead to a bent wing phenotype. 
The overexpression of a gene with the strong, dorsal compartment specific GAL4 driver apterous-
GAL4 (ap-GAL4) therefore is a very sensitive test for growth effects (Montagne et al., 1999). 
Overexpression of dmyc by ap-GAL4 results in larger cell sizes in the dorsal compartment, causing a 
prominent bent down phenotype (P. Gallant, unpublished). Therefore, we expected to see a bent up 
wing phenotype, when dmax levels would be reduced. We were surprised to see that the expression of 
single strong dmax dsRNA transgenes did not cause a noticeable bent wing phenotype (dmax-IR lines 
2-7, 5-2 and 7-3 were tested). We determined the area of the dorsal wing surface and could not find a 
significant difference to the controls (Figure 9, left chart). Since it was imaginable that a putative 
reduction in cell size could be compensated by higher cell number and therefore not result in a smaller 
compartment area, we also determined the dorsal wing cell size. It turned out that there was also no 
significant difference in dorsal wing cell size (Figure 9, right chart).  
Only when we expressed three copies of the dmax dsRNA transgenes, a bent up wing phenotype 
resulted (Figure 10). Since the system is extremely sensitive, this bent up wing phenotype might be 
caused by an only very slight growth phenotype. However, the effect (bent up wings) is opposite to the 
effect of dmyc overexpression, consistent with dMax's presumed role as a dMyc partner. 
30
 Figure 9 
Expression of dmax-dsRNA with single copy inverted repeat transgenes under control of ap-GAL4 
does not significantly reduce dorsal wing blade surface and dorsal wing cell size. Values are given 
relative to the A genotype. For every genotype, 6 wings were measured. The error bars indicate 
standard deviations. 
 
0
0.2
0.4
0.6
0.8
1
1.2
A B C D
do
rs
al
 w
in
g 
bl
ad
e 
su
rf
ac
e
 
0
0.2
0.4
0.6
0.8
1
1.2
A B C D
do
rs
al
 w
in
g 
ce
ll 
si
ze
 
Genotypes: 
A y w/Y; ap-GAL4/+ 
B y w/Y; ap-GAL4/UAS-lacZ-IR(3-1) 
C y w/Y; ap-GAL4/UAS-dmax-IR(7-3) 
D y w/Y; ap-GAL4/+; UAS-dmax-IR(5-2)/+ 
 
 
 
Figure 10 
Expression of three copies of dmax dsRNA with ap-GAL causes a weak bent up wing phenotype. 
 
Genotypes: 
A y w; ap-GAL4/UAS-lacZ-IR(1-1) 
B y w; ap-GAL4/UAS-dmax-IR(2-7); UAS-dmax-IR(5-2) UAS-dmax-IR(6-1)/+ 
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1.8. Genetic interactions 
Strong, ubiquitous expression of dmax dsRNA with the GAL4 drivers actin-GAL4 and daughterless-
GAL4 creates a sensitized situation in which small changes in dmax levels lead to a remarkable 
increase in lethality. The viability of flies which express dmax dsRNA with actin-GAL4 or 
daughterless-GAL4 was variable from experiment to experiment, ranging from complete viability 
(Figure 1) to moderately reduced viability, especially in males (Figure 11). However, the combination 
of two or three dmax dsRNA transgenes invariably led almost complete pupal lethality, as did the 
expression of single strong dmax dsRNA transgenes in a Df(3L)fz2/+ background. We concluded that 
this effect was specific for dmax, since it could be rescued by the coexpression of a UAS-dmax 
transgene (Figure 3). We decided to use this sensitive system to study genetic interactions.   
 
1.8.1. dmax-RNAi interacts with hemizygous dmP0 
We tested the effect of reducing dmax levels in the hypomorphic dmyc mutant dmP0. dmP0 flies are 
viable, but they are smaller than wild type flies, they have a thin bristle phenotype and females are 
sterile (Johnston et al., 1999). Expression of dmax dsRNA under control of the ubiquitous driver da-
GAL4 led to strong pupal lethality in males which are hemizygous for the hypomorphic dmyc allele 
dmP0 (Figure 11), whereas it had no effect on females which were heterozygous for the mutant allele. 
The observed synthetic lethality did not occur in dmP0 males that carried a tub-FRT-dmyc-FRT-GAL4 
(tub>dmyc>GAL4) transgene. The tub>dmyc>GAL4 transgene expresses dmyc under control of the 
tubulin enhancer and is capable of rescuing dmyc null flies to adulthood (Pierce et al., 2004). Notably, 
dmP0 males carrying the rescue construct and expressing dmax dsRNA survived better than y w males 
expressing dmax dsRNA.  
In combination with the demonstrated physical interaction between dMyc and dMax (Gallant et al., 
1996) and the similarity of the dmax loss of function phenotypes to known dmyc loss of function 
phenotypes, these data strongly argue that dMax is an essential co-factor for dMyc.  
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Figure 11 
Interaction with dmP0. The chart depicts the viability of the given genotypes. Whereas heterozygosity 
for the hypomorphic dmP0 allele in females had no effect on viability, when dmax dsRNA was 
expressed (A, B, C), homozygosity for dmP0 in males led to strong pupal lethality (F). The lethality 
could be rescued by the presence of a tub-dmyc transgene. In this experiment, the expression of dmax 
dsRNA in males led to a decrease in viability already in a y w background (D). The indicated 
viabilities were calculated relative to the offspring numbers of sister genotypes of the same cross (e. g. 
in A as the ratio of y w/y w; UAS-dmax-IR(2-7)/+; da-GAL4/+ relative to y w/y w; CyO/+; da-
GAL4/+). For a more detailed explanation of the viability calculations, see Materials and Methods. 
 
Label:  Genotypes: 
 
A  y w/y w; UAS-dmax-IR(2-7)/+; da-GAL4/+ 
B  dmP0 tub>dmyc[y+]>GAL4/y w; UAS-dmax-IR(2-7)/+; da-GAL4/+ 
C  dmP0/y w; UAS-dmax-IR(2-7)/+; da-GAL4/+ 
D  y w/Y; UAS-dmax-IR(2-7)/+; da-GAL4/+ 
E  dmP0 tub>dmyc[y+]>GAL4/Y; UAS-dmax-IR(2-7)/+; da-GAL4/+ 
F  dmP0/Y; UAS-dmax-IR(2-7)/+; da-GAL4/+ 
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1.8.2. dmax-RNAi interacts with reptin and pontin 
Since it has been shown that the transcriptional co-activators Tip48/reptin and Tip49/pontin interact 
with dmyc (Bellosta et al., 2005), we tested whether we would see synthetic lethality with dmax RNAi. 
We could indeed show strong dominant interactions with both reptin and pontin. Both reptin/+ and 
pontin/+ flies are fully viable (Bellosta et al., 2005). Figure 12 shows that expression of dmax dsRNA 
led to a strong reduction of viability in a reptin/+ background and to complete pupal lethality in a 
pontin/+ background. While this data is consistent with Max's role as a cofactor for Myc, the strength 
of the observed interaction is surprising: The loss of one copy of pontin in a dmax-RNAi situation 
leads to a stronger reduction in viability than the combination of dmP0 and dmax-RNAi, even though 
dmyc levels in dmP0 flies are more strongly reduced than pontin levels. Similarly, the loss of reptin 
leads to a strong reduction in viability in the combination with dmax-RNAi, while it does not affect the 
viability of dmP0 flies (Bellosta et al., 2005). 
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Figure 12 
Interaction with reptin and pontin. In all five genotypes, dmax dsRNA was expressed with actin-
GAL4. Whereas this led to only slightly reduced viability when one copy of the dmax dsRNA 
transgene was expressed (A), expression of three copies led to almost complete pupal lethality (B). 
One copy of dmax dsRNA led to almost complete pupal lethality if expressed in a Df(3L)fz2/+ 
background (C). Heterozygosity for reptin reduced lethality to less than 20% (D), whereas 
heterozygosity for pontin led to complete pupal lethality. The indicated viabilities were calculated 
relative to the offspring numbers of sister genotypes of the same cross. For a more detailed 
explanation of the viability calculations, see Materials and Methods. 
 
Label:  Genotypes: 
 
A  y w; UAS-dmax-IR(2-7)/actin-GAL4 
B  y w; UAS-dmax-IR(2-7)/actin-GAL4; UAS-dmax-IR(5-2) UAS-dmax-IR(6-1)/+ 
C  y w; UAS-dmax-IR(2-7)/actin-GAL4; Df(3L)fz2/+ 
D  y w; UAS-dmax-IR(2-7)/actin-GAL4; reptin/+ 
E  y w; UAS-dmax-IR(2-7)/actin-GAL4; pontin/+ 
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1.9. dmax-RNAi in the presence of overexpressed dmyc 
 
1.9.1. Evidence for dmax-independent functions of dmyc 
Expression of dmax dsRNA with the eye-specific GAL4 driver GMR-GAL4 did not alter ommatidial 
size and overall eye morphology in a wild type background (Figure 13 A, D and Figure 14 A, D). 
However, it had a surprising effect on eyes in which dmyc was strongly overexpressed. The analysis of 
this effect has led us to the conclusion that dmyc has functions that do not require dmax. 
Overexpression of one copy of UAS-dmyc by GMR-GAL4 increased ommatidial size by more than 
20% but did neither disrupt the regular arrangement of the ommatidia (Figure 14 A, B) nor did it alter 
eye pigmentation. If a higher dosis of dmyc was expressed using three copies of UAS-dmyc, 
ommatidial size was not further increased, but the regular pattern of ommatidia was disrupted, 
resulting in a rough eye phenotype. Additionally, a pigmentation defect occurred: even though the eye 
color should be a wild type red (having four white+-marked transgenes present, one of which - GMR-
GAL4 - causes very dark eyes on its own), the eyes were of an orange color, with interspersed red dots 
(Figures 13 B, 14 C). When the dmyc dosis is further increased by expressing the three transgenes at a 
higher temperatures than 25° C, the roughness of the eyes (the irregularity of the ommatidial pattern) 
is also increased and the total eye size is reduced (Figure 13 G, H), presumably due to apoptosis 
associated with the overexpression of dmyc in the eye (L. Montero and P. Gallant, unpublished). 
We had expected that a reduction of dmax levels in this system would cause a reversion of the 
observed phenotypes, but instead we found the following: when one copy of UAS-dmyc was 
overexpressed, coexpression of dmax dsRNA did cause a partial reversion of ommatidial size (Figure 
14 B, E). Strikingly, when dmax dsRNA was coexpressed with three copies of UAS-dmyc, the 
ommatidial size was reverted to wild type levels, but roughness was strongly increased and the overall 
eye shape was changed (the eyes appeared narrower than wild type eyes or eyes in which dmyc was 
overexpressed), giving rise to an eye phenotype that was clearly more remote from wild type eyes than 
the one of eyes in which three copies of UAS-dmyc were overexpressed (Figure 13 B, E, C, F, Figure 
14 C, F). dmax-RNAi did also not suppress the pigmentation defect associated with strong 
overexpression of dmyc. We concluded that there must exist functions of dmyc which cause the 
observed roughness and the pigmentation defect and, importantly, that these functions do not require 
dmax. On the contrary, it seemed possible that these functions become stronger, when dmax was 
removed, since the roughness increased. 
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Figure 13a 
Dissecting microscope pictures, showing the effect of dmax-RNAi in the presence of overexpressed 
dmyc. Whereas dmax-RNAi driven by GMR-GAL4 has no effect on its own (A, D), it strongly 
modifies a phenotype caused by the overexpression of three copies of dmyc (B and C, E and F), 
reducing ommatidia size, strongly increasing roughness, but not rescuing the pigmentation phenotype 
associated with the overexpression of three copies of dmyc.  
 
Label:  Genotypes: 
 
A  y w/Y; GMR-GAL4/CyO 
B, C  y w/Y; GMR-GAL4 UAS-dmyc132/CyO; UAS-dmyc13 UAS-dmyc42/+ 
D  y w/Y; GMR-GAL4/UAS-dmax-IR(7-3) 
E, F  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(7-3); UAS-dmyc13 UAS-dmyc42/+ 
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Figure 13b 
Further increase of dmyc levels by overexpression of three copies of UAS-dmyc at a temperature of 29° 
C does not further increase eye size. Instead, the eye becomes rougher and narrower, while overall eye 
size is reduced. The resulting eye phenotype is similar to the phenotype produced by co-
overexpression of dmax dsRNA. 
 
Label:  Genotypes: 
 
G  y w/Y; GMR-GAL4 UAS-dmyc132/CyO; UAS-dmyc13 UAS-dmyc42/+ 25° C 
H  y w/Y; GMR-GAL4 UAS-dmyc132/CyO; UAS-dmyc13 UAS-dmyc42/+ 29° C 
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Figure 14a 
Silencing of dmax has no consequences in a wild type situation (D), partially reduces ommatidia size 
when one copy of UAS-dmyc expressed (E), but strongly decreases ommatidia size and increases 
roughness, when 3 copies of UAS-dmyc are expressed. The pictures are scanning electron micrographs 
obtained at a magnification of 180-fold. 
 
Label:  Genotypes: 
 
A  y w/Y; GMR-GAL4 
B  y w/Y; GMR-GAL4 UAS-dmyc132/CyO, y+ 
C  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
D  y w/Y; GMR-GAL4/UAS-dmax-IR(2-7) 
E  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7) 
F  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/+ 
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Figure 14b 
Ommatidial size (relative to the y w/Y; GMR-GAL4/+ genotype). The labels correspond to Figure 14a. 
For every genotype, the size of 20 centrally located ommatidia of 6 individual eyes was determined. 
The error bars indicate standard deviations. 
 
Label:  Genotypes: 
 
A  y w/Y; GMR-GAL4 
B  y w/Y; GMR-GAL4 UAS-dmyc132/CyO, y+ 
C  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
D  y w/Y; GMR-GAL4/UAS-dmax-IR(2-7) 
E  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7) 
F  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/+ 
     A      B    C     D    E  F 
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Figure 14c 
Strong overexpression of UAS-dmyc causes a pigmentation defect that cannot be suppressed by 
concomitant expression of dmax dsRNA. Labels according to Figure 14a. 
 
Label:  Genotypes: 
 
A  y w/Y; GMR-GAL4 
B  y w/Y; GMR-GAL4 UAS-dmyc132/CyO, y+ 
C  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
D  y w/Y; GMR-GAL4/UAS-dmax-IR(2-7) 
E  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7) 
F  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/+ 
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1.9.2. Specificity of the observed interaction 
In order to demonstrate that part of the observed interaction of dmax dsRNA with overexpressed dmyc 
is not caused by an unspecific titration effect of the UAS-dmax-IR transgene on GAL4, we 
coexpressed a neutral UAS-GFP transgene (Figure 15 A-D, A'-D'). Neither did this modify the eye 
phenotype caused by expression of three copies of UAS-dmyc, nor did it weaken or alter the 
interaction with dmax-RNAi. Hence there is no evidence for limiting GAL4 levels or for titration 
effects. Consistently, coexpression of a lacZ dsRNA transgene did not modify the phenotype caused 
by overexpression of three copies of UAS-dmyc (data not shown).  
Furthermore, we could show that heterozygosity for Df(3L)fz2 or dmax1 had a similar, but slightly 
weaker effect than dmax-RNAi: while being neutral in a GMR-GAL4 background, ommatidial size 
was reduced, but roughness increased in GMR-GAL4 3x UAS-dmyc eyes (Figure 15 E, F, E', F'). The 
described interaction is therefore  a specific consequence of reduced dmax levels and not an unspecific 
consequence of dmax-RNAi. 
 
1.9.3. Contribution of apoptosis 
Because it was known that overexpression of dmyc causes apoptosis (L. Montero and P. Gallant, 
unpublished), we suspected that the roughness and the pigmentation defect which was caused by the 
overexpression of three copies of UAS-dmyc and which could not be suppressed by coexpression of 
dmax dsRNA were due to apoptosis. Therefore, we blocked apoptosis by coexpression of the pan-
caspase inhibitor p35.  
Expression of UAS-p35 slightly increased the ommatidial size on its own without causing a rough eye 
phenotype (Figure 16ab A, B). Strikingly, inhibiting apoptosis while three copies of UAS-dmyc were 
expressed led to a strong increase in ommatidial size and to a partial suppression of the rough eye 
phenotype (Figure 16ab A', B', Figure 16d B). Additionally, the pigmentation defect caused by the 
strong overexpression of dmyc was completely rescued (Figure 16c A', B'). These findings prove that 
apoptosis caused by the strong overexpression of dmyc contributes to the rough eye phenotype and 
causes the observed pigmentation defect (presumably due to the loss of pigment cells) and they also 
explain why the expression of three UAS-dmyc transgenes does not further increase ommatidial size 
than the expression of only one UAS-dmyc transgene.  
Importantly, the strong increase in roughness that was caused by the reduction of dmax levels in the 
dmyc overexpression background, could be rescued by the coexpression of UAS-p35 (Figure 16ab C', 
D', Figure 16d B', C'). Similarly, the pigmentation defect (Figure 16c C', D') was rescued, resulting in 
eyes that were overall nearest to wild type eyes. In accordance with these findings, eye sections 
showed that the overexpression of dmyc causes a loss of ommatidial organization and of pigment cells 
which could not be rescued by dmax-RNAi, but to a large extent by coexpression of UAS-p35 (Figure 
16e). 
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Taken together with the data shown in the Figures 13 and 14, these findings provide evidence that part 
of the effects caused by dmyc are caused by functions of dmyc which do not require dmax. These 
functions are associated with apoptosis. When dmax levels are lowered, dmax-dependent growth is 
reduced, but the consequences of dmax-independent functions are exacerbated. 
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Figure 15a 
The effects of the expression of dmax dsRNA on the dmyc overexpression phenotype (decreased 
ommatidia size, increased roughness) are specific, since the same changes occur, if dmyc is 
overexpressed in Df(3L)fz2/+ or dmax1/+ backgrounds. Moreover, titration effects can be excluded, 
since the co-overexpression of UAS-GFP has no influence. 
 
Label:  Genotypes: 
 
A  y w/Y; GMR-GAL4/+ 
B  y w/Y; GMR-GAL4/+; UAS-GFP/+ 
C  y w/Y; GMR-GAL4/UAS-dmax-IR(2-7) 
D  y w/Y; GMR-GAL4/UAS-dmax-IR(2-7); UAS-GFP/+ 
E  y w/Y; GMR-GAL4/+; dmax1/+ 
F  y w/Y; GMR-GAL4/+; Df(3L)fz2/+ 
A'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
B'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/UAS-GFP 
C'  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/+ 
D'  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/UAS-
  GFP 
E'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/dmax1 
F'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/Df(3L)fz2 
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Figure 15b 
Ommatidial size (relative to the y w/Y; GMR-GAL4/+ genotype). The labels correspond to Figure 15a. 
The genotypes are grouped in pairs: light grey bars belong to genotypes with wild type (endogenous) 
dmyc, dark grey bars belong to the corresponding dmyc overexpression genotypes. For every 
genotype, the size of 20 centrally located ommatidia of 6 individual eyes was determined. The error 
bars indicate standard deviations. 
 
Label:  Genotypes: 
 
A  y w/Y; GMR-GAL4/+ 
B  y w/Y; GMR-GAL4/+; UAS-GFP/+ 
C  y w/Y; GMR-GAL4/UAS-dmax-IR(2-7) 
D  y w/Y; GMR-GAL4/UAS-dmax-IR(2-7); UAS-GFP/+ 
E  y w/Y; GMR-GAL4/+; dmax1/+ 
F  y w/Y; GMR-GAL4/+; Df(3L)fz2/+ 
A'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
B'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/UAS-GFP 
C'  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/+ 
D'  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/UAS-
  GFP 
E'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/dmax1 
F'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/Df(3L)fz2 
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Figure 16a 
Overexpression of three copies of UAS-dmyc causes apoptosis: suppression of apoptosis by UAS-p35 
further increases ommatidia size (A', B'). Strikingly, the increased roughness by co-overexpression of 
dmax dsRNA is suppressed by UAS-p35.  
 
Label:  Genotypes: 
 
A  y w/Y; GMR-GAL4/+ 
B  y w/Y; GMR-GAL4/+; UAS-p35/+ 
C  y w/Y; GMR-GAL4/UAS-dmax-IR(2-7) 
D  y w/Y; GMR-GAL4/UAS-dmax-IR(2-7); UAS-p35/+ 
A'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
B'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/UAS-p35 
C'  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/+ 
D'  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/UAS-
  p35 
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Figure 16b 
Ommatidial size (relative to the y w/Y; GMR-GAL4/+ genotype). The labels correspond to Figure 16a. 
For every genotype, the size of 20 centrally located ommatidia of 6 individual eyes was determined. 
The error bars indicate standard deviations. 
 
Label:  Genotypes: 
 
A  y w/Y; GMR-GAL4/+ 
B  y w/Y; GMR-GAL4/+; UAS-p35/+ 
C  y w/Y; GMR-GAL4/UAS-dmax-IR(2-7) 
D  y w/Y; GMR-GAL4/UAS-dmax-IR(2-7); UAS-p35/+ 
A'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
B'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/UAS-p35 
C'  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/+ 
D'  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/UAS-
  p35 
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Figure 16c 
Overexpression of UAS-p35 rescues the pigmentation defect which is associated with the 
overexpression of three copies of dmyc and which could not be suppressed by dmax-RNAi. The labels 
correspond to Figure 16a. 
 
Label:  Genotypes: 
 
A  y w/Y; GMR-GAL4/+ 
B  y w/Y; GMR-GAL4/+; UAS-p35/+ 
C  y w/Y; GMR-GAL4/UAS-dmax-IR(2-7) 
D  y w/Y; GMR-GAL4/UAS-dmax-IR(2-7); UAS-p35/+ 
A'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
B'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/UAS-p35 
C'  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/+ 
D'  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/UAS-
  p35 
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Figure 16d 
Rescue of the strong rough eye phenotype resulting of the co-overexpression of dmax dsRNA by UAS-
p35, documented with autofluorescence microscopy.  
 
Label:  Genotypes: 
 
A  y w/Y; GMR-GAL4/+ 
B  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
C  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/UAS-p35 
A'  y w/Y; GMR-GAL4/UAS-dmax-IR(2-7) 
B'  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/+ 
C'  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/UAS-
  p35 
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Figure 16e 
Sections through adult eyes reveal a rescue of ommatidial structure (especially of pigment cell 
arrangement) by UAS-p35. 
 
Label:  Genotypes: 
 
A  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
B  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/+ 
C  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/UAS-p35 
D  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/UAS-
  p35 
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1.9.4. Contribution of dmnt 
So far, our interpretation of the dmyc overexpression eye phenotype and the surprising phenotype 
resulting from downregulation of dmax in this context has not taken into consideration a contribution 
of dmnt. One could argue that in a situation of strong overexpression of dmyc, loss of dMnt/dMax 
heterodimers causes the observed rough eye phenotype. We therefore tested the effects of the 
overexpression of three copies of UAS-dmyc and of the coexpression of dmax dsRNA in a dmnt null 
background. For this purpose, flies mutant for dmnt1, a null mutant, and for dmnt2, potentially 
expressing a form of dmnt that lacks the Sin3-interaction domain (SID) interaction domain (Loo et al., 
2005), were used. dmnt2 behaves like a null mutant (Loo et al., 2005). dmnt mutant flies have smooth 
eyes, but an increased ommatidial size (Figure 17ab A, B, C). When three UAS-dmyc transgenes were 
expressed, the resulting eyes were very similar to the ones resulting from overexpression of dmyc in a 
dmnt+ background, showing increased ommatidial size, roughness and a prominent pigmentation 
defect. Downregulation of dmax in this context had the same effect as in a dmnt+ background: it 
decreased the ommatidial size, increased the roughness, but did not rescue the pigmentation defect 
(Figure 17 D'). We therefore concluded that the effects seen with the overexpression of dmyc and the 
interaction with dmax-RNAi are independent of a loss of endogenous dmnt. 
On the other hand, one could argue that in a situation of strong overexpression of dmyc, dMax is 
sequestered away from dMnt. One could then hypothesize that dmax-independent functions of dmnt 
cause the rough eye phenotype. We tested this hypothesis by expressing different dmnt transgenes 
(Figure 18). When a version of dmnt was overexpressed that lacks the leucine zipper (dmnt[dZIP]) but 
retains the SID interaction domain (which is essential to dMnt's binding to the SIN3 corepressor and 
thus for dMnt's function (Loo et al., 2005)), the phenotype of wild type eyes and the one caused by the 
expression of three copies of UAS-dmyc was not changed (Figure 18 A, A', C, C'). We therefore 
consider it unlikely that the dmyc overexpression rough eye phenotype is caused by dmax-independent 
functions of dmnt. Conversely, we could phenocopy the effects of dmax-RNAi by expressing 
dmnt[dSID], a form of dmnt lacking the SID interaction motif but retaining the leucine zipper and 
therefore retaining it's ability to bind dMax (Figure 18 D, D'). Therefore, the effects described so far 
clearly are a consequence of the overexpression of dmyc and of the availability of dMax to dMyc. If 
dMax levels are lowered or dMax is titrated away from dMyc, dmax- dependent growth functions of 
dmyc are impaired, but not other functions that are associated with apoptosis. Expression of a wild 
type dmnt transgene did not cause a rough eye phenotype on its own, but it reduced the ommatidial 
size by slightly more than 10%. When it was coexpressed with three copies of UAS-dmyc, a very 
strong rough eye phenotype arose (considerably stronger than the rough eye phenotype seen in context 
with dmax-RNAi or dmnt[dSID]). This finding may be explained by the combined effect of enhanced 
dMnt-dMax-mediated repression, loss of dmax-dependent functions of dmyc and impaired (or 
unbalanced) dmax-independent functions of dmyc. 
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Figure 17a 
Removal of dmnt does not alter the phenotype associated with strong overexpression of dmyc. Also in 
a dmnt null background, expression of dmax dsRNA causes increased roughness.  
 
Label:  Genotypes: 
 
A  w dmntRev/Y; GMR-GAL4/+ 
B  w dmnt1/Y; GMR-GAL4/+ 
C  w dmnt2/Y; GMR-GAL4/+ 
A'  w dmntRev/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
B'  w dmnt1/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
C'  w dmnt2/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
D'  w dmnt1/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/+ 
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Figure 17b 
Ommatidial size (relative to the y w/Y; GMR-GAL4/+ genotype). The labels correspond to Figure 17a. 
For every genotype, the size of 20 centrally located ommatidia of 6 individual eyes was determined. 
The error bars indicate standard deviations. 
 
Label:  Genotypes: 
 
R  y w/Y; GMR-GAL4/+ 
A  w dmntRev/Y; GMR-GAL4/+ 
B  w dmnt1/Y; GMR-GAL4/+ 
C  w dmnt2/Y; GMR-GAL4/+ 
R'  y w /Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
A'  w dmntRev/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
B'  w dmnt1/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
C'  w dmnt2/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
D'  w dmnt1/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/+ 
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Figure 17c 
The pigmentation defect that is caused by the overexpression of three copies of UAS-dmyc is also 
present in absence of dmnt, and it cannot be rescued by downregulation of dmax. 
 
Label:  Genotypes: 
 
A  w dmntRev/Y; GMR-GAL4/+ 
B  w dmnt1/Y; GMR-GAL4/+ 
C  w dmnt2/Y; GMR-GAL4/+ 
A'  w dmntRev/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
B'  w dmnt1/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
C'  w dmnt2/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
D'  w dmnt1/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/+ 
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Figure 18a 
Titration of dmax by overexpression of UAS-dmnt[dSID], but not UAS-dmnt[dZIP] has the same 
effect as overexpression of dmax dsRNA. 
 
Label:  Genotypes: 
 
A  y w/Y; GMR-GAL4/+ 
B  y w/Y; GMR-GAL4/UAS-dmax-IR(2-7) 
C  y w/Y; GMR-GAL4/+; UAS-dmntBM10-7[dZIP]/+ 
D  y w/Y; GMR-GAL4/+; UAS-dmntN7-4R[dSID]/+ 
E  y w/Y; GMR-GAL4/+; UAS-dmntT2-33[+]/+ 
A'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
B'  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/+ 
C'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/UAS-dmntBM10-7[dZIP] 
D'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/UAS-dmntN7-4R[dSID] 
E'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/UAS-dmntT2-33[+] 
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Figure 18b 
Ommatidial size (relative to the y w/Y; GMR-GAL4/+ genotype). The labels correspond to Figure 18a. 
For every genotype, the size of 20 centrally located ommatidia of 6 individual eyes was determined. 
The error bars indicate standard deviations. 
 
Label:  Genotypes: 
 
A  y w/Y; GMR-GAL4/+ 
B  y w/Y; GMR-GAL4/UAS-dmax-IR(2-7) 
C  y w/Y; GMR-GAL4/+; UAS-dmntBM10-7[dZIP]/+ 
D  y w/Y; GMR-GAL4/+; UAS-dmntN7-4R[dSID]/+ 
E  y w/Y; GMR-GAL4/+; UAS-dmntT2-33[+]/+ 
A'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/+ 
B'  y w/Y; GMR-GAL4 UAS-dmyc132/UAS-dmax-IR(2-7); UAS-dmyc13 UAS-dmyc42/+ 
C'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/UAS-dmntBM10-7[dZIP] 
D'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/UAS-dmntN7-4R[dSID] 
E'  y w/Y; GMR-GAL4 UAS-dmyc132/+; UAS-dmyc13 UAS-dmyc42/UAS-dmntT2-33[+] 
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2. dmax null mutant 
 
So far we have shown that flies, in which dmax levels were reduced by the expression of dmax 
dsRNA, have phenotypes that are in some ways similar to the phenotypes of flies which carry 
hypomorphic alleles of dmyc, such as reduced body weight and thin bristles. These findings met our 
expectations, since it had been shown previously that Max is an essential cofactor of Myc (Blackwood 
and Eisenman, 1991; Amati et al., 1992; Blackwood et al., 1992; Amati et al., 1993a; Amati et al., 
1993b). However, our surprising finding that dmax-RNAi did not suppress the phenotype caused by 
strong dmyc overexpression in the eye but rather increased aspects of the overexpression phenotype 
has led us to the conclusion that a part of the functions of dmyc do not require dmax. It was clear that a 
rigid analysis of the requirement of dmax for dmyc functions is difficult with RNAi, since it was only 
possible to strongly diminish dmax levels, but not to completely abolish dmax function. To continue 
our analysis, we therefore felt that is was crucial to obtain a dmax null mutant. 
 
2.1. Generation of a dmax null mutant by imprecise excision of a P element 
Besides the advantages a GAL4-inducible system provides, one of the main reasons to use an 
inducible RNAi system to study dmax was the lack of P elements in the dmax locus. When the new P 
element insertion P{y+ w+}CG9666EY02775 became available, we decided to use this insertion to 
generate dmax mutants. y w; P{y+ w+}CG9666EY02775 is inserted 472 bp upstream of the start of the 
dmax transcript, in the 3' end of the second exon of CG9666. We mobilized the P element using the 
Δ2-3 P element transposase and collected flies that had lost the w+ marker, indicating that the P 
element had been mobilized and lost from the genome. Since we had shown that downregulation of 
dmax transcript levels by dmax RNAi leads to pupal lethality, we expected to see pupal or earlier 
lethality with strong hypomorphic dmax alleles or with a dmax null allele. It was therefore possible to 
select for imprecise excision events that would cause deletions in the dmax locus by directly crossing 
collected y- w- flies to flies harboring Df(3L)fz2 and selecting for lack of viability. For a detailed 
crossing scheme of the imprecise excision screen, see Material and Methods.  
Out of 180 tested Pmut[y- w-] chromosomes, we identified 5 Pmut[y- w-] third chromosomes which caused 
lethality in conjunction with Df(3L)fz2. We established stable lines carrying these alleles and 
subsequently examined these alleles by PCR. To this end, we used a primer annealing to the 3' end of 
the dmax transcript and a second primer annealing directly upstream (relative to dmax) of the EY02775 
insertion site. These primers amplify a 2.1 kb fragment on a wild type 3rd chromosome. In the case of 
imprecise excision events that would cause asymmetrical deletions stretching from the EY02775 
insertion position into dmax, we expected to see smaller fragments. In two of the five lines, we could 
indeed produce smaller fragments. These fragments were then sequenced, revealing two asymmetrical 
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deletions. The two deletion alleles were termed dmax1 and dmax2. Figure 19 shows the dmax locus, the 
location of the EY02775 insertion and the dmax1 and dmax2 deletions. The exact breakpoints in the 
two alleles are indicated in Materials and Methods.  
In dmax2, a 550 bp deletion has been created that deletes most of the first exon of the dmax transcript, 
ending 27 bp upstream of the start of the dmax ORF. Flies homozygous for dmax2 die as pharate 
imagines. We assumed that dmax2 represents a strong hypomorphic allele of dmax, or possibly a null 
allele, but we did not further study the allele, since we had generated a molecular null allele with 
dmax1. 
The 1.8 kb deletion found in dmax1 starts precisely at the position where EY02775 had been inserted, 
and it stretches into the last exon of dmax, deleting the whole dmax coding region and therefore being 
a molecular null allele of dmax. We subsequently concentrated on the analysis of dmax1. 
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Figure 19 
dmax alleles generated in the imprecise excision screen. The diagram shows the dmax and the CG9666 
gene. Arrows indicate the start of transcription of dmax  and CG9666. Grey boxes indicate transcribed 
sequence, blue boxes indicate coding (translated) sequence. The red triangle shows the position of the 
EY02775 P element insertion. Indicated are the two deletions generated in the imprecise excision 
screen, labeled dmax1 and dmax2.  
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2.2. Characterization of the dmax1 phenotype 
 
2.2.1. Growth and developmental timing of dmax1 flies 
Based on the selection procedure in the imprecise excision screen, it was clear that flies of a 
dmax1/Df(3L)fz2 do not reach the adult stage. We therefore expected that dmax1/dmax1 flies would die 
prior to eclosion. In order to study the phenotype of dmax1 in larvae or pupae, we constructed stable 
lines in which the dmax1 chromosome was put over balancers that were marked by Tb, y+ or by the 
constitutive overexpression of GFP. We then used these lines to study the development of flies that 
were homozygous for dmax1.   
 
2.2.2. dmax1 larvae hatch in normal proportions 
The loss of dmax did not lead to lethality in the embryonal stage, and dmax1 larvae hatch in Mendelian 
proportions, as shown by the following experiment: From a cross of w; dmax1/TM3, Ser GFP flies 
inter se, we collected L1 larvae that had an age of 24-32 h. From the 106 collected larvae, 76 showed 
expression of GFP, whereas 30 scored negative for the expression of GFP. Since homozygosity for 
TM3, Ser GFP leads to embryonic lethality, the GFP-positive larvae had the dmax1/TM3, Ser GFP 
genotype, whereas the GFP-negative larvae were homozygous for dmax1. Based on Mendelian 
inheritance, the number of homozygous dmax1 offspring in the inter se cross is expected to be half the 
number of the dmax1/TM3, Ser GFP offspring, if no lethality occurs. Therefore, the viability of dmax1 
larvae in this cross was high (30 larvae are 78% of the expected 35 larvae). 
 
2.2.3. dmax1 larvae show impaired growth and a developmental delay 
dmax1 larvae grow more slowly than wild type control larvae. At 120 h (5 d) after egg deposition 
(AED), when dmax1/TM3 larvae - which are fully viable and develop normally - had started to 
pupariate, dmax1 homozygous larvae were in the L3 stage, but showed a greatly reduced size (Figure 
20a). At 192 h (8 d) AED, when wild type controls had undergone metamorphosis, the dmax1 L3 
larvae had reached a size slightly smaller than the one of wild type larvae at 120 h AED (Figure 20b). 
The smaller size of the whole larvae correlated with the size of larval polyploid tissues: Figure 20c 
shows fat body and salivary gland cells of dmax1 larvae (at 120 h and at 192 h AED) compared to y w 
control larvae (at 120 h AED). At 192 h AED, dmax1 fat body and salivary gland cell nuclei had 
reached a size slightly smaller than one of y w control cells at 120 h AED.  
Even though the impaired growth of dmax1 larvae becomes apparent already in the first larval stage 
and is clearly visible in the second larval stage, L2-L3 ecdysis is, if at all, only slightly delayed in 
dmax1 larvae: We collected dmax1 larvae that had an age of 54 - 70 h AED. All of these larvae (total 
number: 25) were in L2. Conversely, in a second collection of dmax1 larvae of an age of 80 - 94 h 
AED (total number: 36), all larvae were in the L3 stage. We could therefore define a time window of 
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70 - 80 h AED for the L2-L3 molt in dmax1 larvae. Since the L2-L3 molt occurs at 72 h AED in wild 
type larvae (Ashburner et al., 2005), we concluded that the main developmental delay of dmax1 larvae 
occurs in the third larval stage.  
The viability of dmax1 larvae is only slightly lower than the one of wild type controls. Figure 21 shows 
the percentage of larvae that survived from 48 h AED to 120 h AED (left chart) and from 48 h AED to 
192 h AED (right chart). Thus, the strong developmental delay of dmax1 larvae in L3 is not 
accompanied by elevated lethality. 
 
2.2.4. dmax1 L3 larvae have an abnormal mouth hook phenotype 
The three larval stages of Drosophila can be distinguished by the morphology of the posterior and, 
more easily, of the anterior spiracles, by the number of teeth of the larval mouth hooks and by the 
form of the pharyngeal bars (Ashburner et al., 2005). Based on the morphology of the anterior 
spiracles, the second and the third larval instars of dmax1 larvae could be clearly distinguished. Figure 
22 shows the anterior spiracles of dmax1 L3 larvae (B) compared to ones of dmax1/TM3 heterozygotes 
(A). dmax1 L3 anterior spiracles show the hand-shaped form typical of L3 larvae, albeit at a smaller 
size. However, it proved to be impossible to stage dmax1 larvae based on the mouth hook teeth 
number. Whereas dmax1/TM3 L3 animals had normal-looking mouth hooks with many teeth (Figure 
22 C), all examined dmax1 L3 mouth hooks were found to have no or only few large teeth (Figure 22 
D). The normal number of teeth for L2 wild type larvae is 3, and for L3 wild type larvae is 12 
(Ashburner et al., 2005). Additionally, some of the examined mouth hooks of dmax1 larvae show 
duplicated mouth hook tips. 
61
  
 
Figure 20a 
dmax1 larvae grow more slowly than dmax1/TM3, Ser GFP heterozygotes. At 120 h AED, the 
heterozygote larvae (A) have reached the end of the third larval stage or already have pupated. At this 
time point, dmax1 larvae have all reached L3 stage, but they are much smaller.  
 
Label:  Genotypes: 
 
A  w; dmax1/TM3, Ser GFP 
B  w; dmax1 
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Figure 20b 
dmax1 animals compared to wild type animals at 192 h AED. At this time point, wild type animals 
have nearly completed their pupal development. dmax1 animals are still in the third larval stage, but 
they have reached a size only slightly smaller than the one of wild type late L3 larvae.  
 
Label:  Genotypes: 
 
A  w; dmax1 
B  wt [OreR] 
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Figure 20c 
The sizes of fat body cell nuclei (A, B, C) and salivary gland cell nuclei (A', B', C') of dmax1 larvae 
correlate to the observed total larval sizes at the respective times. The pictures show nuclei stained 
with Hoechst dye and were taken with a 63x objective. Whereas at 5 d AED, dmax1 fat body and 
salivary gland cells (A, A') are clearly smaller than y w control fat body and salivary gland cells (C, 
C'), fat body and salivary gland cells reach almost wild type sizes at 8 d AED (B, B') 
 
 
Label:  Organ:    Time AED:  Genotype 
 
A  fat body cells    120 h AED  w; dmax1 
A'  salivary gland cells  120 h AED  w; dmax1 
B  fat body cells   192 h AED  w; dmax1 
B'  salivary gland cells  192 h AED  w; dmax1 
C  fat body cells   120 h AED  y w 
C'  salivary gland cells  120 h AED  y w 
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The viability of dmax1 animals is only slightly reduced throughout larval development. The graphs 
shows the survival of control OreR and of w; dmax1 animals from the collection of the larvae (at 48 h 
AED) until the indicated time points (120 h and 192 h).  
Indicated is the average percentage of surviving larvae and the standard deviation. For the 120 h 
timepoint, 6 experiments with a total number of 209 animals (A) and 131 animals (B) were performed. 
For the 192 h timepoint, 2 experiments with a total number of 60 animals (A) and 55 animals (B) were 
performed. 
 
 
Label:  Genotypes: 
 
A  wt [OreR] 
B  w; dmax1 
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Figure 22 
Whereas dmax1 L3 larvae show anterior spiracles of wild type morphology (albeit of smaller size) (B), 
their mouth hooks have an aberrant morphology (D): Many mouth hooks have duplicated tips 
(arrowheads). Some mouth hooks show no teeth, whereas others show a strongly reduced number of 
teeth (arrows). In comparison, control animals that are heterozygous for dmax1 show a wild type 
number of teeth and no mouth hook tip duplications. 
 
Label:  Genotypes: 
 
A, C  w; dmax1/TM3, Ser GFP 
B, D  w; dmax1 
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2.2.5. dmax1 larvae pupate and some of them develop into pharate imagines 
dmax1 larvae undergo pupariation between day 8 and day 9 AED, without having attained wild type 
size (Figure 23a, 23b). Besides the reduced size, dmax1 pupae have one feature which distinguishes 
them from wild type pupae: they rarely ever evert the anterior spiracles. Whereas the majority of the 
dmax1 pupae abort metamorphosis and presumably die, a remarkable proportion of the pupae properly 
undergo metamorphosis and develop into late pupae. Figure 23b shows that more than one third of the 
dmax1 pupae developed into pharate adults. The red line in Figure 23b indicates the percentage of 
dmax1 pupae that showed darkened macrochaetae and darkened wings (and overall pharate imaginal 
morphology), markers for late stages of imaginal development. Whereas in wild type pupae these 
events happen between 72 and 86 h post pupariation, dmax1 pupae show the changes in pigmentation 
at 96 h post pupariation and hence are delayed. Even though the resulting dmax1 pharate imagines 
show a wild type morphology (Figure 23c) and movement of the legs, they never eclose. 
 
2.2.6. dmax1 larvae have reduced total RNA levels 
We have shown that dmax1 grow more slowly than wild type control larvae and that they reach the 
pupal stage with a delay of four days (Figures 20, 23). Figure 24 shows that dmax1 larvae also have 
strongly reduced total RNA levels compared to control larvae, both at very early time points of larval 
development (29-39 h AED, Figure 24a) and at 120 h AED (96 h AED for the control) (Figure 24b). 
At the later time point, the difference in total RNA in dmax1 larvae compared to y w larvae roughly 
corresponds to the difference in larval size (Figure 20a). Remarkably, there is as strong a difference in 
total RNA levels already in L1 larvae, when almost no visible growth has occurred and dmax1 larvae 
are very difficult to distinguish from wild type larvae based on total larval size. It has been shown that 
total RNA levels strongly increase already in the first 24 hours after hatching, along with total DNA 
content, whereas protein levels do only marginally increase during that time (Church and Robertson, 
1966). It is therefore conceivable that mutations that have an impact on the accumulation of DNA and 
RNA result in markedly decreased RNA levels at time points when total larval size has not strongly 
increased yet. We furthermore concluded that since the reduction in RNA levels in dmax1 larvae is as 
strong in L1 as it is in L3, it is probable that maternally contributed dmax mRNA or dMax protein do 
not play a role in the larval development of dmax1 animals. 
 
2.2.7. dmax mRNA levels in dmax1 larvae 
In order to confirm that dmax mRNA is absent in dmax1 larvae, we extracted RNA from dmax1 larvae 
at 120 h AED (and control RNA from y w larvae at 96 h AED) and measured dmax mRNA levels with 
qRTPCR. A qRTPCR assay specific for actin5C served as a reference. The resulting transcript levels 
using a dmax-specific primer pair were below 4% compared to the y w control (Figure 25a). We 
analyzed the PCR products generated with the dmax-specific primers using agarose gel electrophoresis 
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and could show that on dmax1 cDNA, the PCR had not resulted in the amplification of the specific 
dmax amplicon, but rather yielded a smear of unspecific bands. Therefore, dmax1 mRNA levels must 
be well below the calculated 4% that resulted from the total amount of amplified DNA in the assay. 
We concluded that dmax mRNA levels in 120 h old dmax1 larvae are below the detection threshold of 
a qRTPCR assay. Similar results were also obtained with primer pairs specific for dmyc and dmnt that 
had been shown to work well in qRTPCR assays, but yielded unspecific amplification products in 
dmyc null and dmnt null mutants, respectively (data not shown). 
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Figure 23a 
dmax1 larvae (B) reach the pupal stage at day 9 AED, without having attained a wild type body size. 
At this time point, y w control larvae are about to eclose. Some dmax1 pupae show signs of defective 
development. However, some of the dmax1 pupae will continue development and develop into late, 
pharate adults (see Figure 23b, 23c). dmax1 pupae almost never show everted anterior spiracles. 
 
Label:  Genotypes: 
 
A  y w 
B  y w; dmax1 
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 Figure 23b 
Development of dmax1 pupae. Depicted are the time courses of puparium formation (blue line) and of 
the emergence of late, pharate adults (red line). In this experiment, 26 dmax1 larvae were collected at 
120 h AED. All of the dmax1 larvae pupated within days 8 and 10. More than one third of the pupae 
continued in development and reached a pharate stage (red line) within days 12 and 13.  
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Figure 23c 
dmax1 pupae develop into perfectly formed pharate imagines. The picture shows imagines that were 
taken out of their pupal cases. dmax1 animals are smaller than controls, and they have thin bristles.  
 
Label:  Genotypes: 
 
A  y w; dmax1/TM3, Ser y+ 
B  y w; dmax1  
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Figure 24a 
dmax1 L1 larvae show strongly decreased total RNA levels compared to y w larvae. Two RNA 
extractions from 20 larvae were performed per genotype. The chart shows average total RNA amounts 
per larva and the standard deviation. 
 
Label:  Genotypes: 
 
A  w; dmax1 
B  y w 
 
A: 120 h AED   B: 96 h AED
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
A B
ug
 to
ta
l R
N
A
 p
er
 la
rv
a
  
Figure 24b 
Total RNA levels of dmax1 larvae at 120 h AED, compared to the total RNA levels of y w larvae at 96 
h AED. A shows the average total RNA amount per larva from 5 RNA extractions (20 larvae per 
extraction) and the standard deviations. B shows the average total RNA amount per larva from 8 RNA 
extractions (12 larvae per extraction) and the standard deviation. 
 
Label:  Genotypes: 
 
A  y w/Y, y+; dmax1 
B  y w 
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Figure 25a 
Relative transcript levels in y w; dmax1 larvae (120 h AED) (B1, B2) compared to y w larvae (96 h 
AED) (A1, A2), measured in a qRTPCR assay with a dmax specific primer pair (dmax_ex2_ex3 
primers). The transcript levels were normalized to a actin5C reference and the relative transcript level 
of A1 was arbitrarily set to 100%. Two cDNA preparations originating from two independent RNA 
extractions were used per genotype (A1, A2, B1, B2), and for each cDNA, 3 PCR reactions were 
performed. The standard deviations arising from the 3 PCR reactions are shown.  
 
Label:  Genotypes: 
 
A1, A2 y w 
B1, B2  y w/Y, y+; dmax1  
 
 
 
Figure 25b 
2% agarose gel, showing the PCR products of the qRTPCR assay with primers specific to dmax 
(dmax_ex2_ex3 primers). Lanes 1, 2, 3 show the PCR product derived from y w cDNA (preparation 
A1 in Figure 25a). Lanes 4, 5, 6 show the PCR products derived from y w; dmax1 cDNA (preparation 
B1 in Figure 25a). On dmax1 cDNA, a smear of weak bands is present. Presumably, this smear is the 
product of unspecific PCR reactions of the dmax_ex2_ex3 primers which occur in the absence of 
dmax cDNA template.  
72
  
2.2.8. Rescue of the dmax1 phenotype 
Since the dmax1 allele consists of a deletion which also deletes the first and most of the second exon of 
the neighboring gene CG9666, it was important to examine to which extent the observed phenotypic 
effects of the dmax1 mutation are due to a loss of dmax function. Our first attempts to rescue the 
effects of dmax1 by expressing UAS-dmax transgenes with the strong, ubiquitous GAL4 driver actin-
GAL4 resulted only in a partial rescue: few adult flies eclosed, and they showed a clearly reduced body 
size and thin bristles (Figure 26). We used two independent UAS-dmax transgenes in single copies or 
in combination without achieving a complete rescue.  
A reason for the only partial rescue might be that the expression of UAS-dmax by actin-GAL4 did not 
fully reflect the expression levels and patterns of endogenous dmax. It was further possible that the 
rescue was not complete because the UAS-dmax cDNA construct did not allow the expression of 
different splice forms of dMax (vertebrate Max exists in different splice forms (Makela et al., 1992), 
and the architecture of the max locus is identical between Drosophila and vertebrates (Gallant, 2006)). 
For these reasons, we decided to clone a genomic dmax construct. The genomic region included in the 
construct is depicted in Figure 27. Relative to dmax orientation, the cloned region starts directly 3' of 
the start of the CG9666 ORF, comprises the dmax transcript, and ends directly 5' of the start of dmax's 
3' neighboring gene CG14084. Therefore, the genomic rescue constructs includes the dmax ORF, but 
not the ORF of CG9666.  
We created transgenic fly lines carrying this construct and used an insertion of the construct on the X 
chromosome (termed dmaxrescue) in rescue experiments. Figure 28a shows that dmaxrescue fully rescued 
the growth and developmental delay phenotype of dmax1 larvae. In addition, the Figure shows that 
dmax1 male and female larvae do not differ in size, a result which will be important for a later 
experiment. dmax1 flies carrying one (in males) or two (in females) copies of dmaxrescue eclosed with 
normal timing and had a wild type appearance (Figure 28b). Figure 29 lists three test crosses that 
showed that rescued dmax1 animals appeared in Mendelian proportions and that rescued dmax1 
females and males are fertile. Stable y w dmaxrescue; dmax1 fly lines were established and could be 
maintained as a stock. Figure 30a shows that rescued dmax1 larvae which were collected at 48 h AED 
survived to adulthood as well as y w control larvae. Figure 30b shows that the wet weights of rescued 
dmax1 females were slightly higher than the ones of y w controls, possibly due to expression levels of 
dmaxrescue that are higher than the ones of endogenous dmax. 
Based on these results, we concluded that the dmax genomic rescue construct provides a full rescue of 
the dmax1 mutant phenotype. Therefore we could exclude that CG9666 functions play a role in the 
phenotypes we had described so far.  
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Figure 26 
Expression of a UAS-dmax transgene under the control of the strong driver actin-GAL4 does only 
partially rescue the lethality associated with the loss of dmax. The few eclosing flies (A) are clearly 
smaller than the heterozygous controls (B).  
 
Label:  Genotypes: 
 
A  y w; UAS-dmax16/actin-GAL4; dmax1 
B  y w; UAS-dmax16/actin-GAL4; dmax1/MKRS 
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Figure 27 
dmax genomic rescue construct. The blue line corresponds to the 2.8 kb fragment that was used to 
rescue the dmax1 mutant flies. The cloned sequence starts directly upstream (relative to CG9666) of 
the start of the coding sequence of CG9666 and ends directly downstream (relative to CG14084) of the 
end of the transcript of CG14084, the 3' neighbor of dmax. Only the end of CG14084 is depicted.  
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Figure 28a 
The presence of one or two copies dmaxrescue fully rescues the growth and developmental delay 
phenotype of dmax1 animals. In addition, the picture shows that male and female dmax1 do, if at all, 
only marginally differ in growth. The animals shown in the picture have an age of 120 h. 
 
Label:  Genotypes: 
 
A  y w dmaxrescue; dmax1 
B  y w 
C  ?  w; dmax1   
D  ?  w; dmax1 
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Figure 28b 
dmax1 flies are rescued to adulthood and full fertility by dmaxrescue. 
 
Label:  Genotypes: 
 
A  ? y w dmaxrescue; dmax1 
B  ? y w dmaxrescue; dmax1 
C  ? y w   
D  ? y w 
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 Figure 29 
Crosses documenting the rescue of viability and fertility of dmax1 animals. Numbers of offspring are 
indicated. The dmax1 parents in cross 2 and cross 3 originated from cross 1. For cross 2, two crosses 
with single virgin females were performed. The numbers of offspring from both crosses are indicated.   
 
Rescue of dmax1 animals by the presence of one or two copies of dmaxrescue: 
 
Cross 1: 5 ? y w dmaxrescue/Y; dmax1/MKRS  x  3 ? y w dmaxrescue /FM7; dmax1/MKRS 
 
Offspring ? y w dmaxrescue/y w dmaxrescue; dmax1/dmax1  22  
? ? ? y w dmaxrescue/Y; dmax1/dmax1   22 
? ? ? y w dmaxrescue/FM7; dmax1/dmax1   16 
? ? ? FM7/Y; dmax1/dmax1       0 
 
  ? y w dmaxrescue/y w dmaxrescue; dmax1/MKRS  42  
? ? ? y w dmaxrescue/Y; dmax1/MKRS   65 
? ? ? y w dmaxrescue/FM7; dmax1/MKRS   23 
? ? ? FM7/Y; dmax1/MKRS     17 
 
 
Rescued females (cross 1 offspring)  were homozygous for dmax1 and they are fertile: 
 
Cross 2: 1 ? y w dmaxrescue/FM7; dmax1/dmax1  x  3 ? y w/Y; dmax0/TM3 (2 crosses) 
 
Offspring: ? y w dmaxrescue/y w; dmax1/dmax1   34 16 
? ? ? y w dmaxrescue/Y; dmax1/dmax1   31 20 
? ? ? y w dmaxrescue/y w; dmax1/TM3   36 12 
? ? ? y w dmaxrescue/Y; dmax1/TM3    18 14 
 
? ? ? y w FM7/y w; dmax1/dmax1      0   0 
? ? ? y w FM7/Y; dmax1/dmax1      0   0 
? ? ? y w FM7/y w; dmax1/TM3    22 14 
? ? ? y w FM7/Y; dmax1/TM3    20   13 
 
 
Rescued males (cross 1 offspring) were homozygous for dmax1 and they are fertile: 
 
Cross 3: 2 ? y w dmaxrescue/Y; dmax1/dmax1  x  4 ? w; Df(3L)fz2/TM6C 
 
Offspring: ? w/Y; dmax1/Df(3L)fz2         0 
? ? ? w/Y; dmax1/TM6C       56 
? ? ? y w dmaxrescue/w; dmax1/Df(3L)fz2   160 
? ? ? y w dmaxrescue/w; dmax1/TM6C     67 
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Figure 30a 
Survival of y w dmaxrescue; dmax1 animals (B) compared to y w controls (A). 100 Larvae of each of the 
respective genotypes were collected at 48 h AED. The chart shows the number of eclosed flies.  
 
Label:  Genotypes: 
 
A  y w 
B  y w dmaxrescue; dmax1 
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Figure 30b 
Wet weight of y w dmaxrescue; dmax1 males (B) and females (D) compared to y w controls (A, C). The 
weight of adult flies of an age between 1 and 5 days was determined. The chart shows the average 
weight and the standard deviation.  
 
Label:  Genotypes:    Number of weighed flies: 
 
A  ?  y w     52 
B  ?  y w dmaxrescue; dmax1  41 
C  ?  y w     60 
D  ?  y w dmaxrescue; dmax1  38 
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2.3. Loss of one copy of dmax has no effects in wild type flies and only minor effects in dmP0 flies 
Since we had observed that dmP0 males did not survive when dmax levels were reduced by dmax-
RNAi (Figure 11), we tested whether the loss of one copy of dmax would affect dmP0 flies. As a 
control in these experiments, we used a fly line in which the P element insertion responsible for the 
dmP0 phenotype had been precisely excised: the wild type revertant dmP0Rev line. We examined the 
survival, the length of development until eclosion and the body weight of hemizygous dmP0Rev (wild 
type revertant) and dmP0 males which were wild type for dmax or heterozygous for dmax1. Figure 31a 
shows the length of development until eclosion for the four genotypes. In dmP0Rev males, loss of one 
copy of dmax had no effect on developmental timing. dmP0 males showed a developmental delay of 1 
day. In this genotype, heterozygosity for dmax had a very slight effect: The average eclosion time of 
dmP0 males is delayed by 3.6 h. This extremely small effect is probably only seen due to the large 
number of flies whose eclosion timing was tracked.  
Figure 31b shows that the loss of one copy of dmax had no effect on the survival of dmP0Rev or dmP0 
males. It also shows that dmP0 males, even though they are developmentally delayed and clearly 
smaller than wild type males, survive well. 
We examined the wet weight of eclosed flies of all four genotypes (Figure 31c). dmP0 males weighed 
150 ug less than wild type dmP0Rev males. In both genotypes, heterozygosity for dmax had no effect on 
body weight. 
Taken together, these data show that dmax is a recessive gene. Furthermore, these data suggest that 
even in a situation of reduced dmyc levels, the loss of one copy of dmax is not sufficient to aggravate 
the growth phenotype caused by reduced dmyc levels.  
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Figure 31a 
The loss of one copy of dmax in dmP0 males leads to a barely detectable developmental delay. The 
charts show the percentage of eclosed flies at given time points. dmP0 animals eclose with a delay of 1 
day compared to the dmP0Rev wild type revertants. Number of eclosed flies: A: 142, B: 241, C: 162, D: 
223. 
 
Label:  Genotypes:   Median eclosion time [hours/days AED]: 
 
A  w dmP0/Y; dmax1/+  234.1/9.76   
B  w dmP0/Y   231.5/9.65 
C  w dmP0Rev/Y; dmax1/+  208.8/8.70 
D  w dmP0Rev/Y   207.9/8.66 
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Figure 31b 
Survival to adulthood is excellent in all of the tested genotypes: The total number of pupae in the four 
test crosses was counted. Based on mendelian inheritance, the expected offspring number of the 
genotypes A - D was calculated and compared to the total number of eclosed flies of the genotypes A-
D. The ratio of expected offspring to counted eclosed flies is very close to 1 for all four genotypes. 
Total number of counted pupae/expected offspring number/counted eclosed flies: A: 1157/145/142, B: 
937/234/241, C: 643/161/162, D: 484/242/223. The labels correspond to the genotypes in Figure 31a. 
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Figure 31c 
The loss of one copy of dmax does not change the wet weight of dmP0 males or of dmP0Rev (wild type 
revertant) males. For each genotype, 53 flies were weighed. The labels correspond to the genotypes in 
Figure 31a. 
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2.4. Comparison of growth and survival in the Max network 
There are drastic differences between the dmyc and the dmax null phenotypes. Figure 32 shows dmax1 
larvae compared to dmA51 larvae at an age of 120 h AED. dmA51 is a dmyc molecular null allele that 
was generated by imprecise excision of a P element and that lacks the entire dmyc ORF. dmA51 animals 
die as larvae, but they can be rescued to adulthood by expression of a tub-dmyc transgene (P. Gallant, 
unpublished). In contrast to the dmax1 larvae that survived well until this time point and do grow, 
albeit at reduced speed (compare Figures 20, 21), the few dmA51 larvae that had survived until 120 h 
AED displayed an almost complete failure to grow. Due to the fact that dmyc null mutants are 
homozygous lethal and due to dmyc's position on the X chromosome, only male dmA51 larvae could be 
collected without employing a rescue construct, whereas the dmax larvae were mixed males and 
females. However, this constitutes no problem for the comparison, since we had shown that dmax1 
females do not differ in size from dmax1 males (Figure 28a).  
The difference between the dmax null and the dmyc null growth phenotypes is highly surprising, if one 
assumes that all functions of dmyc require dmax. A dmax null mutant should then display as severe 
growth phenotypes as a dmyc null mutant, since dmyc would not be functional in the absence of dmax. 
However, if one postulates that dMyc has functions that do not require heterodimerization with dMax, 
and that these encompass functions that are required in larval growth, the phenotypic differences could 
be explained.  
Since Max is not only required in the heterodimerization with Myc, but also forms heterodimers with 
Mad/Mnt proteins, an alternative explanation for the observed difference is possible. The mildness of 
the dmax phenotype could be due to the concomitant loss of dMyc/dMax-mediated activating and 
dMnt/dMax-mediated repressing functions. In the dmyc mutant, the formation of repressive 
dMnt/dMax heterodimers would still be possible (or even be enhanced), giving rise to the more severe 
growth phenotype. Along these lines, one could postulate the existence of an unknown dmax-
dependent negative growth regulator besides dmnt. As the following experiments show, it was 
possible to discriminate between these possibilities by examining the effects of different mutant 
combinations of the Max network components on growth and survival. 
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Figure 32 
Comparison of dmax null larvae and dmyc null larvae (5 d AED), revealing a striking difference in the 
growth phenotype. 
 
Label:  Genotypes: 
 
A  w; dmax1 
B  y w dmA51/Y 
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We included another mutant allele of dmyc in our comparisons: dm2, an allele that had been described 
to behave genetically as a null allele (Maines et al., 2004), at a time when no molecular null alleles of 
dmyc had been available. The dm2 mutation is a nonsense mutation that leads to a truncation of the 
dMyc protein at AA 675, immediately upstream of the leucine zipper motif, but is reported to express 
normal levels of the truncated protein. Since the leucine zipper motif is necessary for 
heterodimerization with Max in vertebrates (Blackwood and Eisenman, 1991; Amati et al., 1993a), it 
is assumed that the mutant form of dMyc which is encoded by the dm2 allele is not able to bind to 
dMax anymore. We reasoned that dm2 should display a less severe phenotype than the molecular null 
allele dmA51, if it were true that dmyc has dmax-independent functions (provided that these functions 
would also not require the leucine zipper). Figure 33 shows a comparison of the survival of dmax1, 
dm2 and dmA51 larvae from 24 h AED to 48, 72 and 96 h AED. Clearly, dm2 larvae survived better than 
dmA51 larvae, but much more poorly than dmax1 larvae. The size of dm2 larvae is also intermediate 
(Figure 34a). These data suggest that dm2 is indeed not a null allele, and since the truncated form of 
dMyc encoded by dm2 is not able to bind to dMax, the better survival of dm2 larvae also suggests that 
there are functions of dmyc which are independent of dmax. However, the phenotype of dm2 is clearly 
not equivalent to dmax1. We next tested indirectly, whether dmnt might contribute to the severity of 
the dm2 and dmA51 phenotypes.  
We argued that dmA51 dmax1 or dm2 dmax1 double mutants should display a less severe growth 
phenotype and should survive better than dmA51 or dm2 single mutants, if it were true that repressive 
functions of dMnt/dMax heterodimers contributed to the severity of the dmA51 and dm2 phenotypes. As 
Figure 34 shows, this was indeed the case. By examining the size of the larvae at 120 h AED and their 
survival at 96 h AED and 120 h AED, we found a rescue both in size and survival for both dmA51 
dmax1 and dm2 dmax1 double mutant larvae. The dm2 dmax1 double mutants were clearly bigger than 
the dmA51 dmax1 double mutants, but still smaller than dmax1 mutants. Taken together, these findings 
showed that two factors contribute to the striking difference in the growth phenotypes of dmyc and 
dmax null mutants: On one hand, there is a contribution of a negative growth regulator that depends on 
dmax (presumably dmnt). On the other hand, there must be dmax-independent functions of dmyc. 
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Figure 33 
Comparison of the survival of dmax1 heterozygote larvae (A), dmax1 larvae (B), dm2 (C) and dmA51 
(D) larvae at 48 h AED, 72 h AED and 96 h AED. The larvae were collected at 24 h AED. The chart 
depicts the relative survival of the larvae until the given time points. Number of collected larvae: 48 h 
AED: 50 each, 72 h AED: 60 each, 96 h AED: 50 (A), 28 (B), 36 (C), 29 (D).  
 
Label:  Genotypes: 
 
A  w; dmax1/TM3, Ser GFP 
B  w; dmax1 
C  y w dm2/Y 
D  y w dmA51/Y1 
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Figure 34a 
Loss of dmax1 in dmA51 and in dm2 larvae leads to a partial rescue of the growth phenotype, but the 
double mutant larvae are still smaller than dmax1 larvae. The larvae were photographed at 120 h AED. 
 
Label:  Genotypes:    Label:  Genotypes: 
 
A  w; dmax1/TM3, Ser GFP  D  y w dmA51/Y; dmax1 
B  w; dmax1    E  y w dm2/Y 
C  y w dmA51/Y    F  y w dm2/Y; dmax1 
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Figure 34b 
Survival of the mutant combinations depicted in Figure 34a, at 96 h AED. Larvae of the indicated 
genotypes were collected at 24 h AED. For the genotypes A - D, two experiments were performed, for 
E and F, one experiment was performed. The error bars indicate the standard deviations. Total 
numbers of collected larvae: A: 80, B: 44, C: 76, D: 69, E: 13, F: 23. 
 
Label:  Genotypes: 
 
A  w; dmax1/TM3, Ser GFP 
B  w; dmax1 
C  y w dm2/Y 
D  y w dmA51/Y 
E  y w dm2/Y; dmax1 
F  y w dmA51/Y; dmax1 
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Figure 34c 
Survival of the mutant combinations depicted in Figure 34a, at 120 h AED. Larvae of the indicated 
genotypes were collected at 24 h AED. For the genotypes B - G, error bars indicate the standard 
deviation of two experiments. For A, only one experiment was performed. Total numbers of collected 
larvae: A: 40, B: 77, C: 63, D: 75 , E: 80 , F: 68, G: 37. 
 
Label:  Genotypes: 
 
A  y w 
B  w; dmax1/TM3, Ser GFP 
C  w; dmax1 
D  y w dm2/Y 
E  y w dmA51/Y 
F  y w dm2/Y; dmax1 
G  y w dmA51/Y; dmax1 
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In order to confirm and augment these findings, we next made use of the dmyc molecular null allele 
dm4 (Pierce et al., 2004), the dmnt molecular null alleles dmnt1 and dmnt2 (Loo et al., 2005) and of a 
dm4 dmnt1 double mutant (unpublished, kindly provided by S. Pierce and R. Eisenman before 
publication). Using the dm4 dmnt1 double mutant, it was possible to generate a dm4 dmnt1 dmax1 triple 
mutant. We compared the size and the survival of different mutant combinations at 120 h AED, 
displayed in Figure 35. dm4 larvae (Figure 35 F) behaved as dmA51 larvae, showing a very severe 
growth phenotype and extremely poor survival. The dm4 dmnt1 double mutants (Figure 35 C) 
displayed a clearly milder phenotype, being intermediate between dm4 and dmax1 larvae (Figure 35 B) 
both in size and survival. dm4 dmax1 double mutant larvae (Figure 35 E) and dm4 dmnt1 dmax1 triple 
mutant larvae (Figure 35 D) were similar to the dm4 dmnt1 larvae, albeit both showed slightly smaller 
sizes and slightly poorer survival. The comparison of the dm4 and dm4 dmnt1 mutants proves that dmnt 
is acting as a negative growth regulator, aggravating the effects of a loss of dmyc. The clear difference 
in size and survival between the dm4 dmnt1 double mutants and the dmax1 mutants again provides 
evidence for dmax-independent functions of dmyc, since the dm4 dmnt1 double mutants should be 
equivalent to dmax1 mutants if one assumes that all the functions of dmyc do require dmax. The fact 
that the dm4 dmnt1 dmax1 triple mutants do not show better growth and survival compared to the dm4 
dmnt1 double mutant excludes the hypothesis that there is an unknown negative growth regulator 
besides dmnt which requires dmax and contributes to the comparative mildness of the dmax1 
phenotype. The slightly smaller sizes and poorer survival of the dm4 dmax1 and dm4 dmnt1 dmax1 
mutants compared to dm4 dmnt1 might rather be an indication that dmax has positive functions 
independent of dmyc and dmnt. 
At 192 h AED, dm4 dmnt1 mutant larvae were clearly smaller than dmax1 larvae. Whereas the dmax1 
larvae showed no decrease in survival in the period between 120 h and 192 h AED, the survival of the 
dm4 dmnt1 larvae dropped from 50% at 120 h AED to 20% at 192 h AED. The fact that the phenotypic 
differences between the dm4 dmnt1 and the dmax1 mutant phenotype stays as large at the later time 
point (regarding size) or even grows larger (regarding survival), taken together with the lack of 
detectable dmax mRNA at 120 h AED, provides strong evidence that the observed differences are not 
due to maternal contribution of dmax mRNA or dmax protein, but rather a consequence of the 
existence of dmax-independent functions of dmyc. 
We also generated dmnt1 dmax1 and dmnt2 dmax1 double mutants and compared their size and survival 
with dm4 dmnt1 and dmax1 mutants, at 192 h AED (dmnt1 being a null mutant, whereas dmnt2 does 
potentially only express the natural dmnt splice variant which does not contain the Sin3-interaction 
domain). Whereas the sizes of the dmnt1 dmax1 and dmnt2 dmax1 double mutants did not differ from 
dmax1 mutants, the survival of the dmnt1 dmax1 double mutant was moderately reduced, much less so 
the survival of the dmnt2 dmax1 double mutant (Figure 36). The fact that the loss of dmnt has no 
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impact on the growth of dmax1 larvae is compatible with a model in which dmnt as a negative growth 
regulator requires dmax function. 
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Figure 35a 
Comparison of the mutant combinations of the Max network. The larvae were photographed at 120 h 
AED. 
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 Figure 35a (continued) 
 
Label:  Genotypes:    Label:  Genotypes: 
 
A  wt [OreR]    D  w dm4 dmnt1/Y; dmax1 
B  w; dmax1    E  w dm4/Y; dmax1 
C  w dm4 dmnt1/Y    F  w dm4/Y 
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Figure 35b 
Survival of the mutant combinations depicted in Figure 35a, at 120 h AED. Larvae of the indicated 
genotypes were collected at 48 h AED. Error bars indicate standard deviations from independent 
experiments (A: 6, B: 3, C: 6, D: 3, E: 3, F: 5 experiments). Total number of collected larvae: A: 209, 
B: 71, C: 236, D: 45, E: 38, F: 147.  
 
 
Label:  Genotypes: 
 
A  wt [OreR] 
B  w; dmax1 
C  w dm4 dmnt1/Y 
D  w dm4 dmnt1/Y; dmax1 
E  w dm4/Y; dmax1 
F  w dm4/Y 
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Figure 36a 
dmax null larvae do not differ in their growth phenotype from dmax dmnt double mutant larvae. The 
larvae were photographed at 192 h AED.  
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 Figure 36a (continued) 
 
Label:  Genotypes:    Label:  Genotypes: 
 
A  wt [OreR]    D  w dmnt2; dmax1 
B  w dmntRev; dmax1   E  w dm4 dmnt1/Y; dmax1 
C  w dmnt1; dmax1     
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Figure 36b 
Survival of the mutant combinations depicted in Figure 36a, at 192 h AED. Larvae of the indicated 
genotypes were collected at 48 h AED. Error bars indicate standard deviations from two independent 
experiments. Total number of collected larvae: A: 60, B: 55, C: 52, D: 60, E: 68. 
 
Label:  Genotypes: 
 
A  wt [OreR] 
B  w [71NN]; dmax1 
C  w dmnt1; dmax1 
D  w dmnt2; dmax1 
E  w dm4 dmnt1/Y; dmax1 
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The difference in the severity of the growth phenotypes between dm4 dmnt1 larvae and dmax1 larvae 
does not only cause different total larval sizes at given time points AED, but is also seen in the sizes of 
polyploid organs and in total RNA content.  
Figure 37a shows larval fat bodies stained with Hoechst dye of dm4 dmnt1, dmax1 at an age of 120 h or 
192 h AED, compared to y w control fat bodies at an age of 120 h AED. Whereas at 120 h AED, 
dmax1 fat bodies were clearly smaller than y w fat bodies, they attained a size only slightly smaller 
than the one of y w control tissue at 192 h AED. dm4 dmnt1 fat body tissue was much smaller than 
dmax1 tissue at 120 h AED, and it showed much less growth in the period from 120 h AED until 192 h 
AED, being still smaller at 192 h AED than dmax1 tissue at 120 h AED. Figure 37b shows fat body 
nuclei of the described genotypes at a higher magnification. We also examined the size of salivary 
gland tissue (Figure 37c) with very similar results: Whereas dmax1 salivary gland cell nuclei reached 
almost wild type sizes at 192 h AED, dm4 dmnt1 salivary gland cell nuclei at 192 h AED were still 
smaller than dmax1 salivary gland cell nuclei at 120 h AED. 
The growth difference between dm4 dmnt1 and dmax1 larvae is also reflected in the total RNA content 
of the larvae: total RNA content of dm4 dmnt1 larvae is strongly decreased in comparison to dmax1 
larvae, both in L1 (at 29-39 h AED, Figure 37d) and at 120 h AED (Figure 37e). At the later time 
point, the total RNA content roughly correlated to the differences in larval size. Surprisingly, the 
differences in total RNA content were already equally strong at the early time point, when not much 
visible growth had occurred. 
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Figure 37a 
Size comparison of fat bodies of y w, dmax1 and dm4 dmnt1 larvae (magnification: 5x). The fat bodies 
were stained with Hoechst dye. The circle-shaped organs embedded in the fat body tissue are the 
gonads (a female gonad in A, a male gonad in B and C). 
 
Label:  Genotypes:  Age: 
 
A  y w   120 h AED 
B  w; dmax1  120 h AED 
C  w dm4 dmnt1/Y  120 h AED 
D  y w   120 h AED 
E  w; dmax1  192 h AED 
F  w dm4 dmnt1/Y  192 h AED 
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Figure 37b 
Hoechst dye-stained fat body nuclei of y w, dmax1 and dm4 dmnt1 larvae (magnification: 63x). 
 
Label:  Genotypes:  Age: 
 
A  y w   120 h AED 
B  w; dmax1  120 h AED 
C  w dm4 dmnt1/Y  120 h AED 
D  y w   120 h AED 
E  w; dmax1  192 h AED 
F  w dm4 dmnt1/Y  192 h AED 
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Figure 37c 
Hoechst dye-stained salivary gland nuclei of y w, dmax1 and dm4 dmnt1 larvae (magnification: 63x). 
 
 
Label:  Genotypes:  Age: 
 
A  y w   120 h AED 
B  w; dmax1  120 h AED 
C  w dm4 dmnt1/Y  120 h AED 
D  y w   120 h AED 
E  w; dmax1  192 h AED 
F  w dm4 dmnt1/Y  192 h AED 
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Figure 37d 
Comparison of the total RNA levels of dm4 dmnt1 larvae, dmax1 larvae and y w larvae at 29-39 h AED. 
Two RNA extractions from 20 larvae were performed per genotype. The chart shows average total 
RNA amounts per larva and the standard deviation. 
 
Label:  Genotypes: 
 
A  w dm4 dmnt1/Y 
B  w; dmax1 
C  y w 
 
A, B: 120 h AED   C: 96 h AED
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Figure 37e 
Total RNA levels of dm4 dmnt1 larvae and dmax1 larvae at 120 h AED, compared to the total RNA 
levels of y w larvae at 96 h AED. A and B show the average total RNA amount per larva from 5 RNA 
extractions (20 larvae per extraction) each and the standard deviations. C shows the average total RNA 
amount per larva from 8 RNA extractions (12 larvae per extraction) and the standard deviation. 
 
Label:  Genotypes: 
 
A  w dm4 dmnt1/Y 
B  y w/Y, y+; dmax1 
C  y w 
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2.5. Loss of mlx has no effect in dmax1 larvae 
The comparison of the growth phenotypes and of the survival of different null mutant combinations of 
the Max network members has provided strong evidence that dmyc is still partly functional in the 
absence of dmax. We hypothesized that dmyc could retain part of its functions, if a protein with 
similarity to Max existed which would partially complement the loss of Max in dmax1 mutants. One 
candidate for such a factor was Mlx (Max-like factor X), a transcription factor with a bHLHzip 
domain similar to Max which had been shown to form repressive heterodimers with Mad proteins and 
activating heterodimers with the Myc-like transcription factor Mondo, thereby forming a 
transcriptional network that functions in parallel to the canonical Myc/Max/Mad transcriptional 
network (Billin et al., 1999; Billin et al., 2000). Since Mondo/Mlx and Mad/Mlx heterodimers also 
bind to E-Boxes, it was conceivable that hypothetical Myc/Mlx heterodimers might partially 
complement the loss of Max protein in dmax1 mutants. However, such a scenario was unlikely for 
several reasons: Mlx had been shown to bind poorly to Myc (Billin et al., 1999) and was found to 
locate primarily to the cytoplasm (Billin et al., 2000). Furthermore, our own finding that dm2 is still 
partially functional suggested that the dmax-independent functions of dmyc do not require binding to 
another bHLHzip transcription factor.  
If Mlx would indeed complement the loss of Max, we could expect that dmax1 mlx double mutants 
should display a growth phenotype similar to the one of dm4 dmnt1 mutants. To generate dmax1 mlx  
double mutants, we recombined the dmax1 allele with the P element insertions mlxGE25479 (inserted 13 
bp downstream of the transcription start site of mlx and 13 bp upstream of the mlx ORF) and mlxGE2850 
(inserted 250 bp upstream of the start of the mlx transcript). Both these P element insertions are 
homozygous viable. mlxGE25479 is the only known P element that is located inside the mlx transcript. As 
Figure 38 shows, there was no size difference between the double mutants and the dmax1 single 
mutants. We therefore concluded, that mlx does not complement the loss of dmax.  
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Figure 38 
Loss of mlx does not alter the growth phenotype of dmax1 larvae. The larvae were photographed at 192 
h AED.  
 
Label:  Genotypes: 
 
A  w; dmax1 
B  w; dmax1 mlxGE25479 
C  w; dmax1 mlxGE28050 
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2.6. Clonal analysis 
Since the effects of dmyc and dmnt on growth had shown to be cell-autonomous (Johnston et al., 1999; 
Pierce et al., 2004; Loo et al., 2005), we expected to see the observed growth differences between 
dmyc null, dmyc dmnt null and dmax null larvae also in mutant clones. We had shown that the 
differences in total larval size correlate with (and are probably caused by) different cell sizes of the 
polyploid organs (Figure 37abc). Using clonal analysis, we could also study the behavior of mutant 
diploid imaginal disc cells. 
 
2.6.1. Clonal analysis in the eye: ey-flp clones 
In order to generate flies that have dmyc null eyes, we used a tub>dmyc>GAL4 transgene that rescues 
dmA51 null mutant flies to adulthood. Expression of this transgene in wild type flies does not induce 
lethality, but results in an increase in body weight, due to larger cell size (Bellosta et al., 2005). 
Flipase-mediated recombination at the FRT sites that flank the dmyc sequence in the transgene under 
control of the eyeless-flipase (ey-flp) transgene early in development results in a loss (flip-out) of dmyc 
in the eyes, in virtually all cells (D. Schwinkendorf, unpublished), producing dmyc null eyes (in a 
dmA51 background) or wild type eyes (in a dmyc wild type background). Figure 39 shows that the eye-
specific loss of dmyc in dmA51 males resulted in small eyes with small ommatidia (Figure 39A, B). 
dmyc null eyes generated with this system often displayed a rough eye phenotype that was particularly 
pronounced in the ventral part of the eye.  
We next generated dmax1 mutant clones in the eye. To this end, we had recombined the dmax1 allele 
with the FRT80B recombination site, which allowed us to generate dmax1 somatic clones by flipase-
mediated recombination (Xu and Rubin, 1993). In y w ey-flp c-lacZ/w; FRT80B Pw+ M(3)i55/FRT80B 
dmax1 flies, the action of ey-flp resulted in the generation of dmax1 homozygous mutant clones 
(marked by the absence of white expression) in the eye. Since the sister chromosome arm carried a 
Minute allele (M(3)i55), only heterozygous tissue (marked w+) and dmax1 homozygous mutant tissue 
survived. Strikingly, dmax1 mutant clones survived well and could cover large portions of the eye 
(Figure 39C, control: 39D). The size of dmax1 mutant ommatidia was not visibly reduced compared to 
the wild type control and we never observed roughness in the eyes containing dmax1 clones. It seemed 
that dmax, in contrast to dmyc, was not required to form a wild type eye. However, dmax1 mutant 
macrochaetae of the head capsule were strongly reduced in size. 
We next investigated whether the concomitant loss of dmnt in dmax1 mutant clones was responsible 
for the milder phenotype of dmax1 clones. We recombined the dm4 and the dm4 dmnt1 chromosomes 
with the FRT19 recombination site and generated ey-flp clones of dm4, dm4 dmnt1 and of dmax1. In 
these experiments, recessive cell lethal alleles were used which allow for the elimination of 
homozygous wild type tissue, resulting in an eye that consists of heterozygous tissue (marked w+) and 
homozygous mutant tissue (marked w-). Figure 40 shows that the generation of dm4 and of dm4 dmnt1 
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mutant clones resulted in eyes that consisted mainly of heterozygous tissue, with very few surviving 
dm4 or dm4 dmnt1 mutant clones (Figure 40 A, B). The size of surviving dm4 dmnt1 mutant clones was 
slightly larger than the one of dm4 mutant clones. In both cases, the heterozygous tissue very often was 
rough. dmax1 clones survived clearly better than dm4 dmnt1 clones and the resulting eyes never showed 
roughness, but the size of dmax1 clones was smaller than the size of wild type control clones (Figure 
40 C, D) and smaller than the size of dmax1 clones produced in a Minute background (Figure 39 C). 
Since heterozygous Minute cells are viable, but suffer from cell competition, the larger size of dmax1 
cells in a Minute background could be an indication for a competitive disadvantage of dmax1 cells. 
The observed roughness of the heterozygous tissue in eyes where dm4 or dm4 dmnt1 clones had been 
produced is an indication of cell competition: Roughness in the heterozygous tissue results when the 
homozygous mutant tissue does survive for a certain time and only then disappears. If two cell lethal 
mutations are juxtaposed on homologous chromosomes and ey-flp clones are generated, the only 
remaining unrecombined (heterozygous) tissue is never rough (H. Stocker, personal communication). 
If the homozygous mutant tissue first survives and only later dies (as it would occur due to cell 
competition), the remaining heterozygous tissue does not seem to be able to fully compensate for the 
loss of the homozygous tissue, resulting in roughness. dm4 and, to a lesser extent dm4 dmnt1, mutant 
clones seem to be affected more strongly by cell competition than dmax1 mutant clones which can 
reach considerable - but not wild type - sizes and are not accompanied by roughness of the 
heterozygous tissue.  
Cell competition seemed to play a lesser role in the experiments depicted in Figure 39. In the case of 
the dmA51 mutant eyes (Figure 39 A), flipase-mediated recombination occurs in cis at two FRT sites 
only separated by the dmyc transgene, making it occurring more frequently than between to FRT19 
sites located in trans on homologous chromosomes. Therefore, most of the resulting tissue will be 
mutant for dmyc and almost no heterozygous tissue will remain, thus presumably eliminating cell 
competition. In the case of the dmax1 clones of Figure 39 C, cell competition is alleviated, because the 
Minute/+ heterozygous tissue has a competitive disadvantage compared to dmax1/dmax1.  
Taken together, these data show that also in mutant clones in the eye, the dmax1 phenotype is less 
severe than the dmyc null phenotype and also less severe than the dm4 dmnt1 phenotype, consistent the 
existence of dmax- independent functions of dmyc.  
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Figure 39 
Whereas loss of dmyc in the eye results in a small and rough eye phenotype (A, control: B), dmax1 
clones in the eye (w- tissue) survive well and form wild type ommatidia (C, control: D). 
 
Label:  Genotypes: 
 
A  y w dmA51 tub>dmyc>GAL4 hs-flp/Y; CyO, ey-flp/+ 
B  y w dmRev tub>dmyc>GAL4 hs-flp/Y; CyO, ey-flp/+ 
C  y w ey-flp c-lacZ/w; FRT80B Pw+ (70C) M(3)i55/FRT80B dmax1 
D  y w ey-flp c-lacZ/w; FRT80B Pw+ (70C) M(3)i55/FRT80B 
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Figure 40 
dm4 and dm4 dmnt1 clones in the eye (generated with the ey-flp system in a cell lethal background) 
survive poorly (A, B), resulting in rough eyes with almost no homozygous mutant w- ommatidia, in 
contrast to dmax1 clones (C). However, dmax1 clones occupy smaller areas compared to wild type 
control clones (D). 
 
 
Label:  Genotypes: 
 
A  w dm4 FRT19/y cl(15b) FRT19; Sp/ey-flp 
B  w dm4 dmnt1 FRT19/y cl(15b) FRT19; Sp/ey-flp 
C  y w ey-flp/Y; +; FRT80 dmax1/FRT80 clw+ 
D  y cl(15b) FRT19/y w FRT19; ey-flp/+ 
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2.6.2. Clonal analysis in the wing disc: twin spot clones 
We next observed the growth and survival of dm4, dm4 dmnt1 and dmax1 clones in the imaginal wing 
disc, using the hs-flp FRT system. This system allows for a timed generation of mutant clones in a 
heterozygous tissue. Every recombination event creates a homozygous mutant clone (marked by the 
lack of GFP expression) and a homozygous wild type twin spot (marked by two copies of GFP). Since 
mutant clone and wild type twin spot are created simultaneously, growth and survival of the mutant 
clone can be directly compared to the wild type twin spot, allowing an accurate analysis of growth, 
proliferation and cell competition. We examined dm4, dm4 dmnt1 and dmax1 clones at an age of 72 h 
and dmax1 clones at an age of 96 h. All ages indicate the time that had elapsed since the generation of 
the clone. Figure 41 shows that dm4, dm4 dmnt1 and dmax1 clones behaved very differently: Whereas 
dm4 and dm4 dmnt1 clones (Figure 41 A, B) at an age of 72 h were very small and often did not survive 
(as indicated by the presence of a twin spot clone un-accompanied by a mutant clone), dmax1 clones at 
the same age (Figure 41 C) showed sizes similar to the sizes of the twin spots, and most twin spots 
were accompanied by a dmax1 clone. At an age of 96 h, dmax1 clones showed a smaller size than the 
twin spot clones, and the number of twin spots without mutant clone was higher. Figure 42 shows a 
statistical analysis of the clone size distribution and the size of mutant cells compared to wild type 
cells. Both dm4 and dm4 dmnt1 clones were more than three times smaller than dmax1 clones at 72 h. 
For dm4, 36% of the examined twin spots were not accompanied by a mutant clone (dm4 dmnt1: 46%), 
whereas only 3% single twin spots were found for dmax1. We concluded that both dm4 and dm4 dmnt1 
clones showed strong signs of cell competition, whereas there was no clear indication for cell 
competition for dmax1 clones at 72 h (dmax1 clones were smaller than the wild type twin spots, but it 
is not possible to decide whether this was due to cell competition or due to slower proliferation of the 
dmax1 cells). However, at 96 h, 19% single twin spots were found in discs where dmax1 clones had 
been induced, and the dmax1 mutant clones showed a slightly smaller median size. We therefore find 
that also dmax1 clones suffered from cell competition, albeit at a smaller extent than dm4 or dm4 dmnt1 
clones. The cell size in both dm4 and dm4 dmnt1 clones was clearly smaller than the cell size in the 
twin spot clones, whereas the cell size in dmax1 clones was similar to the cell size of the twin spot 
clones.  
Taken together, these data indicate that dmax1 clones are clearly different from dm4 and dm4 dmnt1 
clones, both in their susceptibility to cell competition and in cell size. Whereas dm4 dmnt1 clones 
survived better than dm4 clones in the eye (Figure 40), they did as poorly as dm4 clones in the imaginal 
wing disc. This finding might be explained by stronger cell competition in the wing disc. 
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Figure 41 
dm4 and dm4 dmnt1 mutant clones (GFP- cells) survive poorly and are smaller than wild type twin spot 
clones (harboring two copies of GFP) (A, B). At the same age (72 h), dmax1 clones are only slightly 
smaller than the wild type twin spot clones (C). 96 h old dmax1 clones are clearly smaller than the wild 
type twin spot clones (D). For better visibility of the GFP- clones are encircled with a red line. 
 
Label:  Genotypes:      Age of the clones: 
 
A  w dm4 FRT19/y w hs-flp hs-GFP FRT19  72 h 
B  w dm4 dmnt1 FRT19/y w hs-flp hs-GFP FRT19 72 h 
C  y w hs-flp; dmax1 FRT80/FRT80 ubi-GFP  72 h 
D  y w hs-flp; dmax1 FRT80/FRT80 ubi-GFP  96 h 
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Figure 42a 
Clone size distribution and average cell size of 72 h old dm4 clones (orange) and wild type twin spot 
clones (blue) in imaginal wing discs.   
 
Median clone size: dm4 clone    502 pixels  
   wt twin spot  3556 pixels 
 
Average cell size: dm4 clone      31 pixels 
   wt twin spot      43 pixels 
 
Single twin spots: 36 % 
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Figure 42b 
Clone size distribution and average cell size of 72 h old dm4 dmnt1 clones (orange) and wild type twin 
spot clones (blue) in imaginal wing discs.   
 
Median clone size: dm4 dmnt1 clone    373 pixels  
   wt twin spot   3137 pixels 
 
Average cell size: dm4 dmnt1 clone      29 pixels 
   wt twin spot       41 pixels 
 
Single twin spots: 46 % 
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Figure 42c 
Clone size distribution and average cell size of 72 h old dmax1 clones (orange) and wild type twin spot 
clones (blue) in imaginal wing discs.   
 
Median clone size: dmax1 clone  1525 pixels 
   wt twin spot  2321 pixels 
 
Average cell size: dmax1 clone      35 pixels 
   wt twin spot      39 pixels 
 
Single twin spots: 3 % 
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Figure 42d 
Clone size distribution and average cell size of 96 h old dmax1 clones (orange) and wild type twin spot 
clones (blue) in imaginal wing discs. 
 
Median clone size: dmax1 clone  1441 pixels 
   wt twin spot  4489 pixels 
 
Average cell size: dmax1 clone      40 pixels 
   wt twin spot      41 pixels 
 
Single twin spots: 19 % 
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2.6.3. dmyc causes cell competition in dmax1 larvae 
The clonal analysis of ey-flp clones in the eye (Figure 40) and of hs-flp twin spot clones in the wing 
disc (Figures 41, 42) had revealed that both dm4 and dm4 dmnt1 mutant clones suffered more strongly 
from cell competition than dmax1 clones. Apparently, the dmax-independent functions of dmyc that 
were still present in the dmax1 cells, but not in dm4 dmnt1 cells, had partially protected the dmax1 cells. 
We now asked whether differences in dmyc levels were still capable to induce cell competition in the 
absence of dmax. To study this question, we used a tub>dmyc>GAL4 flip-out transgene (Bellosta et 
al., 2005). In flies which carry this transgene, clones can be induced in which the transgene has 
recombined to tub>GAL4. Therefore, the clones possess endogenous dmyc levels, whereas the 
surrounding unrecombined tissue has endogenous dmyc plus ectopically expressed dmyc. Since dmyc 
levels are higher in the surrounding tissue, the clones suffer from cell competition (Moreno and 
Basler, 2004). We generated dmax1 larvae which carried the tub>dmyc>GAL4 transgene and asked 
whether tub>GAL4 clones would still suffer from cell competition. As a control, neutral clones were 
generated in dmax1 larvae that carried the actin>CD>GAL4 flip-out cassette. In both cases, clones 
were marked by the expression of GFP. We induced the clones at 5 d AED (a time when no detectable 
dmax mRNA was present anymore, see Figure 25), and examined the clones 4 d later, at 9 d AED. 
Figure 43 shows that the act>CD2>GAL4 control clones were bigger (Figure 43 A) than the 
tub>dmyc>GAL4 clones. The average clone size of the act>CD2>GAL4 clones was 2213 pixels, the 
size of the tub>dmyc>GAL4 clones was 1452 pixels. Since both types of clones contain the same 
endogenous levels of dmyc, the most likely explanation for the smaller size of the tub>dmyc>GAL4 
clones is that these clones suffer from cell competition caused by the surrounding tissue which has 
higher dmyc levels. Therefore, cell competition can also be induced by differing levels of dmax-
independent functions of dmyc.  
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Figure 43a 
dmyc causes cell competition in dmax1 larvae. Clones which had lower dmyc levels than the 
surrounding tissue (B) were smaller than control clones (A) whose dmyc levels were identical to the 
dmyc levels of the surrounding tissue. Clones were induced at 5 d AED and allowed 4 d to grow. The 
clones are marked by the expression of UAS-GFP. 
 
Label:  Genotypes: 
 
A  y w hs-flp/[y w or Y]; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 
B  y w tub>dmyc>GAL4 hs-flp/[y w or Y]; UAS-GFP/+; dmax1 
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Figure 43b 
Comparison of the clone sizes (orange: A genotype, red: B genotype). For A, the clone size of 53 
clones from 14 wing discs, for B, the clone size of 39 clones from 6 wing discs was determined. A 
clones had an average clone size of 2213 pixels. B clones had an average clone size of 1452 pixels. 
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2.6.4. dmax1 bristles are small 
Whereas dmax1 mutant cells in mutant clones in the wing disc did not show a reduced size (Figure 
42c, 42d), we observed that the size of dmax1 prothoracic and thoracic macrochaetae was severely 
reduced (Figure 44). Bristles are very sensitive to the loss of dmyc or dmax function, since already 
weak hypomorphic alleles of dmyc and dmax-RNAi show a thin bristle phenotype, presumably due to 
a strong requirement for dmyc function in situations of high protein biosynthesis. A differential 
requirement for dMyc/dMax function might also explain why in ey-flp clones dmax1 ommatidia 
develop like wild type ommatidia, while dmax1 bristles of the head capsule are strongly affected. 
 
2.6.5. dm4 dmnt1 and dmax1 clones in the fat body 
We had shown that the cell size and the total organ size of dm4 dmnt1 fat bodies is smaller than the cell 
and total organ size of dmax1 fat bodies. In order to investigate whether this difference is cell-
autonomous, we generated dm4 dmnt1 and dmax1 mutant fat body cells in a heterozygous background 
using the hs-flp FRT system. Figure 45 shows that dm4 dmnt1 mutant cells were clearly smaller than 
dmax1 mutant cells. Some dmax1 mutant cells were only slightly smaller than the cells of the 
surrounding heterozygous tissue In both cases, the size of the cell nuclei was proportional to the 
overall cell size. These results show that the different cell sizes found in the fat bodies of dm4 dmnt1 
and dmax1 fat bodies are caused by cell-autonomous differences. It is therefore probable that an 
important part of the differences in the total larval sizes are a direct consequence of these cell-
autonomous differences.  
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Figure 44 
dmax1 macrochaetae (indicated with an asterisk) are very thin and short. dmax1 bristles were generated 
in y w hs-flp; dmax1 FRT80/FRT80 ubi-GFP animals which were subjected to a heat shock at 24 h 
AED. 
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Figure 45 
dm4 dmnt1 and dmax1 fat body cell clones, generated with the hs-flp FRT system. dm4 dmnt1 fat body 
cells and nuclei (A) are smaller than dmax1 fat body cell and nuclei (B). Mutant cells are marked by 
the lack of GFP expression and indicated by arrows. Nuclei were stained with Hoechst dye. Clones 
were induced at 6 h AED. Depicted are fat bodies of wandering larvae. 
 
Label:  Genotypes: 
 
A  w dm4 dmnt1 FRT19/y w hs-flp hs-GFP FRT19 
B  y w hs-flp; FRT80 dmax1/FRT80 ubi-GFP 
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2.7. dmyc overexpression in dmax1 larvae 
The comparison of null mutant combinations of the Max network members had revealed that dmyc is 
still partly functional in the absence of dmax. Using RNAi, we had furthermore shown that the effects 
of overexpression of dmyc in the Drosophila eye were partly dmax-independent. We next examined 
the consequences of overexpression of dmyc in dmax1 mutants. Assuming that all functions of dmyc do 
require dmax, one would have to expect that a dmyc transgene is silent in a dmax1 background. 
However, if dmyc indeed had dmax-independent functions, then we could hope that overexpression of 
dmyc in dmax1 mutants should still produce observable effects.  
In the following experiments, we used the UAS-dmyc132 transgene. Expression of UAS-dmyc132 under 
control of GMR-GAL4 led to an increase in ommatidial size of more than 20% (Figure 14). Strong and 
ubiquitous expression of UAS-dmyc132 with actin-GAL4 leads to partial larval lethality (Figure 47b), 
but most larvae reach the pupal stage and die as pupae. Expression of UAS-dmyc132 under control of 
actin-GAL4 had a striking effect in dmax1 larvae: at a time point of 192 h AED, no y w; actin-
GAL4/UAS-dmyc132; dmax1 could be found (Figure 46). We repeated the experiment and collected the 
larvae at 120 h AED, a time point when wild type larvae which overexpress UAS-dmyc132 would still 
be alive. Figure 47 shows that at this time point, less than 20% of the y w; actin-GAL4/UAS-dmyc132; 
dmax1 larvae were still alive. These surviving dmax1 larvae were smaller than the sister genotype (y w; 
CyO, y+/UAS-dmyc132; dmax1) which had reached L3, and they were all in L2. dmax1/TM6B larvae 
were much less affected by the overexpression of UAS-dmyc132: more than 60% were still alive, 
however some of them being smaller than the control sister genotype (y w; CyO, y+/UAS-dmyc132; 
dmax1/TM6B.  
It was very surprising to find that the overexpression of UAS-dmyc not only did have an effect in 
dmax1 larvae, but that this effect was stronger in dmax1 homozygous mutants than in heterozygous 
dmax1/TM6B animals. In order to examine the effect more closely, we switched to a system which 
allows for a conditional overexpression of UAS-dmyc. To this purpose, we generated y w hs-flp; 
actin>CD2>GAL4 UAS-GFP dmax1/TM6B flies. Crossed to y w; UAS-dmyc132; dmax1/TM6B or y w; 
UAS-dmyc132; + flies, the actin>CD2>GAL4 flip-out cassette enabled the ubiquitous expression of 
UAS-dmyc132 upon a strong heat shock. The co-expressed UAS-GFP transgene was used to monitor 
the efficiency of heat-shock induced expression. The following experiments were all done with heat 
shocks of 2 hours at 37° C. With such a heat shock regimen, strong ubiquitous GFP expression 
resulted within few hours (data not shown).  
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Figure 46 
Constitutive expression of UAS-dmyc132 with the strong, ubiquitous GAL4 driver actin-GAL4 is lethal 
in dmax1 larvae. At 192 h AED, no y w; actin-GAL4/UAS-dmyc132; dmax1 could be found (B). 
 
 
Label:  Genotypes: 
 
A  y w; CyO, y+/UAS-dmyc; dmax1 
B  y w; actin-GAL4/UAS-dmyc132; dmax1 
C  y w; CyO, y+/+; dmax1 
D  y w; actin-GAL4/+; dmax1 
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Figure 47a 
At 120 h AED, dmax1 larvae in which UAS-dmyc132 is expressed by actin-GAL4 were reduced in 
numbers, had not reached L3 and stayed small (B). dmax1/TM6B larvae were much less affected by the 
overexpression of UAS-dmyc132, showing a only a slight reduction in survival and all being in the L3 
stage. Note: The rounded shape of the larvae in panel C and D is the Tb phenotype (one of the marker 
mutations of the TM6B balancer).   
 
Label:  Genotypes: 
 
A  y w; CyO, y+/UAS-dmyc132; dmax1 
B  y w; actin-GAL4/UAS-dmyc132; dmax1 
C  y w; CyO, y+/UAS-dmyc132;dmax1/TM6B 
D  y w; actin-GAL4/UAS-dmyc132;dmax1/TM6B 
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Figure 47b 
Survival of dmax1 and dmax1/TM6B larvae in the context of overexpressed dmyc at 120 h AED. The 
survival of the B, D and F genotypes is indicated relative to the control genotypes A, C and E. For A, 
B, C and D, two experiments were performed and the standard deviation is indicated. For E and F, one 
experiment was performed. Total number of offspring: A: 52, B: 7, C: 28, D: 28, E: 60, F: 40. 
 
Label:  Genotypes: 
 
A  y w; UAS-dmyc132/CyO, y+; dmax1 
B  y w; UAS-dmyc132/actin-GAL4; dmax1 
C  y w; +/CyO, y+; dmax1 
D  y w; +/actin-GAL4; dmax1 
E  y w; UAS-dmyc132/CyO, y1; dmax1/TM6B 
F  y w; UAS-dmyc132/actin-GAL4; dmax1/TM6B 
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Using the conditional expression system, we could show that the timing of the onset of dmyc 
overexpression is critical to induce lethality in dmax1 larvae. Figure 48 shows that induction of dmyc 
at an age of 3-4 d AED had no negative consequences on the survival of dmax1 larvae to an age of 8 d 
AED. However, when dmyc was induced at an age of 2-3 d AED, less than 10% of the dmax1 larvae 
survived until 8 d AED. The number of dmax1/+ pupae was also reduced when the heat shock was 
given at the earlier time point, but to a much lesser degree.  
In the above experiment, the survival of the dmax1 larvae was examined only at 8d AED. It was 
therefore not clear, how long dmax1 larvae would survive after induction of dmyc at the critical early 
time point. In the next experiment, a heat shock was given at 3 d AED, and the larvae were collected 
at 5 d AED. Figure 49 shows that less than 10% of the dmax1 larvae were alive at 5 d AED, if dmyc 
was expressed. In this experiment as well, dmax1/+ larvae suffered much less from the overexpression 
of dmyc.  
From these experiments, we concluded that at an age of 3 d AED, a critical event occurs in dmax1 
larvae. If dmyc is induced prior to this time point, the dmax1 larvae die within a short time. Induction 
of dmyc after this time point has no visible consequences and the larvae survive normally. Since we 
had shown that the time window for the L2-L3 molt of dmax1 larvae is 70-80 h AED, we suspected 
that the critical event might be the L2-L3 molt. 
In the next experiment, we induced dmyc expression at 2 d AED, well before the L2-L3 molt, both in 
dmax1/+ and in dmax1 homozygous larvae. We then examined the larvae at 4 d AED, shortly after the 
L2-L3 molt should have occurred. Figure 50a shows that the dmax/+ larvae were all in L3 at 4 d AED, 
with and without expression of dmyc. dmax1 larvae in which dmyc was not expressed had also reached 
the L3 stage (Figure 50b A). However, of the 16 dmax1 larvae in which dmyc had been induced, 8 
were dead. Two of these dead larvae displayed double sets of anterior spiracles, and in others, it 
became clear that they possessed two sets of cuticles, since the outer cuticle could be moved and 
detached easily (Figure 50b B). Of the surviving larvae, two displayed two sets of anterior spiracles, 
one was in L3, the rest were in L2.  
From this experiment, it became clear that dmax1 larvae fail to properly undergo the L2-L3 molt or do 
not even initiate it, when dmyc is expressed prior to the molt. The molting phenotypes described 
(double sets of spiracles, double sets of cuticles) are reminiscent to the ones of EcR-B mutants 
(Schubiger et al., 1998). When dmyc was expressed ubiquitously under control of actin-GAL4, the few 
dmax1 larvae that were found at 5 d AED were all in L2. We therefore believe that also in this case, 
the rest of the dmax1 larvae had died due to problems with the L2-L3 molt. The experiments above 
show that it is sufficient to induce expression of dmyc shortly before the molt (as late as at 3 d AED) 
in order to provoke strong lethality in dmax1 larvae.  
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Figure 48 
Survival of dmax1 and of dmax1/+ larvae, measured at 8 d AED, upon heat shock induced 
overexpression of UAS-dmyc. Whereas a heat shock given at 2-3 d AED leads to strong lethality in 
dmax1 larvae, a heat shock given at 3-4 d AED does not. A heat shock at 2-3 d AED has not such a 
strong effect in dmax1/+ larvae. For the genotypes A, B, D, E and F, two experiments were performed, 
for the genotype C, four experiments were performed, resulting in the indicated standard deviations. 
The survival rates were determined relative to control sister genotypes in the respective crosses. Total 
number of control genotype offspring: A: 137, B: 326, C: 247, D: 214, E: 309, F: 268. 
 
Label:  Genotypes/Heat shock (HS) timing: 
 
A  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 
  HS 2-3 d AED 
B  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 
  HS 3-4 d AED 
C  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 
  no HS 
D  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/+ 
  HS 2-3 d AED 
E  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/+ 
  HS 3-4 d AED 
F  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/+ 
  no HS 
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Figure 49 
Overexpression of UAS-dmyc kills dmax1 larvae within 2 d after the heat shock. The chart depicts the 
survival of dmax1 and dmax1/+ larvae at 5 d AED, after a heat shock was given at 3 d AED. For A and 
B, four experiments were performed, for C, three experiments were performed. The error bars indicate 
standard deviations. The survival rates were determined relative to control sister genotypes in the 
respective crosses. Total number of control genotype offspring: A: 325, B: 280, C: 205. 
 
Label:  Genotypes/Heat shock (HS) timing: 
 
A  y w hs-flp/[y w or Y]; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 
  HS 3 d AED 
B  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 
  HS 3 d AED 
C  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/+ 
  HS 3 d AED 
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Figure 50a 
dmax1/+ larvae undergo the L2-L3 molt without problems also when UAS-dmyc is expressed (A). The 
picture shows L3 larvae that were collected at 4 d AED, after a heat shock was given at 2 d AED.  
 
Label:  Genotypes/Heat shock (HS) timing: 
 
A  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/+ 
  HS 2 d AED 
B  y w hs-flp/[y w or Y]; actin>CD2>GAL4 UAS-GFP dmax1/+ 
  HS 2 d AED 
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Figure 50b 
dmax1 larvae die during the L2-L3 molt when UAS-dmyc is expressed. The picture shows larvae that 
were collected at 4 d AED, after a heat shock was given at 2 d AED. Whereas control dmax1 larvae 
have normally undergone the L2-L3 transition (A), dmax1 larvae in which UAS-dmyc was expressed 
have died with molting phenotypes (B). The larvae have an L2 and an L3 cuticle (visible where the L2 
cuticle has detached from the L3 cuticle). In the left and the middle larva, two sets of anterior spiracles 
are visible (indicated with arrows). In the right larva, the L2 cuticle is detached from the L3 cuticle 
near the posterior spiracles (arrow).  
 
Label:  Genotypes/Heat shock (HS) timing: 
 
A  y w hs-flp/[y w or Y];  actin>CD2>GAL4 UAS-GFP dmax1/dmax1 
  HS 2 d AED 
B  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 
  HS 2 d AED 
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In the experiments where we had overexpressed dmyc under control of GMR-GAL4 in the eye, we had 
shown that the strong eye phenotype caused by dmax-RNAi could be partially suppressed by UAS-p35 
(Figure 16). Therefore, we had concluded that the dmax-independent functions of dmyc that caused the 
eye phenotype were associated with apoptosis. We now tested whether the lethality which we 
observed in dmax1 larvae when dmyc was overexpressed prior to the L2-L3 molt could be rescued by 
blocking apoptosis. We induced the expression of UAS-dmyc and UAS-p35 at 3 d AED. Figure 51a 
shows that coexpression of UAS-p35 could not rescue the lethality associated with the L2-L3 molt. We 
also checked whether escapers which had survived the molt would develop differently, when UAS-p35 
was coexpressed, but we could not detect a difference (Figure 51b). 
For control purposes, we had also collected y w hs-flp; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP 
dmax1/UAS-p35 dmax1 larvae which had been subjected to a heat shock at 4 d AED. To our great 
surprise, we found that these larvae had not undergone pupariation. At an age of 31 d AED, 15 out of 
80 collected larvae were still alive and in the L3 stage. The rest of the larvae had died as L3. Figure 52 
shows one of the living L3 larvae and one that had recently died (Figure 52 B, C). These larvae were 
bigger than dmax1 larvae at an age of 9 d AED (shortly before a dmax1 larva would pupariate), but 
smaller than wandering y w larvae (Figure 52 A). The surviving larvae were found on top of the food, 
feeding only occasionally. They showed slow movements and intermittent phases in which no 
movement occurred and the larvae appeared stiff. The body of the larvae had a taut appearance and 
was almost translucent, no fat body tissue was visible. Dissection of the larva depicted in Figure 52 B 
revealed that the fat body was extremely reduced in size and that the fat body cells were translucent 
(Figure 52 D). The salivary glands were present and looked normal. Figure 52 E shows three leg discs 
that had undergone fusion. The surfaces of the two hemispheres of the brain and the imaginal wing 
discs had a wrinkled appearance. The failure of the larvae to initiate pupariation is reminiscent of the 
phenotype of common domain EcR mutants (embryonic lethal mutants in which all EcR protein 
isoforms (EcR-A, EcR-B1, and EcR-B2) are inactivated) that are rescued into the third larval stage by 
heat shock dependent expression of EcR-B2 (Li and Bender, 2000). Taken together with the molting 
phenotypes that are produced when dmyc is expressed in dmax1 larvae prior to the L2-L3 molt, the 
findings above provide strong evidence that the overexpression of dmyc in dmax1 larvae interferes 
with the systems that govern molting and metamorphosis, possibly by interfering directly with the 
ecdysone system.  
We next took a closer look at the pupariation behavior of dmax1/+ heterozygous larvae and dmax1 
homozygous larvae, with and without overexpression of UAS-dmyc or UAS-p35 alone, or with co-
overexpression of UAS-dmyc and UAS-p35. We again used the conditional overexpression system, 
inducing the expression of the transgenes with a 2 h heat shock at 4 d AED. Figure 53a shows that the 
formation of dmax1/+ pupae was normal (the pupae were photographed at 8 d AED), regardless of the 
overexpression of dmyc and/or p35. Whereas the formation of the pupae was normal, both transgenes 
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caused pupal lethality. Figure 53b shows the dmax1 animals, photographed at 28 d AED. Again, the 
co-overexpression of dmyc and p35 had blocked pupariation and resulted in long-lived L3 larvae of 
which some were still alive at 28 d AED (Figure 53b D). Overexpression of p35 alone resulted in the 
formation of pupae which looked similar to dmax1 pupae (Figure 53b C), displaying in most cases no 
eversion of the anterior spiracles. Interestingly, the overexpression of dmyc alone resulted in pupae 
that did differ from the shape of dmax1 pupae (Figure 53b B). Many of these pupae had not retracted 
the mouth hook and did not show a proper barrel-like shape, rather being bent and flattened in the 
head region. Even though pupariation seems to have been aberrant, these animals had clearly hardened 
larval cuticle and apolysis had taken place.  
We also determined the timing of pupariation for the 4 genotypes (Figure 53c). Clearly, the 
overexpression of dmyc resulted in a delay in pupariation. Whereas most dmax1 larvae that did not 
express any of the transgenes had pupariated in the time between 8 d AED and 11 d AED, less than 
30% of the dmax1 larvae that overexpressed dmyc had pupariated until day 11 AED and some even 
only pupariated in the time between 14 d AED and 20 d AED. This finding, taken together with 
aberrant morphology of the resulting pupae is reminiscent of certain classes of EcR mutants (Bender et 
al., 1997), providing further evidence that the overexpression of dmyc in dmax1 mutants interferes with 
the ecdysone system. 
dmax1 larvae which overexpress p35 were even more delayed than dmax1 larvae which overexpress 
dmyc, and 40% of the larvae did never appear as pupae. While most of these larvae had died, 5 of 118 
larvae were found to be alive at 20 d AED, none at 28 d AED. This indicates that overexpression of 
UAS-p35 alone is sufficient to delay the pupariation of dmax1 larvae or even block it to a certain 
extent. 
Co-overexpression of dmyc and p35 resulted in a strong block of pupariation: less than 20% of the 
larvae ever reached the pupal stage. At 20 d AED, only few dead larvae were found. In the time 
between 20 d AED and 28 d AED, most larvae died. At 28 d AED, 21 of 207 larvae were still alive.  
These findings show that both dmyc and p35 did modify the timing of pupariation if expressed alone. 
Expressed together, the two transgenes seemed to act synergistically, imposing a very strong block of 
pupariation. Interestingly, the strong block of pupariation did go along with longer survival of the non-
pupariating larvae. Regarding dmyc, the data presented so far indicate strongly that in dmax1 mutants, 
overexpression of dmyc interferes with the systems that govern molting and metamorphosis. It is not 
clear why these effects were only seen in dmax1 homozygous larvae and not in heterozygous larvae, 
but of course this means that the described effects are dmax-independent. Regarding p35, it is 
conceivable that a block of apoptosis might interfere with metamorphosis, since apoptosis plays an 
important role in the process. However, the exact nature of the interaction between dmyc and p35 
remains unclear.  
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Figure 51a 
Suppression of apoptosis by the expression of UAS-p35 cannot rescue the lethality associated with the 
overexpression of dmyc in dmax1 larvae. The survival of the larvae was determined at 5 d AED, after 
administration of a heat shock at 3 d AED. Four experiments were performed per genotype. The error 
bars indicate standard deviations. The survival rates were determined relative to control sister 
genotypes in the respective crosses. Total number of control genotype offspring: A: 280, B: 274, C: 
349.  
 
 
Label:  Genotypes/Heat shock (HS) timing: 
 
A  y w hs-flp/[y w or Y]; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 
  HS 3 d AED 
B  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 
  HS 3 d AED 
C  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/UAS-p35 
  dmax1 
  HS 3 d AED 
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Figure 51b 
At 7 d AED, dmax1 larvae that express dmyc (A) or dmyc and p35 (B) since day 3 AED - i.e. escapers 
that survived the L2 L3 molt - have developed normally and do not differ in phenotype from regular 
dmax1 larvae. 
 
Label:  Genotypes/Heat shock (HS) timing: 
 
A  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 
  HS 3 d AED 
B  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/UAS-p35 
  dmax1 
  HS 3 d AED 
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Figure 52 
dmax1 larvae which coexpress UAS-dmyc and UAS-p35 do not pupariate, but survive for extended 
periods as L3 larvae. The pictures show a y w larva at 5 d AED in the wandering stage (A) and two y w 
hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP UAS-p35 dmax1/dmax1 larvae at 33 d 
AED (B, C). The larva in C had died at 32 d AED, whereas the larva in B was still alive at the time the 
picture was taken. The transparent look of the larva in picture B is due to a largely dissolved fat body 
(D). Picture E shows leg discs of the larva in picture B which have fused, presumably due to ongoing 
metamorphosis. 
 
Label:  Description: 
 
A  y w larva, age: 5 d AED 
B, C  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/UAS-p35 
  dmax1 larvae, HS 4 d AED, age: 33 d AED 
D  fat body of larva B 
E  fused leg discs of larva B 
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Figure 53a 
dmax1/+ larvae pupariated normally also when UAS-dmyc, UAS-p35 or both are expressed. The 
presence of p35 frequently led to aberrant metamorphosis. The expression of the indicated transgenes 
was initiated with a heat shock at 4 d AED. The pupae were photographed at 8 d AED. 
 
Label:  Genotypes/Heat shock (HS) timing/age at collection: 
 
A  y w hs-flp/[y w or Y]; actin>CD2>GAL4 UAS-GFP dmax1/+ 
  HS 4 d AED, age: 8 d AED 
B  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/+ 
  HS 4 d AED, age: 8 d AED 
C  y w hs-flp/[y w or Y]; actin>CD2>GAL4 UAS-GFP dmax1/UAS-p35 
  HS 4 d AED, age: 8 d AED 
D  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/UAS-p35 
  HS 4 d AED, age: 8 d AED 
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Figure 53b 
Phenotype of dmax1 animals in which expression of UAS-dmyc (B), UAS-p35 (C) or both (D) was 
initiated at 4 d AED, photographed at 28 d AED. Whereas expression of UAS-p35 did not change the 
phenotype of dmax1 pupae, expression of UAS-dmyc led to malformed pupae in which frequently the 
mouth hook had not been properly retracted (B, see arrows). Coexpression of UAS-dmyc and UAS-p35 
inhibited the formation of pupae in most animals (D). Picture D shows 3 dead larvae and one larva that 
was still alive at 28 d AED. 
 
Label:  Genotypes/Heat shock (HS) timing/age at collection: 
 
A  y w hs-flp/[y w or Y]; actin>CD2>GAL4 UAS-GFP dmax1/ dmax1 
  HS 4 d AED, age: 28 d AED 
B  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 
  HS 4 d AED, age: 28 d AED 
C  y w hs-flp/[y w or Y]; actin>CD2>GAL4 UAS-GFP dmax1/UAS-p35 dmax1 
  HS 4 d AED, age: 28 d AED 
D  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/UAS-p35 
  dmax1 
  HS 4 d AED, age: 28 d AED 
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Figure 53c 
Timing of pupariation of dmax1 larvae in which UAS-dmyc, UAS-p35 or both were expressed. Both 
UAS-dmyc and UAS-p35 caused a delay in pupariation (B, C), but a majority of the larvae did 
pupariate. When UAS-p35 and UAS-dmyc were coexpressed (D), less than 20% of the larvae 
underwent pupariation. Total number of experiments/total number of animals: A: 3/110, B: 6/198, C: 
3/118, D: 5/207.  
 
Label:  Genotypes/Heat shock (HS) timing: 
 
A  y w hs-flp/[y w or Y]; actin>CD2>GAL4 UAS-GFP dmax1/ dmax1 
  HS 4 d AED 
B  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 
  HS 4 d AED 
C  y w hs-flp/[y w or Y]; actin>CD2>GAL4 UAS-GFP dmax1/UAS-p35 dmax1 
  HS 4 d AED 
D  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/UAS-p35 
  dmax1 
  HS 4 d AED 
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Since the data presented so far suggested that the overexpression of dmyc in dmax1 larvae interferes 
with ecdysone signaling, we tested whether we could overcome the block of pupariation that occurred 
when dmyc and p35 were coexpressed in dmax1 larvae by feeding them ecdysone. We again induced 
the overexpression of dmyc and p35 at 4 d AED, knowing that this would block the formation of 
pupae in dmax1 larvae. At 6 d AED, we put the larvae on yeast paste that contained 1 mg/ml 20-
hydroxyecdysone or on control yeast without ecdysone. Figure 54 shows that we could indeed induce 
pupariation in dmax1 larvae which co-overexpress dmyc and p35 when they were kept on ecdysone-
supplemented food (Figure 54 B). However, pupariation was aberrant and incomplete. Pupariation 
started at 10 d AED. The larvae clearly contracted and hardened their cuticle, and apolysis took place, 
but the process of the hardening and darkening of the cuticle was slower than in the controls. The 
resulting pupae were more elongated than normal pupae and did not retract the mouth hooks. 
Frequently, the cuticle around the tip of the larvae did not sclerotise at all. Feeding the larvae with 2 
mg/ml ecdysone did not improve the rescue (data not shown). Ecdysone-feeding per se had no 
negative effects, since dmax1 control larvae that did not co-overexpress dmyc and p35 did pupate 
normally in the presence of 20OH-ecdysone.  
These findings provide strong evidence that overexpression of dmyc in dmax1 larvae interferes with 
ecdysone signaling. While it is possible that supplementation of ecdysone might rescue a partial defect 
in the signaling cascade downstream of the ecdysone receptors, it is more likely that an upstream 
defect can be rescued by ecdysone feeding. Therefore, all the data gathered so far would be compatible 
with a model in which overexpression of dmyc in dmax1 larvae blocks the production of ecdysone.  
133
  
 
Figure 54 
20-hydroxyecdysone rescues the pupariation block caused by the coexpression of UAS-dmyc and UAS-
p35 in dmax1 larvae. Expression of the indicated transgenes was initiated by a heat shock at 4 d AED. 
The larvae were transferred onto yeast paste containing 1 mg/ml 20-hydroxyecdysone (A, C) or 0 
mg/ml 20-hydroxyecdysone (B) at 6 d AED. The presence of ecdysone induced the pupariation of y w 
hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/UAS-p35 dmax1 larvae (C), 
which did not pupariate on unsupplemented medium (B). However, the rescue was partial: the 
emerging pupae were malformed, frequently displayed incomplete body contraction and rounding, 
failed to retract the mouth hooks and incompletely sclerotised the cuticular region around the mouth 
hook. A animals were photographed at 10 d AED, B and C animals were photographed at 13 d AED. 
 
Label:  Genotypes/Ecdysone treatment: 
 
A  y w hs-flp/[y w or Y]; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 
  1 mg/ml 20-hydroxyecdysone at 6 d AED 
B  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/UAS-p35 
  dmax1 
  0 mg/ml 20-hydroxyecdysone at 6 d AED 
C  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/UAS-p35 
  dmax1 
  1 mg/ml 20-hydroxyecdysone at 6 d AED 
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2.8. Analysis of target gene expression in dmax1 larvae that overexpress dmyc 
The genetic analysis presented so far provided strong evidence that dmyc is still partly functional in 
the absence of dmax, contradicting the current model. In order to gain more insight into the nature of 
these dmax-independent functions of dmyc, we decided to compare the expression levels of selected 
target genes in response to dmyc overexpression, both in dmax1 homozygous larvae and dmax1/+ 
heterozygotes. As in the dmyc overexpression experiments shown before, we used the 
act>CD2>GAL4 heat shock inducible expression system to initiate the overexpression of UAS-
dmyc132. We induced the expression of dmyc by a 2 h heat shock at 37° C in dmax1 larvae at 5 d AED 
and in dmax1/+ larvae at 4 d AED. These induction times ensured that the larvae of both genotypes 
were in the third larval stage both at the time of dmyc induction and at the time when the larvae were 
collected (10 h later). dmax1 and dmax1/+ larvae that did not carry the UAS-dmyc132 transgene, but 
were subjected to the same heat shock, served as controls. 10 h after the heat shock, we collected the 
larvae. We chose a relatively short interval between induction and collection because we were 
interested in the direct consequences of dmyc on target gene expression. As additional genotypes, we 
collected dmax1 male larvae (at 5 d AED) and y w larvae (at 4 d AED). Immediately after the 
collection, we extracted total RNA from the larvae. We confirmed the integrity of the extracted total 
RNA on bioanalyzer chips and generated cDNA. Subsequently, we analyzed the expression of 
selected genes with qRTPCR assays.  
Based on microarray analysis, a set of direct dmyc targets had been established previously (Hulf et al., 
2005). In this study, most of the genes found to be regulated by dmyc contained E-boxes, with a strong 
preference for a localization of the E-box downstream of the promoter. We included two of these 
dmyc-regulated genes: nnp1 and CG5033. Both of these genes contain a downstream E-box, and for 
both of the genes it had been shown that their expression depends on the presence of the E-box (Hulf 
et al., 2005). The ability of these genes to be reliably upregulated by dmyc overexpression and 
downregulated by loss of dmyc had been confirmed by qRTPCR assays and luciferase reporter 
transgenes (Hulf et al., 2005, M. Furrer, personal communication). We deemed it unlikely that these 
E-box containing genes (or any of the E-box containing genes found in the microarray analysis) would 
still respond to overexpression of dmyc in the absence of dmax, since their expression most likely 
depends on dMyc/dMax heterodimers. Furthermore, we have shown that also the truncated form of 
dmyc which is expressed in dm2 mutants retains growth functions, making it unlikely that the dmax-
independent functions of dmyc would require dimerization of Myc with an unknown protein and 
binding to E-boxes.  
The microarrays used in the analysis mentioned above did only include RNA polymerase II-
transcribed protein-coding genes, but not RNA polymerase I- and RNA polymerase III-transcribed 
RNA genes. Since it had been shown that Myc also controls the transcription of RNA polymerase III-
dependent small RNA genes (Gomez-Roman et al., 2003; Grewal et al., 2005) in mammals and of 
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RNA polymerase I-dependent ribosomal RNA (Grandori et al., 2005; Grewal et al., 2005) in mammals 
and in Drosophila, we included rRNA, 5sRNA and tRNA(Leu) in our analysis. 
Two further small RNA genes were included in the analysis: snoRNA U3 and snoRNA 46. We 
speculated that dmyc might be implicated in the biogenesis of snoRNAs, since first, many of the target 
genes found in Hulf et al. (2005) have a function in the nucleolus, second, symplekin, a gene found to 
interact with dmyc (C. Li, unpublished), was also shown to interact with snoRNAs (Kolev and Steitz, 
2005), and third, dmyc was shown to interact with reptin and pontin (Bellosta et al., 2005). snoRNA 
U3 had been shown to bind the human orthologs of reptin and pontin and its accumulation had been 
shown to be dependent on these proteins (Watkins et al., 2004). In yeast, the biogenesis of both 
snoRNA U3 and snoRNA 46 had been shown to depend on depend on the yeast orthologs of reptin and 
pontin.  
Figure 55 shows the expression levels of dmyc, dmax, nnp1, CG5033, rRNA, 5sRNA, snoRNA U3 and 
snoRNA 46, in dmax1 and dmax1/+ larvae, with and without heat shock-induced ectopic expression of 
dmyc. For every genotype, two independent RNA extractions had been performed. The levels were 
normalized against the reference gene actin5C and charted relative to their expression levels in the y w 
hs-flp; actin>CD2>GAL4 UAS-GFP dmax1/+ genotype (genotype C).  
The induction of dmyc was efficient, since dmyc levels were more than ten-fold higher in the 
genotypes containing UAS-dmyc132 than in the control genotypes. Interestingly, compared to dmax1/+ 
larvae, dmyc levels were tripled in dmax1 homozygous larvae even in the absence of UAS-dmyc132. 
This suggests that the ability of dMyc to (auto)repress its own transcription, which has been 
documented for Drosophila and vertebrate myc genes (Penn et al., 1990; Goodliffe et al., 2005), 
depends on association with Max and hence cannot take place in dmax1 larvae. 
dmax was absent in dmax1 larvae, the small remaining signals were shown to be a consequence of 
unspecific amplification products (see Figure 25).  
The E-box dependent dmyc target genes nnp1 and CG5033 were strongly upregulated by 
overexpression of dmyc in dmax1/+ larvae, but not so in dmax1 homozygotes. In dmax1 larvae, nnp1 
levels were lower upon overexpression of dmyc (a result that could not be confirmed in the second 
qRTPCR experiment, see Figure 56), whereas CG5033 levels were slightly upregulated. However, 
these effects were small in comparison to the strong effect of dmyc in heterozygotes. We concluded 
that most likely, dmyc overexpression can no longer upregulate nnp1 or CG5033 in the absence of 
dmax.  
We monitored rRNA with a primer pair specific to an internal transcribed spacer region (ITS1) which 
is excised from the maturing rRNA, thus measuring the production of rRNA, and not total 
accumulated levels. In dmax1 larvae, transcription levels were lower than in dmax1/+ larvae. In both 
genotypes, overexpression of dmyc had no effect. 
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However, we found strong upregulation of 5sRNA and snoRNA U3 levels in dmax1 larvae upon 
overexpression of dmyc. In heterozygous larvae, dmyc had no effect on these small RNAs. Also 
snoRNA 46 levels were upregulated in dmax1 larvae, but only to the expression level shown by 
snoRNA 46 in dmax1/+ larvae. For snoRNA 46 as well, overexpression of dmyc had no effect in 
dmax1/+ larvae. These data provide evidence that dmyc is able to regulate the levels of the small RNA 
genes 5sRNA, snoRNA U3, and snoRNA 46 in a dmax-independent fashion.  
To confirm these findings, we performed a second qRTPCR experiment, using a third independent 
RNA sample for the y w hs-flp; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 and the y w hs-flp; UAS-
dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 genotypes. Additionally, we included two y w 
RNA samples and two RNA samples of dmax1 male larvae that had not been subjected to the heat 
shock. Figure 56 shows that for all tested genes, the heat shocked y w hs-flp; actin>CD2>GAL4 UAS-
GFP dmax1/dmax1 larvae showed the same expression levels as the y w/Y, y+; dmax1 control. 
Endogenous dmyc levels were 2.5-fold upregulated in these dmax1 genotypes, similar to the first 
experiment. Again, overexpression of dmyc in the dmax1 larvae had no effect on the expression of 
nnp1, CG5033 and rRNA. In all four dmax1 samples, rRNA levels were lower than in the y w control 
samples, as they were lower in comparison to dmax1/+ larvae in the first experiment. Strikingly, the 
levels of 5sRNA, snoRNA U3, snoRNA 46 and of tRNA(Leu) (a gene that was not included in the first 
qRTPCR experiment) were strongly upregulated in dmax1 larvae upon overexpression of dmyc, but not 
so in y w larvae. Without overexpression of dmyc, the levels of snoRNA U3 and of snoRNA 46 were 
lower in dmax1 larvae than in the y w control, as they were lower than in dmax1/+ larvae in the first 
experiment. The levels for 5sRNA and tRNA(Leu) were as high in the dmax larvae as in the y w 
controls.  
Taken together, these data provide strong evidence that dmyc is capable of regulating the levels of 
small RNA genes in the absence of dmax. It is presently not clear why the overexpression of dmyc 
resulted in such a strong increase in the levels of these genes in dmax1 larvae, but not in dmax1/+ 
larvae. One explanation for this finding might be that systems that regulate protein biosynthesis are 
affected by the loss of dmax-dependent functions in dmax1 larvae, resulting in a different outcome 
when dmyc is overexpressed. However, the finding that dmyc can regulate the levels of small RNA 
genes in the absence of dmax provides an intriguing explanation for the dmax-independent growth 
functions of dmyc described in this study, since the function of these genes is crucial for protein 
biosynthesis. 
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Figure 55 
dmyc fails to upregulate nnp1 and CG5033 levels in dmax1 larvae, but surprisingly upregulates 5sRNA, 
snoRNA U3 and snoRNA 46 levels. Transcript levels of dmyc, dmax, nnp1, CG5033, rRNA, 5sRNA, 
snoRNA U3, and snoRNA46 were determined with qRTPCR in larvae of the indicated genotypes. The 
chart shows average values and the standard deviations for the indicated transcript levels, relative to 
the reference gene actin5C. The values are indicated normalized to the values of the C genotype. Two 
RNA samples were used per genotype, and 3 PCR reactions were performed per assayed transcript. 
 
Label:  Genotypes/HS treatment/age at collection: 
 
A  y w hs-flp/[y w or Y]; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 
  HS 5d AED, collection: 10 h post HS 
B  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 
  HS 5d AED, collection: 10 h post HS 
C  y w hs-flp/[y w or Y]; actin>CD2>GAL4 UAS-GFP dmax1/+ 
  HS 4d AED, collection: 10 h post HS 
D  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/+ 
  HS 4d AED, collection: 10 h post HS 
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Figure 56 
qRTPCR experiment, confirming the data presented in Figure 55. Transcript levels of dmyc, dmax, 
nnp1, CG5033, rRNA, 5sRNA, snoRNA U3, snoRNA46 and tRNA(Leu) were determined with qRTPCR 
in larvae of the indicated genotypes. The chart shows average values and the standard deviations for 
the indicated transcript levels, relative to the reference gene actin5C. The indicated values are 
normalized against the values of the C genotype. One RNA samples was used per genotype, and 3 
PCR reactions were performed per assayed transcript. 
 
Label:  Genotypes/HS treatment/age at collection: 
 
A, B  y w/Y, y+; dmax1 
  no HS, collection: 5 d AED 
C  y w hs-flp/[y w or Y]; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 
  HS 5d AED, collection: 10 h post HS 
D  y w hs-flp/[y w or Y]; UAS-dmyc132/+; actin>CD2>GAL4 UAS-GFP dmax1/dmax1 
  HS 5d AED, collection: 10 h post HS 
E, F  y w 
  no HS, collection: 4 d AED 
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Discussion 
 
In this study, we present an RNAi system that allows to create situations of low dmax levels (as they 
would be found in hypomorphic dmax mutants) and we report the generation of dmax null mutants. 
With both these tools, we conducted a detailed functional analysis of dmax. Together with already 
published null mutants of the other Max network members, dmyc and dmnt (Pierce et al., 2004; Loo et 
al., 2005), the dmax null mutants were a prerequisite for a rigorous functional analysis of the 
Drosophila Max network. The analysis proved fruitful and yielded a highly surprising result: We 
could show that an important part of the functions of dmyc do not require the presence of dmax. For 
these dmax-independent functions of dmyc, we present several lines of evidence, analyzing the 
consequences of both dmyc loss of function and dmyc overexpression in a variety of situations. 
In the first part of this discussion, the phenotypes of dmax-RNAi and of the dmax1 mutants and their 
similarity to known dmyc loss of function phenotypes will be discussed. In a second and third part, we 
will recapitulate and discuss the evidence for dmax-independent functions of dmyc.  
 
1. Functional analysis of dmax 
Based on the demonstrated physical interaction between dMax and dMyc, on dMax's ability to 
stimulate dMyc-dependent transcription (Gallant et al., 1996) and on the wealth of data from 
mammalian systems (see Introduction), we expected that a loss of dmax function should result in 
phenotypes similar to the ones seen with a loss of dmyc function. However, since we could also expect 
that a loss of dmax function would abrogate dmnt function, it was possible that the consequences of a 
loss of dmax would differ from the ones of a loss of dmyc function.  
Using the dmax-RNAi system, we could indeed show that the loss of dmax phenocopies the loss of 
dmyc. Animals in which dmax levels were lowered by dmax-RNAi showed phenotypes that were 
similar to the phenotypes of dmP0 animals (flies that carry a hypomorphic mutation of dmyc). Like 
dmP0 flies, dmax-RNAi flies showed a reduced body weight (Figures 6, 31c). When dmax levels were 
ubiquitously reduced, or specifically reduced in bristle precursor cells, a marked decrease in bristle 
size resulted (Figures 7, 8), similar to the small bristle size observed in weak dmyc hypomorphic 
mutants (Johnston et al., 1999). A stronger reduction in dmyc levels, like in dmPG45 or dmPL35 animals, 
results in pupal lethality (Benassayag et al., 2005). Similarly, ubiquitous expression of three dmax 
dsRNA transgenes in wild type animals or ubiquitous expression of one dmax dsRNA transgene in 
Df(3L)fz2/+ or dmax1/+ animals led to strong pupal lethality (Figure 3).  
Consistent with the assumption that dMax is a cofactor of dMyc, we could show positive genetic 
interactions between dmyc and dmax: In dmP0 animals, which did not show reduced viability (Figure 
31b), a reduction of dmax levels by dmax-RNAi caused strong pupal lethality (Figure 11). Conversely, 
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the increase in ommatidial size that was caused by overexpression of dmyc by the eye-specific driver 
GMR-GAL4 could be shown to be partially dependent on dmax (Figures 13-18). Close examination of 
this interaction yielded also strong evidence for dmax-independent functions of dmyc which will be 
discussed separately. dmax was also shown to positively interact genetically with reptin and pontin 
(Figure 12), two genes that had been previously shown to be required for dmyc function (Bellosta et 
al., 2005).  
Complete removal of dmax in the dmax1 mutants resulted in strong growth phenotypes. Like it had 
been reported for dmyc null mutants (Pierce et al., 2004), dmax1 mutants hatched at approximately the 
same rate and size as control larvae. However, larval growth was reduced throughout the development 
of dmax1 larvae (Figures 20ab). While the clearly reduced size of dmax1 L2 larvae was not 
accompanied by a delay in the L2-L3 molt, dmax1 L3 larvae showed a strong developmental delay, 
initiating the L3-P molt only at 9 d AED (Figure 23c), without having reached the final size of control 
larvae (Figure 23a). The size of fat body and salivary gland cells and cell nuclei was reduced in dmax1 
larvae (Figure 20c) and correlated to the reduced total larval size. It is therefore likely that the growth 
phenotype of dmax1 larvae is due to reduced growth of the larval polyploid tissues. The smaller sizes 
of the nuclei of the polyploid cells points to reduced levels of endoreplication in dmax1 larvae. Since 
loss of dmyc function strongly reduces endoreplication (Maines et al., 2004; Pierce et al., 2004), it is 
likely that the underlying cause for the reduced growth of dmax1 larvae is the loss of dmax-dependent 
growth functions of dmyc.  
Loss of dmax1 function was associated with strongly reduced total RNA content (Figure 24). At 120 h 
AED, the reduction in RNA content roughly correlated to the size difference between dmax1 and 
control larvae (Figure 20a). Strikingly, already L1 larvae showed equally strongly reduced total RNA 
levels compared to controls, even though not much visible growth had occurred at this time point. 
Since the accumulation of total RNA (consisting mainly of rRNA) precedes protein accumulation in 
young larvae (Church and Robertson, 1966), it is likely that loss of dmax1 has a direct impact on rRNA 
synthesis. It has been shown that dmyc controls rRNA synthesis and ribosome biosynthesis during 
larval development by regulating the levels of the Pol I transcriptional machinery (Grewal et al., 
2005). Therefore, the reduced RNA levels in young dmax1 larvae can be explained by a reduction of 
dmyc-driven rRNA synthesis. A reduced rate of rRNA synthesis is presumably one the reasons for the 
reduced growth rates of dmax1 larvae. Consistent with such an explanation, a qRTPCR assay specific 
for the internal transcribed spacer 1b (ITS1b) region of the primary rRNA transcript - therefore 
reflecting transcription rates, not total rRNA levels - showed reduced levels in dmax1 larvae (Figures 
55, 56).  
Surprisingly, loss of dmax did not forestall imaginal development. More than 40% of the dmax1 mutant 
larvae developed into pharate imagines with a delay of not more than one day (compared to the 
duration from pupariation to the pharate stage in wild type animals) (Figure 23b). The resulting 
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pharate animals were smaller in size than controls (Figure 23c), proportional to the smaller size of 
dmax1 pupal cases, and had thin bristles, but showed an otherwise completely wild type morphology. 
Some dmax1 pharate imagines showed the typical limb movements that occur prior to eclosion, but 
none never eclosed. The reason for the failure to eclose is not clear - it is probably not to be found in 
the size of the imagines, since chico mutant flies (Bohni et al., 1999) or strongly starved flies do eclose 
at even smaller sizes.  
In order to investigate the role of dmax in imaginal growth more closely, we generated dmax1 clones in 
different imaginal tissues. While dmax1 mutant bristles were very small and thin (Figure 44), dmax1 
mutant ommatidia did not show a reduced size, nor was the ommatidial pattern disrupted in dmax1 
mutant clones (Figures 39 C, 40 C). Clearly, different requirements for dmax functions exist in 
different cell types. Since the formation of bristles requires high rates of protein biosynthesis, and thin 
bristle phenotypes emerge when protein synthesis is impaired, like in Minute or dmyc mutant 
situations (Lambertsson, 1998; Johnston et al., 1999), it is likely that the thin bristle phenotype in 
dmax1 mutants arises because dmax-dependent dmyc functions in protein biosynthesis are rate-limiting 
in bristle precursor cells. In the eye, wild type ommatidia can develop in the absence of dmax, possibly 
because dmax-dependent functions of dmyc in protein biosynthesis are not rate-limiting in this 
situation. However, dmax1 mutant clones showed impaired growth. While dmax1 mutant clones could 
reach large sizes when surrounded by Minute/+ tissue (Figure 39), the clones were much smaller 
compared to control when surrounded by cl/+ tissue (Figure 40 C) - unlike the dominant Minute allele, 
the cl allele is fully recessive and only serves to eliminate cl/cl tissue. This finding indicates that in the 
imaginal eye disc, dmax1 mutant cells grow more slowly than wild type cells and/or suffer from cell 
competition. Growth phenotypes were also found when dmax1 clones were generated in the imaginal 
wing disc. While the loss of dmax1 did not result in smaller cells (Figures 42c, 42d), it strongly 
affected clonal size. Clearly, dmax1 mutant clones suffered from cell competition: The median clone 
size was smaller at 96 h than at 72 h, and the frequency of single wild type twinspots was higher at the 
later time point (Figures 42c, 42d). Possibly, slower proliferation does also contribute to the smaller 
size of dmax1 mutant clones, but solely based on clone size, it was not possible to discriminate 
between the effect of cell competition and cell proliferation. 
In the experiments discussed so far, reduction of dmax levels resulted in phenotypes that had also been 
described for dmyc loss of function situations. Taken together with the positive genetic interactions 
with dmyc, reptin and pontin and the demonstrated physical interaction between dMyc and dMax 
(Gallant et al., 1996), these data show (not surprisingly, given the wealth of evidence from vertebrate 
systems) that dMax is an essential cofactor of dMyc. However, a comparison of the null mutant 
phenotypes of the Max network members (and of combinations thereof) revealed - next to an 
important contribution of dmnt - that dmyc also has functions that do not require dmax. 
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2. Functional analysis of the Max network 
Even though a loss of dmax functions recapitulates the consequences of a loss of dmyc, we found 
striking differences in the severity of the resulting phenotypes. While dmyc null larvae showed an 
almost complete failure to grow and very poor viability, dmax null larvae had much less pronounced 
growth defects and high survival rates (Figures 32 - 36). In order to explain the comparatively mild 
phenotype of the dmax1 mutants, we considered three hypotheses: Firstly, the loss of dmyc might have 
more severe consequences because dmyc has dmax-independent functions. Secondly, dmax1 mutants 
might show a milder phenotype than dmyc null mutants due to the concomitant loss of dmnt mediated 
repression. Thirdly, and along the lines of the second hypothesis, the loss of repression by as yet 
unknown negative dmax-dependent growth factors besides dmnt might contribute to the mildness of 
the dmax1 phenotype. We could discriminate between these hypotheses by comparing the growth and 
survival of different null mutant combinations of dmyc, dmax and dmnt.  
We could indeed show that removal dmnt in dmyc null larvae rescued part of the poor growth and 
survival of dmyc null mutants (Figure 35). However, dm4 dmnt1 larvae grew more slowly and showed 
lower survival rates than dmax1 larvae (Figures 35, 36). Therefore, two factors contribute to the 
mildness of the dmax1 phenotype: the loss of dmnt function in dmax1 mutants and dmax-independent 
functions of dmyc. Consistent with this interpretation, removal of dmax in dmyc null mutants led to 
similarly improved growth and survival as the removal of dmnt (Figures 34, 35), while removal of 
dmnt in dmax1 mutants did not alter the dmax1 phenotype (Figure 36). These results show that dmnt 
has fully dmax-dependent functions which antagonize dmyc function in larval growth, probably via 
repression of dmyc-dependent E-box promoters. In its direct antagonistic effect, dmnt hence behaves 
similar to vertebrate mnt (see Introduction). 
Since both dm4; dmax1 or dmA51; dmax1 double mutants and dm4 dmnt1; dmax1 triple mutants did not 
show better growth or viability compared to dm4 dmnt1 mutants (Figures 34, 35), we could exclude 
that an unknown dmax-dependent negative growth factor is responsible for the difference in growth 
and survival between dmax1 and dm4 dmnt1 mutants. These findings also rule out the possibility that 
the milder phenotype of dmax1 larvae (compared to dm4 dmnt1 larvae) is due the loss of hypothetical 
repressive dMax homodimers. However, both dm4; dmax1 double mutants and dm4 dmnt1; dmax1 triple 
mutants were slightly smaller and showed slightly reduced survival compared to the dm4 dmnt1 double 
mutants (Figure 35). Therefore, it is possible that dmax has dmyc- and dmnt-independent positive 
growth functions.  
Consistent with the assumption that dmyc has dmax-independent growth functions, we found that dm2 
mutants, expressing a form of dMyc that lacks the leucine zipper and therefore cannot bind to dMax, 
grow und survive better than dmyc null mutants, both in the presence and the absence of dmax 
(Figures 33, 34). However, dm2; dmax1 mutants did not reach the growth and survival rates of dmax1 
animals, indicating that either part of dmyc's dmax-independent functions do require the leucine zipper 
143
  
or that the form of dMyc that is expressed in the dm2 mutants is less stable than wild type dMyc. The 
observation that dm2 retains a part of dmyc's growth functions suggests that these functions do not 
require heterodimerization and subsequent E-box binding with a dMax-like partner molecule (i.e. a 
hypothetical bHLHzip protein with similarities to dMax, to which dMyc could bind) . Consistent with 
this assumption, we could show that the two E-box-regulated genes nnp1 and CG5033 failed to 
respond to dmyc overexpression in dmax1 larvae (Figures 55). In addition to these findings, we could 
exclude that Mlx, an obvious candidate "dMax surrogate" (see Results, 2.5.), complements the dMax 
function in dmax1 mutants (Figure 38). 
We found that the size difference between dm4 dmnt1, dmax1 and control larvae correlated with the 
size differences of the polyploid larval organs (e.g. the fat body, see Figure 37a). Both in the fat body 
and in the salivary glands, we found strong differences in nuclear and overall cell sizes between the 
three genotypes (Figures 37b, 37c). Strikingly, dm4 dmnt1 mutant fat body and salivary gland cells did 
only show a minor increase in cells size between 5 d AED and 8 d AED, while dmax1 cells showed 
robust growth, reaching a final size that was only slightly smaller compared to the cell size in 5 d old y 
w larvae. These findings suggest that dmyc can support growth and endoreplication in the absence of 
dmax. Moreover, the sustained growth of the polyploid tissues at late time points rules out the trivial 
explanation that the differences between dm4 dmnt1 and dmax1 mutants would merely arise from the 
presence of maternally contributed Max protein. The different sizes of dm4 dmnt1 and dmax1 mutant 
polyploid cells is due to a cell-autonomous growth difference, since dm4 dmnt1 mutant clones in the fat 
body showed a clearly smaller cell size (and smaller cell nuclei) than dmax1 mutant clones (Figure 45). 
Total RNA content correlated to the differing larval sizes of dm4 dmnt1, dmax1 and control larvae at 5 
d AED (Figure 37e). Strikingly, there were already as big differences in total RNA content in L1 
larvae at 29-39 h AED, when almost no visible growth had occurred (Figure 37d). Since ribosomal 
RNA makes up most of the total RNA, we concluded that dmyc can contribute to the accumulation of 
rRNA in the absence of dmax. A dmax-independent role of dmyc in ribosome biosynthesis (and 
protein synthesis as a consequence) might be one of the underlying causes for the observed growth 
difference between dm4 dmnt1 and dmax1 mutants. Consistent with such a scenario, we could show 
that overexpression of dmyc in dmax1 larvae resulted in the upregulation of 5sRNA, tRNA(Leu) and 
two snoRNAs (Figure 55, 56). 
Examining dm4, dm4 dmnt1 and dmax1 mutant clones in adult eyes and L3 wing discs, we could show 
that dmax-independent growth functions of dmyc do also play an important role in imaginal tissues. In 
the eye, both dm4 and dm4 dmnt1 mutant clones occupied smaller areas than dmax1 clones, and the 
surrounding heterozygous tissue was rough, suggesting that dm4 and dm4 dmnt1 mutant tissue was lost 
during development, likely due to cell competition (Figure 40). In the imaginal wing disc, we analyzed 
mutant and twin spot clones that had an age of 72 h. At this time point, dm4 and dm4 dmnt1 mutant 
clones showed reduced cell sizes, were extremely small compared to the twinspots (less than 15% twin 
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spot size), and more than 30% of the twinspots were not accompanied by a dm4 or dm4 dmnt1 mutant 
clone (Figures 42a, 42b). In contrast to this, dmax1 clones of the same age did not show a reduced cell 
size. dmax1 clonal area was only reduced by 35%, and only 3% of the twin spots were not 
accompanied by a dmax1 mutant clone (Figure 42c). The difference in cell size between dm4 dmnt1 and 
dmax1 mutant cells shows that dmax-independent functions of dmyc contribute to the cell growth of 
wing disc cells, while the difference in the frequency of single twin spots, together with the strongly 
reduced clonal size, shows that dm4 dmnt1 mutant clones suffer more strongly from cell competition 
than dmax1 clones. It is likely that dm4 and dm4 dmnt1 mutant cells are also more defective in 
proliferation than dmax1 cells, but based on clonal area, it is not possible to discriminate between the 
effects of reduced proliferation and of cell competition. Consistent with the finding that cell 
competition is induced more severely in cells that lack dmax-independent functions of dmyc, we could 
show that dmyc is still able to induce cell competition in dmax1 mutant wing discs (Figure 43). 
It is tempting to speculate that the observed differences between dm4 dmnt1 and dmax1 mutant 
situations (growth and endoreplication in polyploid cells, cell growth and cell competition in diploid 
imaginal cells) might have a common basis: namely, that dmyc can still partially drive protein 
biosynthesis in the absence of dmax, potentially because of a dmax-independent function of dmyc in 
ribosome biosynthesis (as the differing rRNA levels in L1 larvae (Figure 37d) and the dmyc-
dependent upregulation of 5sRNA, tRNA(Leu), snoRNA U3 and snoRNA 46 in dmax1 larvae suggest). 
The hypothesis that the same process (protein biosynthesis) is already affected in dmax1 mutant 
situations (due to downregulation of E-box regulated target genes involved in protein biosynthesis - 
like nnp1 and CG5033), but even more strongly in dm4 dmnt1 mutant situations (due to additional loss 
of dmax-independent functions of dmyc), would fit well with the observed phenotypes.  
A combination of observations suggests that reptin and pontin are required in the dmax-independent 
functions of dmyc. In dmP0 flies, loss of one copy of pontin frequently results in small, irregularly 
shaped, and slightly rough eyes (Bellosta et al., 2005). Eye-specific, complete removal of dmyc in y w 
dmA51 tub>dmyc>GAL4/Y; +/CyO, ey-flp flies produces similar eye phenotypes (Figure 39), 
suggesting that dmyc function falls below a critical threshold for normal development in dmP0/Y; 
pontin/+ flies. A similar interaction was demonstrated between reptin and the stronger dmyc 
hypomorphic allele dmPL35 (Bellosta et al., 2005). In stark contrast to these findings, complete removal 
of dmax in the eye does not produce a rough eye phenotype and seems not to reduce ommatidial size 
(Figure 39). This finding indicates that dmax is not required for normal eye development, in contrast to 
dmyc. From this it follows that reptin and pontin are required for dmyc functions that do not require 
dmax. Consistent with this conclusion, dmP0/Y; dmax1/+ flies never showed a rough eye phenotype, 
were not reduced in viability or weight and showed only an extremely small developmental delay 
compared to dmP0/Y flies (Figure 31), in contrast to dmP0/Y; pontin/+ flies that frequently show a 
rough eye phenotype, reduced viability and weight and a strong developmental delay (Bellosta et al., 
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2005). While these findings suggest that reptin and pontin are required in the dmax-independent 
functions of dmyc, the data leave open the question whether these proteins are also involved in the 
dmax-dependent functions of dmyc. Several reports have pointed to connections between reptin, 
pontin and certain snoRNAs (see Results, 2.9.), which was the reason for us to examine the effect of 
dmyc overexpression on snoRNA U3 and snoRNA 46. Indeed we could show that the levels of snoRNA 
U3 and snoRNA 46 are elevated in dmax1 larvae upon overexpression of dmyc. The upregulation of 
these snoRNAs might be mediated by reptin and pontin. Given the importance of snoRNAs in 
ribosome biosynthesis and hence protein biosynthesis, such a function of reptin and pontin could at 
least partially account for the dmyc-dependent growth in the absence of dmax. 
 
3. dmax-independent effects of dmyc overexpression 
Besides the broad evidence for dmax-independent growth functions in polyploid and imaginal tissues 
discussed above, we have observed specific consequences of dmax-independent functions when dmyc 
is overexpressed. We have studied two situations: overexpression of dmyc with the eye-specific GAL4 
driver GMR-GAL4 in wild type animals, and ubiquitous overexpression of dmyc with actin-GAL4 (for 
constitutive overexpression) or with the hs-flp actin>CD2>GAL4 system (for conditional 
overexpression) in dmax1/+ and dmax1 larvae. We could show that the eye phenotype that is caused by 
strong overexpression of dmyc in the eye with GMR-GAL4 is a result of both dmax-dependent and 
dmax-independent functions, and that the dmax-independent functions in this situation are associated 
with apoptosis. Using the constitutive or conditional ubiquitous overexpression system, we made the 
surprising discovery that overexpression of dmyc in dmax1 larvae interferes with the ecdysone system. 
The findings in both overexpression situations will be discussed below. 
 
3.1. dmax-independent functions of overexpressed dmyc in the eye  
We have overexpressed dmyc with GMR-GAL4, a GAL4 driver that causes high-level expression in 
the eye imaginal discs in cells posterior to the morphogenetic furrow (Freeman, 1996; Hay et al., 
1997). The morphogenetic furrow - wandering from the posterior margin of the eye imaginal disc to 
the anterior margin - marks the onset of cell fate specification and the end of asynchronous 
proliferation of the unspecified imaginal eye disc cells. The cell cycle arrests in the morphogenetic 
furrow, and cell fate specification begins with the formation of 5-cell preclusters that define the future 
ommatidia. The remaining cells reenter the cell cycle in a second mitotic wave posterior to the 
morphogenetic furrow and later give rise to further cell types (reviewed in Neufeld and Hariharan, 
2002).  
Overexpression of dmyc posterior to the morphogenetic furrow therefore cannot not have an influence 
on the total number of ommatidia (which is already determined by the amount of 5-cell preclusters that 
in turn depends on the total number of unspecified cells), but can be expected to influence the growth 
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of the developing ommatidia. We could indeed show that the expression of one copy of dmyc with 
GMR-GAL4 increases the ommatidial size by 28%, without causing a rough eye phenotype. Strikingly, 
expression of three copies of dmyc did not further increase ommatidial size (ommatidia were 24% 
bigger than control), but resulted in rough eyes with a pigmentation defect (Figure 14), suggesting that 
additional growth by the increased dmyc dosis is cancelled out by dmyc-induced apoptosis. Consistent 
with this assumption, blockage of apoptosis by coexpression of the pan-caspase inhibitor p35 resulted 
in an additional 10% increase of ommatidial size (i.e. it increased the overgrowth by almost one third). 
At the same time, block of apoptosis resulted in smoother eyes, partially rescued the internal structure 
of the ommatidia and fully rescued the pigmentation defect (Figure 16). Taken together with direct 
measurements of apoptosis levels (L. Montero and P. Gallant, unpublished), these findings clearly 
show that strong overexpression of dmyc by GMR-GAL4 is associated with apoptosis.  
Downregulation of dmax by expression of dmax dsRNA with GMR-GAL4 did not change ommatidial 
size (Figure 14), suggesting that either dmax levels have not been sufficiently reduced, or that normal 
ommatidial growth and development does not require dmax, a conclusion that is supported by the 
finding that in dmax1 mutant clones, normal ommatidia are formed (Figures 39, 40). When one copy 
of dmyc was overexpressed, dmax-RNAi did only partially rescue the dmyc-induced increase in 
ommatidial size. Strikingly, dmax-RNAi in the context of overexpression of three copies of dmyc led 
to a strong decrease in ommatidial size, resulting in ommatidia that were smaller than wild type 
ommatidia, but removal of dmax could not rescue the rough eye phenotype nor the pigmentation 
defect (Figure 14). From this we concluded that removal of dmax could only partially suppress the 
effects of strongly overexpressed dmyc: While it reduced dmax-dependent growth functions, dmyc-
induced apoptosis levels stayed high, the combination of both resulting in smaller-than-wild type 
ommatidia. Consistent with this interpretation, coexpression of p35 in these eyes increased ommatidial 
size, partially rescued the rough eye phenotype and restored wild type pigmentation, completely 
analogous to the effect p35 had in the absence of dmax-RNAi (Figure 16). 
A direct comparison of the measured ommatidial sizes in the different genotypes in Figure 16 
(overexpression of three copies of dmyc ("3xdmyc") with or without dmax-RNAi and with or without 
p35) strongly supports the assumption that dmyc-induced apoptosis is dmax-independent: 3xdmyc 
ommatidia with normal dmax levels are ~30% bigger than 3xdmyc ommatidia in which dmax has been 
removed, regardless of whether apoptosis is blocked. At the same time, 3xdmyc ommatidia in which 
apoptosis is blocked are ~10% bigger, regardless of whether dmax has been removed. Based on 
ommatidial size, apoptosis is therefore completely uncoupled from dmax levels.  
With a simple model, the final ommatidial sizes in all 3xdmyc genotypes of Figure 16 can be explained 
as a combination of dmax-dependent growth, dmax-independent growth, dmax-dependent and dmax-
independent apoptosis. Assuming that dmax-RNAi completely removes dMax and that expression of 
p35 completely blocks apoptosis, and taking into account that the expression of p35 with GMR-GAL4 
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increases ommatidial size by 10% on its own, we set up and solved a system of equations with 4 
variables (dmax-dependent and -independent growth and apoptosis). The following contributions to 
final ommatidial size resulted: dmax-dependent growth: +29%, dmax-independent growth: +6%, 
dmax-dependent apoptosis: -0.2%, dmax-independent apoptosis: -9%. These calculated contributions 
coincide remarkably well with the values derived with the comparative approach, where no 
assumptions about the efficiency of dmax-RNAi and p35 had been made (see preceding paragraph), 
indicating that the assumptions in the model are not unreasonable. Also in this model, apoptosis turns 
out to be almost completely dmax-independent. 
From the phenotypes and calculations above, we concluded that strong overexpression of dmyc with 
GMR-GAL4 results in both dmax-dependent and dmax-independent growth, but also in dmax-
independent apoptosis. Presumably, the dmax-dependent growth is a function of dMyc/dMax 
heterodimers, while the dmax-independent growth and apoptosis are functions of free dMyc. Based on 
the changes in ommatidial size, one further has to assume that dmax-independent growth and 
apoptosis are not increased when dMax levels are lowered and more free dMyc would be available, 
suggesting that upon wild type dMax levels, the presence of bound dMax does not interfere with these 
dmax-independent functions. 
An alternative model in which the loss of dMnt function through titration of dMax from dMnt by high 
levels of dMyc is the cause for the observed apoptosis could be ruled out, since the same dmyc 
overexpression phenotype (and the same interaction with dmax) could be observed in dmnt null flies 
(Figure 17). With the same argument, we can exclude that the observed dmax-independent apoptosis 
would be the result of dmax-independent functions of dmnt. 
Overexpression of myc has been shown to induce apoptosis both in vertebrate systems and in 
Drosophila. Intriguingly, c-myc has been shown to induce apoptosis in PC12 cell, in the absence of 
functional dmax (Wert et al., 2001), reminiscent of our findings. However, it is not clear whether the 
dmax-independent apoptosis we describe is representative for situations in which dmyc induces 
apoptosis in exponentially growing cells, or whether the apoptosis in the eye is caused by a specific 
function of dmyc in the differentiation of the ommatidia. We have shown that loss of dmyc, but not 
loss of dmax results in a rough eye phenotype (Figure 39), and it might well be that this phenotype is 
not just a consequence of the lack of dmax-independent growth, but also results from the loss of 
specific, dmax-independent functions in the development of the ommatidia. In such a scenario, strong 
overexpression of dmyc might interfere with these functions and cause apoptosis.  
Even though the nature of these functions, and the connection to apoptosis remains unclear, we could 
provide unequivocal evidence that the effects of dmyc overexpression with GMR-GAL4 are partly 
caused by dmax-independent functions of dmyc. 
 
148
  
3.2. dmyc overexpression in dmax1 larvae interferes with molting and pupariation  
Given the broad evidence for dmax-independent functions of dmyc derived from the comparison of 
dmax and dmyc dmnt loss of function situations, we did expect that ubiquitous dmyc overexpression in 
dmax1 larvae would have observable consequences. However, it was greatly surprising to discover that 
dmyc overexpression in dmax1 larvae resulted in very specific phenotypes: Induction of dmyc 
expression prior to the L2-L3 molt killed most of the dmax1 larvae during the molt (Figures 48-50), 
while dmyc induction after the molt did not increase lethality. Even more astounding, coexpression of 
dmyc and p35 after the L2-L3 molt almost completely blocked the pupariation of dmax1 larvae, letting 
these animals survive as larvae for up to one month (Figure 52). Similar phenotypes have been 
described for mutants defective in ecdysone synthesis, like ecdysoneless (ecd) mutants (Garen et al., 
1977), and for mutants defective in ecdysone signaling, like Ecdysone Receptor B (EcR-B) mutants 
(Schubiger et al., 1998; Li and Bender, 2000). We could rescue the pupariation block imposed by 
coexpression of dmyc and p35 in dmax1 larvae by ecdysone feeding, proving that overexpression of 
dmyc interferes with the ecdysone system (Figure 54). The finding that exogenous ecdysone can 
rescue the pupariation block might indicate that dmyc overexpression in dmax1 larvae results in defects 
in ecdysone signaling upstream of the receptors. However, we cannot rule out the possibility that a 
defect at the level of the ecdysone receptors or downstream of the receptors might be overcome by 
higher than wild type levels of exogenous ecdysone.  
While we could convincingly show that the overexpression of dmyc in dmax1 larvae interferes with 
ecdysone signaling, the nature of this interaction remains mysterious in many aspects. Evidently, the 
observed effects are dmax-independent. However, it is not clear why dmax1/+ larvae are much less 
affected. A significant decrease in viability could also be observed in heterozygotes (Figure 48), but 
no pupariation block. It is possible that the loss of dmax creates a sensitized situation in which an 
interaction between dmyc and the ecdysone system is uncovered. It has indeed been shown that dmyc 
overexpression in the ring gland of starved animals, but not in normal animals, leads to a 
developmental delay (P. Léopold, personal communication). One might speculate that dmax1 mutants 
share characteristics with starved animals, which would explain why the interaction between dmyc and 
ecdysone signaling creates stronger phenotypes in dmax1 animals, even though it is not clear why 
starvation increases the response to dmyc overexpression. Whatever is the reason for the different 
response to dmyc overexpression in dmax1 and dmax1/+ larvae, it is not restricted to the observed 
molting and pupariation phenotypes: similarly, dmyc overexpression has resulted in strong 
upregulation of 5sRNA, tRNA(Leu) and two snoRNAs only in dmax1 larvae, but not in the 
heterozygotes. A common cause might exist for both observations. Another mysterious aspect of the 
observed interaction between dmyc and ecdysone signaling is the connection to apoptosis. dmyc 
overexpression in dmax1 also interferes with pupariation when apoptosis is not blocked, resulting in a 
strong delay and misshapen pupal cases, but upon coexpression of p35, pupariation is almost 
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completely blocked (Figure 53). While it is possible that this is an additive effect, one could also 
imagine that p35 prevents dmyc-induced apoptosis of tissues in which dmyc exerts its pupariation-
inhibiting role, e.g. the in the ring gland, thereby intensifying dmyc's effects.  
Our findings might point to a role of dmyc in the control of developmental timing. Recently, several 
studies have shown connections between insulin signaling and the control of developmental timing by 
ecdysone signaling (Caldwell et al., 2005; Colombani et al., 2005; Mirth et al., 2005). Given dmyc's 
importance in the control of cell growth, it is conceivable that links between dmyc and ecdysone 
signaling exist. The exact nature of the interaction between dmyc and ecdysone signaling remains to be 
elucidated. 
 
4. Conclusion 
In this work, we present unequivocal evidence for dmax-independent functions of dmyc. This finding 
is of great importance, since it shows that the standard model of myc function (heterodimerization with 
max and subsequent E-box-dependent regulation of target gene transcription) does not sufficiently 
describe the scope of myc's functions. We found that a substantial part of the growth-promoting effect 
of dmyc does not require dmax and we could draw the same conclusion for other known aspects of 
dmyc activity, like cell competition and dmyc-induced apoptosis. Furthermore, we describe a 
previously unknown aspect of dmyc function: We discovered that dmyc interferes with the ecdysone 
system in a dmax-independent way. 
The elucidation of the molecular mechanisms underlying these dmax-independent functions of dmyc  
will be crucial for a better understanding of the biological functions of dmyc in growth control. Given 
the high degree of functional conservation of dmyc between Drosophila and vertebrates, it is likely 
that our findings are also of importance for the understanding of vertebrate myc.   
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Materials and Methods 
 
1. dmax- and lacZ-RNAi constructs 
For a detailed description of the cloning strategy, see Steiger (2002). The dmax and lacZ inverted 
repeats were cloned into the KpnI and BglII sites of pUAST. The repeats are separated by a single SfiI 
restriction site. The following table shows the end coordinates of the single repeat cDNAs relative to 
the indicated Genbank and Flybase entries as well as the 5'-most (respectively 3'-most) sequences of 
the repeats. These end sequences are given in 5'-3' orientation relative to the primer sequences. 
 
1.1. dmax-RNAi 
Repeat length: 784 bp 
 
Sequence: AE003517.3 (Genbank entry) 
End  Coordinate  Sequence in primer 
5'  64690   5’ TTTGCGCGCAATCCGTGCAAAAC 3’ 
3'  63243   5’ TAAGGTCGATTGGGTGGGTTAC 3’ 
 
Sequence: Max-RA (Flybase entry FBtr0075018) 
Length: 1011 bp 
End  Coordinate  
5'  132   
3'  915   
 
1.2. lacZ-RNAi 
Repeat length: 769 bp 
 
Sequence: J01636.1 (Genbank entry) 
End  Coordinate  Sequence in primer 
5'  3092   5' TATGAACGGTCTGGTCTTTGCCG 3' 
3'  3860   5' AATCCGGTAGGTTTTCCGGCT 3' 
 
Sequence: lacZ cDNA 
Length: 3113 bp 
End  Coordinate  
5'  1847 
3'  2615 
 
 
2. Generation and characterization of dmax mutants 
 
2.1. Imprecise excision screen to generate dmax mutants 
To generate dmax mutants, flies of the genotype y w; P{y+ w+}CG9666EY02775 were used. These flies 
harbor a P{EPgy2} insertion at the 3' end of the second exon of CG9666 (insertion positions: 
19257703..19257704 on chromosome 3L, 65233..65234 on AE003517.3), 412 bp upstream of the start 
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of the dmax transcript. This P element was mobilized using the Δ2-3 P element transposase. Based on 
the assumption that strong hypomorphic dmax alleles and dmax null alleles should lead to pupal or 
earlier lethality if put over Df(3L)fz2, we isolated putative dmax mutants with the following screening 
scheme: 
 
P0 y w; P{y+ w+}CG9666EY02775   x   y w; Δ2-3 Sb/TM6B 
 
F1 3 ?  y w; P{y+ w+}CG9666EY02775 / Δ2-3 Sb   x   3 ?  y w; D gl/TM3, Ser y+ 
 
 402 F1 crosses were set up. The offspring of these crosses were screened for Sb+ males that had lost the w+ 
 marker, indicating successful mobilization of P{y+ w+}CG9666EY02775. 270 Sb+ w- males from individual 
 crosses were collected. Note: w/[y w or Y]; P{y+ w+}CG9666EY02775/Df(3L)fz2 flies were fully viable. 
 
F2 single ?  y w; Pmut[y- w-]/[TM3, Ser y+ or D gl]   x   3 ?  w; Df(3L)fz2/TM6C, Tb Hu Sb 
 
 180 F2 crosses were set up, of which all had offspring. In 5 crosses, no w/[y w or Y]; Pmut[y- w-]/Df(3L)fz2 flies 
 eclosed. In further 2 crosses, the viability of  w/[y w or Y]; Pmut[y- w-]/Df(3L)fz2 flies was reduced. Subsequently, 
 lines carrying these Pmut[y- w-] chromosomes were established. Additionally, lines containing Pmut[y- w-] 
 chromosomes that did not result in lethality in heterozygosity with Df(3L)fz2 were established, since these 
 chromosomes were expected to be derived from precise excision events. 
 
Established lines (named after the F1 cross they originated from): 
50, 70, 85, 100, 283   lethal over Df(3L)fz2 
9, 54     semilethal over Df(3L)fz2 
25, 188, 296, 301, 377  viable over Df(3L)fz2 
 
2.2. Molecular characterization of the alleles isolated in the imprecise excision screen 
We used PCR to characterize the Pmut[y- w-] chromosomes isolated in the imprecise excision screen. To 
this end, genomic DNA from adult Pmut[y- w-]/Balancer flies was isolated. The following PCR primers 
were used (the positions indicated correspond to the 3' most base of the primer sequence and are 
relative to AE003517.3. The P* primer is specific for P element ends. The indicated position 
corresponds to the EY02775 insertion. It allows for generation of PCR products if used with primers in 
the flanking genomic sequence): 
 
dmax3B.SfiI 
5' GCGGCGGCCATCTAGGCCTAAGGTCGATTGGGTGGGTTAC 3' 
63264 
 
CG9666rev1 
5' GTCGGCTGTCCCAGCAACTGGGG 3' 
65320 
 
CG9666forw1 
5' GCCGAGACGAACCGCAAGATAC 3' 
65157 
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P* 
CGACGGGACCACCTTATGTTATTTCATCATG 
65233 
 
Analysis of the lines 9 and 54 revealed that both ends of the P element were still present, even though 
the w+ and y+ markers were lost. In line 283, none of the P element ends was detectable anymore. In 
the lines 50, 70, 85 and 100, the 3' P element end (the one closer to CG9666) was still present, but not 
the P element end close to dmax. In the lines 85 and 100, PCR with the primers dmax3B.SfiI, situated 
near the 3' end of the dmax transcript, and CG9666.5prime.rev, situated 3' of the P{y+ 
w+}CG9666EY02775 insertion site (relative to the genome annotation) yielded bands that were shorter 
than the bands generated on wild type genomic DNA, indicating deletions caused by imprecise 
excision events. DNA from these bands were isolated and sequenced to reveal the molecular nature of 
the lesions. Based on the results of the sequencing, the allele from line 100 was termed dmax1, the 
allele from line 85 was termed dmax2. With the lines, 50, 70 and 283, no bands other than the one 
derived from the wild type sequence on the balancer was derived. Together with the early lethal 
phenotype of the larvae, it is probable that in these cases large deletions had been produced that do 
also affect neighboring essential genes. A PCR with the primers CG9666forw1 and CG9666rev1 
which are situated directly next to the P element insertion site revealed that in line 25, a precise 
excision event had occurred. 
 
2.3. Sequence of the dmax1 (line 100) and dmax2 (line 85) mutant alleles 
The direction of the sequences in the following description is corresponding to the scaffold sequence 
AE003517.3 and to the sequence of the Drosophila chromosome 3L: AE014296.4, i.e. opposite to the 
sequence of the dmax transcript. Position indications are referring to the positions of the breakpoint 
nucleotides (underlined and marked in bold) on AE003517.3 and AE014296.4. 
 
2.3.1. dmax1 sequence 
In line 100, a deletion has been created that stretches from the EY02775 insertion position (at the 3' 
end of the second exon of CG9666) until the last exon of dmax (position 729 on the dmax transcript), 
spanning 1804 bp. The deletion uncovers the whole of the dmax ORF. 
Sequence until breakpoint (63428 (AE003517) / 19255898 (AE014296): 
5' TGGAACCGTTTCCTTCACAACTTTTCGAGGGCTATT 
GCTTTCGTATAACACAACTCAAAGTTGAACTAAATC 3' 
Sequence after breakpoint (65233 (AE003517) / 19257703 (AE014296): 
5' GTCTGAGTCCGCCGAACCAGGTGAGTTCGTTGGGAAC 3' 
 
Between these breakpoints, the sequence GATAAATGTTATTTCATCATG was found, of which 
ATGTTATTTCATCATG is identical to the P element end, whereas the GATAA sequence is of 
unknown origin.  
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2.3.2. dmax2 sequence 
In line 85, a 550 bp deletion has been created that stretches from the EY02775 insertion position until 
the first exon of dmax (position 139 on the dmax transcript), 27 bp upstream of the start of the dmax 
ORF.  
Sequence until breakpoint (64682 (AE003517) / 19257152 (AE014296): 
5' ACTCATGTTGCTTCACTTGTTTTGCACGGATTG 3' 
Sequence after breakpoint (65233 (AE003517) / 19257703 (AE014296): 
5' GTCTGAGTCCGCCGAACCAGGTGAGTTCGTTGGGAAC 3' 
 
Between these breakpoints, the sequence TTATTTCATCATG was found, originating from the P 
element end. 
 
3. Cloning of the dmax genomic construct 
The following primers were used to generate the dmax genomic construct (indicated is the whole 
primer sequence in 5'-3' direction. The position indications are relative to the AE003517.3 scaffold 
sequence and to the sequence of the Drosophila chromosome 3L: AE014296.4. They denote the 5' 
most annealing nucleotide of the respective primer (underlined): 
rescue2 primer: CGG GGTACC GCGGCCGC GGTTGTATTTGGTTCGGAATG 
   62792 (AE003517) / 19255262 (AE014296) 
rescue3 primer : CGG GGTACC TCCGGCTATTTGCTGATACTG 
   65579 (AE003517) / 19258049 (AE014296) 
These primers amplify a 2788 bp sequence that extends from the end of the transcript of CG14084, the 
gene 3' of the end of the dmax transcript, to the start of the ORF of CG9666. The bold sequences in the 
primer sequences denote Asp718 restriction sites. The amplicon was cut with Asp718 and ligated into 
the Asp718 site of pCaSpeR 4. With the resulting generated plasmid, pDS29, transgenic fly lines were 
established. 
 
4. Fly culture 
Flies were kept on standard Drosophila medium. If not indicated otherwise, test crosses were 
performed in climate chambers at 25° C. 
 
5. Weight measurements 
The wet weight of adult flies was measured with a Mettler Toledo MX5 micro balance. Before the 
weighing, the flies were killed by freezing. The flies had an age of 1-7 d (Figure 6), 1-5 d (Figure 
30b), and 1-4 d (Figure 31c). 
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6. Determination of bristle size 
Scutella were removed, cleaned from attaching muscle tissue and mounted on glass slides, in glycerol. 
Pictures were taken with a Zeiss Axiophot microscope / Progres scanner camera system (objective 
magnification: 5x). Bristle size was determined as the total pixel count a bristle covers in a picture. 
Pixel counts were determined with Adobe Photoshop. 
 
7. Determination of wing area and wing cell size 
Wings were mounted on glass slides with the dorsal side up, in glycerol. Pictures were taken with a 
Zeiss Axiophot microscope / Progres scanner camera system (objective magnification: 2.5x (total 
wings), 20x (determination of cell density)). The total wing surface area (pixel count) was directly 
determined in Adobe Photoshop. For the determination of wing cell size, the number of dorsal 
microchaetae (which occur once per cell) was counted in a defined rectangle of 300 x 300 pixels. Cell 
size was calculated as the reciprocal value of the determined bristle density.  
 
8. Determination of ommatidial size 
Pictures of fly eyes were acquired with a JEOL JSM-6360 LV scanning electron microscope at a 
magnification of 180x. The depicted eyes were gold-coated (except for the following cases, where 
uncoated eyes of flies that had been killed by freezing were photographed: Figure 14, panels BE, 
Figure 17, panels A'B'C'D'). The area of 20 central ommatidia was determined using Adobe 
Photoshop. For each genotype, at least 5 eyes were scored. Fusions of two ommatidia were counted as 
two individual ommatidia.  
 
9. Autofluorescence microscopy of fly eyes 
The pictures of Figure 16d were taken with a Leica DMRA compound microscope, using a 10x 
objective. Whole flies (killed by freezing) were positioned on a glass slide (dry, without coverslip). 
Excitatory light that is suitable to induce fluorescence of GFP causes autofluorescence in the 
ommatidial tissue, allowing the acquisition of the pictures of Figure 16d. 
 
10. Determination of survival rates (viability rates) and larval growth 
Figure 3: The genotypes A, B, C originated from a cross of ? y w; actin-GAL4/CyO, y+ x ? y w; UAS-
dmax-IR(2-7)/CyO. The viability of B (or C) was determined as the ratio of B (or C) offspring number 
(eclosed flies) compared to A offspring number (eclosed flies), in %. The genotypes D, E, F originated 
from a cross of ? y w; actin-GAL4/CyO, y+; dmax1/TM6B x ? y w; UAS-dmax-IR(2-7)/CyO. The 
viability of E and F was indicated relative to D. The genotypes G and I originated from a cross of ? y 
w; [actin-GAL4; Df(3L)fz2]/SM5-TM6B x ? y w; UAS-dmax; UAS-dmax-IR(6-1), the genotypes H and 
K originated from a cross of ? y w; [actin-GAL4; Df(3L)fz2]/SM5-TM6B x ? y w; +; UAS-dmax-IR(6-
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1). The viability of G and H were compared by normalizing with I and K. Since G showed higher 
viability than the genotypes I and K, the viability of G was set to 100%. 
 
Figure 11: The genotypes A and D originated from the cross ? y w; da-GAL4/MKRS x ? y w; UAS-
dmax-IR(2-7)/CyO, B and E from ? w dmP0 tub>dmyc>GAL4/FM7; da-GAL4/MKRS x ? y w; UAS-
dmax-IR(2-7)/CyO, C and F from ? w dmP0/FM7; da-GAL4/MKRS x ? y w; UAS-dmax-IR(2-7)/CyO. 
The viabilities of A-F was determined as the ratio of (A-F) offspring number (eclosed flies) compared 
to the offspring numbers (eclosed flies) of the sister genotypes indicated below, the ratio of 
[genotype/reference (sister offspring) genotype] is indicated in brackets: A: y w/y w; CyO/+; da-
GAL4/+ (38/48), B: dmP0 tub>dmyc>GAL4/y w; CyO/+; da-GAL4/+ (18/22), C: dmP0/y w; CyO/+; 
da-GAL4/+ (28/29), D: y w/Y; CyO/+; da-GAL4/+ (17/50), E: dmP0 tub>dmyc>GAL4/Y; CyO/+; da-
GAL4/+ (14/17), F: dmP0/Y; CyO/+; da-GAL4/+ (1/18). 
 
Figure 12: Crosses from which the genotypes A-E originated: A: ? y w; actin-GAL4/CyO, y+ x ? y w; 
UAS-dmax-IR(2-7)/CyO, B: ? y w; actin-GAL4/CyO, y+ x ? y w; UAS-dmax-IR(2-7)/CyO, y+; UAS-
dmax-IR(5-2)UAS-dmax-IR(6-1)/TM6B, C: ? y w; actin-GAL4/CyO, y+ x ? y w; UAS-dmax-IR(2-
7)/CyO, y+; Df(3L)fz2/TM6B, D: ? y w; actin-GAL4/CyO, y+ x ? y w; UAS-dmax-IR(2-7)/CyO, y+; 
reptin/TM6B, E: ? y w; actin-GAL4/CyO, y+ x ? y w; UAS-dmax-IR(2-7)/CyO, y+; pontin/TM6B. The 
viability of the genotypes A-E (% eclosed flies) was determined relative to the offspring numbers 
(eclosed flies) of the following reference (sister offspring) genotypes (numbers in brackets indicate the 
total number of eclosed reference genotype animals).: A: y w; actin-GAL4/CyO (82), B: y w; CyO, 
y+/UAS-dmax-IR(2-7); UAS-dmax-IR(5-2) UAS-dmax-IR(6-1)/+, y w; actin-GAL4/CyO, y+; TM6B/+, 
y w; CyO, y+/UAS-dmax-IR(2-7); TM6B/+ (98), C: y w; actin-GAL4/CyO, y+; Df(3L)fz2/+, y w; actin-
GAL4/CyO, y+; TM6B/+, y w; CyO, y+/UAS-dmax-IR(2-7); Df(3L)fz2/+, y w; CyO, y+/UAS-dmax-
IR(2-7); TM6B/+ (119), D: y w; actin-GAL4/CyO, y+; reptin/+, y w; CyO, y+/UAS-dmax-IR(2-7); 
reptin/+ (85), E: y w; actin-GAL4/CyO, y+; pontin/+, y w; CyO, y+/UAS-dmax-IR(2-7); pontin/+ (74). 
In the cases where more than one reference genotype is listed, the viability ratios were calculated 
using the combined total offspring numbers of the indicated genotypes. 
 
Figures 20ab, 21, 23a, 28a, 32, 33, 34abc, 35ab, 36ab, 38: Egg lays (duration: 6-10 h) were performed 
on apple agar plates supplemented with yeast paste. At 48 h AED (Figures 33, 34: 24 h AED), hatched 
larvae were flushed from the plates using tap water and collected in a sieve (indications for the time 
AED usually refer to the midpoints of the egg lays). Subsequently, the larvae were genotyped and put 
into tubes containing standard fly food (numbers of collected larvae: see Figures). At the time points 
indicated in the figures (e.g. 120 h AED) the larvae (or pupae) were collected by floatation with 30% 
glycerol. The survival rates of the larvae were determined as the ratio of larvae (or pupae) that were 
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found alive at the time of collection compared to the number of larvae that were initially put into the 
tubes (at 48 or 24 h AED). To compare larval size, the larvae were frozen and later photographed, 
using a Zeiss AxioCam HRc camera attached to a Zeiss Stemi SV 11 microscope. 
 
Figure 48: The following crosses were set up: ? y w hs-flp; actin>CD2>GAL4 UAS-GFP 
dmax1/TM6B x ? y w; UAS-dmyc132 (offspring D, E, F) and ? y w hs-flp; actin>CD2>GAL4 UAS-GFP 
dmax1/TM6B x ? y w; UAS-dmyc132; dmax1/TM6B (offspring A, B, C). Egg lays (duration: 24 h) were 
performed on standard food and a heat shock (2 h 37° C in a water bath) was given at the time points 
indicated in the Figure. At 8 d AED, the offspring was collected by floatation with 30% glycerol. To 
calculate survival rates, the number of surviving A-F larvae was compared to the total number of sister 
genotype offspring in the respective crosses. Sister genotypes used in the calculation: D-F: y w hs-
flp/[y w or Y]; UAS-dmyc132/+; TM6B/+, A-C: y w hs-flp/[y w or Y]; UAS-dmyc132/+; TM6B/dmax1, y 
w hs-flp/[y w or Y]; UAS-dmyc132/+; TM6B/actin>CD2>GAL4 UAS-GFP dmax1. 
 
Figure 49: The following crosses were set up: ? y w hs-flp; actin>CD2>GAL4 UAS-GFP 
dmax1/TM6B x ? y w; dmax1/TM6B (offspring A), ? y w hs-flp; actin>CD2>GAL4 UAS-GFP 
dmax1/TM6B x ? y w; UAS-dmyc132; dmax1/TM6B (offspring B), ? y w hs-flp; actin>CD2>GAL4 
UAS-GFP dmax1/TM6B x ? y w; UAS-dmyc132 (offspring C). Egg lays (duration: 5 h) were performed 
on standard food. At 3 d AED, a heat shock (2 h 37° C in a water bath) was given. At 5 d AED, the 
offspring was collected by floatation with 30% glycerol. To calculate survival rates, the number of 
surviving A-C larvae was compared to the total number of sister genotype offspring in the respective 
crosses. Sister genotypes used in the calculation: A: y w hs-flp/[y w or Y]; TM6B/dmax1, y w hs-flp/[y 
w or Y]; TM6B/actin>CD2>GAL4 UAS-GFP dmax1, B: y w hs-flp/[y w or Y]; UAS-dmyc132/+; 
TM6B/dmax1, y w hs-flp/[y w or Y]; UAS-dmyc132/+; TM6B/actin>CD2>GAL4 UAS-GFP dmax1, C: y 
w hs-flp/[y w or Y]; UAS-dmyc132/+; TM6B/+. 
 
Figure 50: The following crosses were set up: ? y w hs-flp; actin>CD2>GAL4 UAS-GFP 
dmax1/TM6B x ? y w; UAS-dmyc132 (offspring 50a A), ? y w hs-flp; actin>CD2>GAL4 UAS-GFP 
dmax1/TM6B x ? y w (offspring 50a B), ? y w hs-flp; actin>CD2>GAL4 UAS-GFP dmax1/TM6B x ? y 
w; dmax1/TM6B (offspring 50b A), ? y w hs-flp; actin>CD2>GAL4 UAS-GFP dmax1/TM6B x ? y w; 
UAS-dmyc132; dmax1/TM6B (offspring 50b B). Egg lays (duration: 12 h) were performed on standard 
food. At 2 d AED, a heat shock (2 h 37° C in a water bath) was given. At 3 d AED, larvae of the 
genotypes indicated in Figure 50ab were collected, staged and put on apple agar plates (supplemented 
with yeast paste). 24 h later (at 4 d AED), the larvae were inspected and staged again. 
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Figure 51a: The following crosses were set up: ? y w hs-flp; actin>CD2>GAL4 UAS-GFP 
dmax1/TM6B x ? y w; dmax1/TM6B (offspring A), ? y w hs-flp; actin>CD2>GAL4 UAS-GFP 
dmax1/TM6B x ? y w; UAS-dmyc132; dmax1/TM6B (offspring B), ? y w hs-flp; actin>CD2>GAL4 
UAS-GFP dmax1/TM6B x ? y w; UAS-dmyc132; UAS-p35 dmax1/TM6B (offspring C). Egg lays 
(duration: 8 h) were performed on standard food. At 3 d AED, a heat shock (2 h 37° in a water bath) 
was given. At 5 d AED, At 5 d AED, the offspring was collected by floatation with 30% glycerol. To 
calculate survival rates, the number of surviving A-C larvae was compared to the total number of 
sister genotype offspring in the respective crosses. Sister genotypes used in the calculation: A: y w hs-
flp/[y w or Y]; TM6B/dmax1, y w hs-flp/[y w or Y]; TM6B/actin>CD2>GAL4 UAS-GFP dmax1, B: y w 
hs-flp/[y w or Y]; UAS-dmyc132/+; TM6B/dmax1, y w hs-flp/[y w or Y]; UAS-dmyc132/+; 
TM6B/actin>CD2>GAL4 UAS-GFP dmax1, C: y w hs-flp/[y w or Y]; UAS-dmyc132/+; TM6B/UAS-
p35 dmax1, y w hs-flp/[y w or Y]; UAS-dmyc132/+; TM6B/actin>CD2>GAL4 UAS-GFP dmax1. 
 
Figures 52, 53: Egg lays (duration: maximally 12 h) were performed on standard food. Heat shocks (2 
h 37° in water baths) were given as described in the figures. At an age of 6-9 d AED (Figure 53) or 4 d 
(Figure 52), larvae of the genotypes indicated in the figures were collected by floatation with 30% 
glycerol and put into fresh tubes. At 8, 11, 14, 20 and 28 d AED, the number of pupae was counted. 
The larvae (or pupae) were collected and photographed at the time points indicated in the figures. 
 
11. Comparison of the sizes of larval fat bodies and salivary glands  
Egg lays (duration: 10 h) were performed on standard fly food. At 5 d AED, w dm4 dmnt1, w; dmax1 
and y w larvae were collected, at 8 d AED, w dm4 dmnt1 and w; dmax1 were collected. The larvae were 
dissected in Ringer's solution, fat bodies and salivary glands were collected. The fat bodies and 
salivary glands were fixed in 4% paraformaldehyde in PBS for 20 min and washed in PBS three times 
for 10 min (each step). To stain the nuclei, 0.5 ug/ml Hoechst dye (33342) was included in the second 
washing step. Subsequently, the fat bodies and salivary glands were mounted in Vectashield mounting 
solution. Pictures (objective magnification: 5x and 63x) were taken using a Leica DMRA compound 
microscope. 
 
12. Determination of larval total RNA content 
Larvae of the genotypes and ages indicated in the Figures 24a, 24b, 37d and 37e were collected on ice. 
Subsequently, the larvae were homogenized in 1 ml of TRIZOL reagent (Invitrogen) using a Polytron 
tissue homogenizer (duration: 60 s). Immediately after homogenization, the homogenate was frozen at 
-80° C for at least 1 d. The total RNA was extracted and purified according to the protocol supplied 
with the TRIZOL reagent. The precipitated purified total RNA was redissolved in 20 ul ddH2O. The 
concentration of the purified total RNA was measured with a Nanodrop ND-1000 spectrophotometer. 
158
  
Based on the numbers of larvae that were homogenized, the total RNA content per larva was 
calculated. 
 
13. Clonal analysis 
 
13.1. ey-flp clones 
The genotypes depicted in the Figures 39 and 40 originate from the following crosses: 
 
y w dmA51 tub>dmyc>GAL4 hs-flp/Y; CyO, ey-flp (Figure 39, panel A): 
? y w dmA51 tub>dmyc>GAL4 hs-flp/FM7 x ? y w; CyO, ey-flp/Bc Gla bw 
 
y w dmRev tub>dmyc>GAL4 hs-flp/Y; CyO, ey-flp (Figure 39, panel B): 
? y w dmRev tub>dmyc>GAL4 hs-flp x ? y w; CyO, ey-flp/Bc Gla bw 
 
y w ey-flp c-lacZ/w; FRT80B Pw+(70C) M(3)i55/FRT80B dmax1 (Figure 39, panel C): 
? y w ey-flp c-lacZ/FM6; FRT80B Pw+(70C) M(3)i55/TM6B x ? w; FRT80B dmax1/TM6B 
 
y w ey-flp c-lacZ/w; FRT80B Pw+(70C) M(3)i55/FRT80B (Figure 39, panel D): 
? y w ey-flp c-lacZ/FM6; FRT80B Pw+(70C) M(3)i55/TM6B x ? w; FRT80B 
 
w dm4 FRT19/y cl(15B) FRT19; Sp/ey-flp (Figure 40, panel A): 
? y cl(15B) FRT19/FM6; ey-flp x ? w dm4 FRT19/Y; tub>dmyc>GAL4/Sp 
 
w dm4 dmnt1 FRT19/y cl(15B) FRT19; Sp/ey-flp (Figure 40, panel B): 
? y cl(15B) FRT19/FM6; ey-flp x ? w dm4 dmnt1 FRT19/Y; tub>dmyc>GAL4/Sp 
 
y w ey-flp/Y; FRT80 dmax1/FRT80 clw+ (Figure 40, panel C): 
? y w ey-flp; FRT80 clw+/TM6B, y+ x ? w; FRT80 dmax1/TM6B 
 
y w FRT19/y cl(15B) FRT19; ey-flp/+ (Figure 40, panel D): 
? y cl(15B) FRT19/FM6; ey-flp x ? y w FRT19 
 
The fly lines y w ey-flp c-lacZ/FM6; FRT80B Pw+(70C) M(3)i55/TM6B, y w ey-flp; FRT80 
clw+/TM6B, y+ and y cl(15B) FRT19/FM6; ey-flp were kindly provided by H. Stocker. 
 
13.2. hs-flp clones 
 
13.2.1. Crosses  
To generate dmax1 clones, y w hs-flp; FRT80 dmax1/TM6B males were crossed to y w hs-flp; FRT80 
ubi-GFP virgins. To generate dm4 clones, w dm4 FRT19/FM7 virgins were crossed to y w hs-flp hs-
GFP FRT19 males. To generate dm4 dmnt1 clones, w dm4 dmnt1 FRT19/FM7 virgins were crossed to y 
w hs-flp hs-GFP FRT19 males. The y w hs-flp hs-GFP FRT19 line was kindly provided by K. Basler. 
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13.2.2. Generation and analysis of wing disc clones 
Egg lays (duration: 6 h) were performed on standard food. dm4 and dm4 dmnt1 clones with a final age 
of 72 h were induced at 48 h AED (Heat shock: 15 min 37°C in a water bath). dmax1 clones with a 
final age of 72 h were induced at 48 h AED (Heat shock: 30 min  37°C in a water bath). dmax1 clones 
with a final age of 96 h were induced at 24 h AED (Heat shock: 30 min  37°C in a water bath). At 120 
h AED, the larvae were dissected in Ringer's solution and the wing discs were collected. In the dm4 
and dm4 dmnt1 genotypes, the expression of hs-GFP was induced by a heat shock (1 h 37° in a water 
bath) at 3 h prior to dissection. The wing discs were fixed in 4% paraformaldehyde in PBS for 15 min 
and washed in PBS three times for 10 min. To stain the nuclei, 0.5 ug/ml Hoechst dye (33342) was 
included in the second washing step. Subsequently, wing discs were mounted in Vectashield mounting 
solution. Pictures of the wing discs were taken with a Leica SP2 confocal microscope (objective 
magnification: 40x). Clone (and twin spot) size was determined as the total pixel count a clone (and a 
twinspot) covers in a picture. Pixel counts were determined with Adobe Photoshop. Counting the 
number of cell nuclei in a clone, the cell sizes were calculated. Number of analyzed clones/twinspots: 
dm4 72 h: 12/15, dm4 dmnt1 72 h: 15/19, dmax1 72 h: 16/16, dmax1 96 h: 5/7. In order to determine the 
frequency of single twin spots, the following number of twin spots was checked for the presence of a 
mutant clone: dm4 72 h: 28, dm4 dmnt1 72 h: 24, dmax1 72 h: 106, dmax1 96 h: 16. 
 
13.2.3. Generation of clones in the fat body 
The clones had to be induced prior to polyploidization (after which FRT-mediated recombination 
would only shuffle chromosome arms, but not create homozygous mutant cells). An egg lay of 3 h was 
performed. 6 h later, clones were induced by a heat shock of 1 h (37° in a water bath). At 120 h AED, 
the larvae were dissected in Ringer's solution and the fat bodies were collected. In the dm4 dmnt1 
genotype, the expression of hs-GFP was induced by a heat shock (1 h 37° in a water bath) at 3 h prior 
to dissection. The fat bodies were fixed in 4% paraformaldehyde in PBS for 15 min and washed in 
PBS three times for 10 min. To stain the nuclei, 0.5 ug/ml Hoechst dye (33342) was included in the 
second washing step. Subsequently, fat bodies were mounted in Vectashield mounting solution. 
Pictures (objective magnification: 10x) were taken using a Leica DMRA compound microscope. 
 
13.2.4. Generation of dmax1 mutant bristles 
A heat shock of 1 h at 37° C in a water bath was given at 24 h AED.  
 
13.3. Analysis of competition in dmax1 larvae 
To generate tub>dmyc>GAL4 flp-out clones, the following cross was set up: ? y w tub>dmyc>GAL4 
hs-flp; dmax1/TM6B, ubi-GFP x ? y w; UAS-GFP; dmax1/TM6B, ubi-GFP. To generate 
actin>CD2>GAL4 flp-out clones, the following cross was set up: ? y w hs-flp; actin>CD2>GAL4 
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UAS-GFP dmax1/TM6B x ? y w; dmax1/TM6B. Egg lays (duration: 12 h) were performed on standard 
food. Flp-out clones with a final age of 96 h were induced at 120 h AED (Heat shock: for the 
act>CD2>GAL4 clones: 5 min 37°C in a water bath, for the tub>dmyc>GAL4 clones: 12 min 37°C in 
a water bath). At 216 h AED, dmax1 larvae were dissected in Ringer's solution and the wing discs 
were collected. The wing discs were fixed in 4% paraformaldehyde in PBS for 15 min and washed in 
PBS three times for 10 min. To stain the nuclei, 0.5 ug/ml Hoechst dye (33342) was included in the 
second washing step. Subsequently, wing discs were mounted in Vectashield mounting solution. 
Pictures (objective magnification: 10x) were taken using a Leica DMRA compound microscope. 
Clone size was determined as the total pixel count a clone covers in a picture. Pixel counts were 
determined with Adobe Photoshop. The sizes of 53 act>CD2>GAL4 clones from 14 discs and 39 
tub>CD2>GAL4 from 6 discs were determined. 
 
14. Ecdysone feeding assay 
The protocol used in the feeding assay is a modified version of Gates et al. (2004). Larvae of the 
genotypes indicated in Figure 54 were grown on standard food. At 6 d AED (in a second experiment 
that gave similar results: at 7 d AED), the larvae were collected by floatation with 30% glycerol and 
placed on plates with yeast paste containing 1 mg/ml ecdysone or control plates with yeast paste 
without ecdysone. Subsequently, the development of the larvae was observed.  
Preparation of the yeast plates: To make yeast paste for 1 feeding plate containing 1 mg/ml 20-
hydroxyecdysone (H5142, Sigma-Aldrich), 16.8 ul of a 12 mg/ml stock solution (in EtOH abs.) was 
diluted in 183.2 ul water and added to 0.1 g of dry yeast. For control plates, 16.8 ul of EtOH abs. was 
diluted in 183.2 ul water and added to 0.1 g of dry yeast. The yeast paste was placed as a blob on 
damp filter paper (Schleicher & Schuell filter papers circles, diameter: 55 mm, Ref. No. 10336207) in 
plastic petri dishes (Greiner Bio-One, diameter 60 mm). Small holes were burnt into the petri dish 
covers to allow circulation of air. The covered petri dishes had to be sealed tightly to prevent escape of 
the larvae. To prevent drying of the yeast, the filter paper was moistened with water every 24 h. 
 
15. qRTPCR 
Figure 5: Wandering third instar larvae of the genotypes y w; +/actin-GAL4 (10 larvae), y w; UAS-
dmax-IR(2-7)/actin-GAL4; TM6B/+ (9 larvae), y w; UAS-dmax-IR(2-7)/actin-GAL4; UAS-dmax-IR(5-
2) UAS-dmax-IR(6-1)/+ (8 larvae) and y w; P{y+ w+}CG9666EY02775 (10 larvae) were collected. The 
larvae were homogenized in 800 µl TRIZOL reagent (Invitrogen) using a Polytron tissue homogenizer 
(duration: 30 s). RNA was extracted and purified according to the protocol supplied with the TRIZOL 
reagent. The RNA was further purified with the RNeasy Mini Kit (Qiagen) and subjected to an on-
column DNase digestion (RNase-Free DNase Set (Qiagen)). The resulting RNA (elution volume: 30 
ul) had concentrations between 0.2 ug/ul and 0.9 ug/ul. The quality of the extracted RNA was assessed 
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with agarose gel electrophoresis. cDNA was synthesized with the Omniscript Reverse Transcription 
Kit (Qiagen) using an oligo dT primer (AffyT7 2450969-F, sequence 5’ 
GGCCAGTGAATTGTAATACGACTCACTATAGGGAGGCGG (dT)24 3’). 2 ul of template RNA 
was used in the reverse transcription step. Control reactions lacking the RT enzyme were set up to 
control for genomic DNA contamination. qRTPCR reactions were performed on an ABI 7900 Real 
Time PCR Instrument (Applied Biosystems) using the SYBR GREEN PCR Master Mix (Applied 
Biosystems). PCR conditions: volume (total): 20 ul, volume (primer pairs at 10 uM): 2 ul, volume 
(template): 1 ul, cycling parameters: 2 min 50° C, 10 min 95° C, 40 x [15 s 95° C, 1 min 60° C]. 
Dissociation curve measurements were included in the PCR run to document the specificity of the 
amplification reaction. Data collection and primary analysis were conducted using SDS 2.0 software 
(Applied Biosystems), subsequent analyses and relative target gene quantitation was performed using 
Microsoft Excel. The amount of target, normalized to act42A, and relative to the calibrator (target 
gene levels in the y w; +/actin-GAL4 genotype), is given by 2-ΔΔCt, where ΔΔCt = ΔCt(sample) - 
ΔCt(calibrator), and ΔCt is the Ct of the target gene subtracted from the Ct of the act42A reaction. The 
following primer pairs were used in the qRTPCR reactions: 
 
Gene   Primer name   Sequence (5'-3') 
dmax   dmaxF.3UTR   AACCCACCCAATCGACCTTAAT 
   dmaxR.3UTR   TTCTTTGCGCACAGAGTGACA 
CG9666  CG9666.3prime.forw  GTTTACTCCCTACACAAGACGTCAAC 
   CG9666.3prime.rev  CCCCATTCCAGTGCCTTTT 
Act42A  Act42A.F   GAGCGCGGTTACAGCTTCA 
   Act42A.R   TCCTTGATGTCGCGCACA 
RpL32   RpL32_fwd   GCAAGCCCAAGGGTATCG 
   RpL32_rev   TTGGGCATCAGATACTGTCCC 
 
Figures 25a, 55, 56: Larvae of the genotypes and ages indicated in the Figures 25a, 55 and 56 were 
collected on ice (y w and dmax1/+ larvae: 12 larvae per RNA sample, dmax1 larvae: 20 larvae per 
RNA sample). Subsequently, the larvae were homogenized in 1 ml of TRIZOL reagent (Invitrogen) 
using a Polytron tissue homogenizer (duration: 60 s). Immediately after homogenization, the 
homogenate was frozen at -80° C for at least 1 d. The total RNA was extracted and purified according 
to the protocol supplied with the TRIZOL reagent. The precipitated purified total RNA was 
redissolved in 20 ul ddH2O. The concentration of the purified total RNA was measured with a 
Nanodrop ND-1000 spectrophotometer. To remove traces of genomic DNA, 10 ug of RNA were 
subjected to a DNase digestion, using the Ambion TURBO DNA-free kit. Subsequently, the quality of 
the purified RNA was confirmed using Bioanalyzer chips (Agilent). The Bioanalyzer 
electropherograms also served to confirm the Nanodrop concentration measurements. cDNA was 
synthesized with the Omniscript Reverse Transcription Kit (Qiagen) using random hexamer primers. 1 
ug of template RNA was used in the reverse transcription step. Mock RT reactions (containing 1 ug of 
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template RNA and H2O) were performed in order to control for remaining traces of genomic DNA. 
qRTPCR reactions were performed on an ABI 7900 Real Time PCR Instrument (Applied Biosystems) 
using the SYBR GREEN PCR Master Mix (Applied Biosystems). PCR conditions: volume (total): 10 
ul, volume (primer pairs at 10 uM): 0.3 ul, volume (template): 2 ul, cycling parameters: 2 min 50° C, 
10 min 95° C, 40 x [15 s 95° C, 1 min 60° C]. Dissociation curve measurements were included in the 
PCR run to document the specificity of the amplification reaction. Data collection and primary 
analysis were conducted using SDS 2.0 software (Applied Biosystems), subsequent analyses and 
relative target gene quantitation was performed using Microsoft Excel. The amount of target, 
normalized to actin5C, and relative to the calibrator (target gene levels in y w hs-flp/[y w or Y]; 
actin>CD2>GAL4 UAS-GFP dmax1/+ larvae for Figure 55, in y w larvae for Figure 56), is given by 2-
ΔΔCt, where ΔΔCt = ΔCt(sample) - ΔCt(calibrator), and ΔCt is the Ct of the target gene subtracted from 
the Ct of the actin5C reaction. The following primer pairs were used in the qRTPCR reactions: 
 
Assay/Gene  Primer name    Sequence (5'-3') 
actin5C  PG_act5C_F1    GCCCATCTACGAGGGTTATGC 
   PG_act5C_R1    AATCGCGACCAGCCAGATC 
dmyc   dmyc_RTPCR_f   GAATCGCGCTCGGTTAGTG 
   dmyc_RTPCR_r   CTACGCCGCCGCTTTAAG 
dmax   dmax_qRTPCR_ex2ex3_forw CACAAACACCGCCAATTTCA 
   dmax_qRTPCR_ex2ex3_rev  CGCCTTCGCTCCAAAGC 
nnp1   PG_nnp1_F1    CTATACACACGAAAGTTTCC 
        ATGCTATA 
   PG_nnp1_R1    CAACACGGAACTATCGTAAATTTCA 
CG5033  PG_CG5033_F1   TAACCGCTCGGCTTTAATTCAT 
   PG_CG5033_R1   CCCTTGCTCTTGGAGAATGG 
rRNA(ITS1b)*  rDNA_ITS1_2fw   GCTTGGCAACCTCATAAAAAGATTT 
   rDNA_ITS1_rev   AGGAAACGCCGTTGTTGTAAGT 
5sRNA   5sRNA_fw    CGTCCGATCACCGAAATTAAG 
   5sRNA_rev    CCAAGCGGTCCCTCATCTAA 
snoRNA U3  PG_U3_f    TTTCACACTAGCTGAAAGCCAAGT 
   PG_U3_r    CCTCACGCTGCCGAATAGAA 
snoRNA 46  PG_snR46_f    CTTTGTCGAAGACCGTTTTGC 
   PG_snR46_r    TGCTTTGGGCTTCGTTTTG 
tRNA(Leu)  tRNALeu.L    TAAGGCGCCAGACTCAAGAT 
   tRNALeu.R    CCTCAAAGAGGACCAGAACG 
 
* The primers in the rRNA(ITS1b) assay bind to the internal transcribed spacer 1 (ITS1) of the 
polycistronic gene cassette encoding the 18sRNA, 5.8sRNA, 2sRNA and 28sRNA. Tandem arrays of 
this gene cassette form the X-chromosomal bobbed and the Y-chromosomal Y-bobbed locus. 
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16. Data represented in multiple figures  
For the sake of clarity, the data listed below were shown in multiple figures. The data are listed in the 
order of their appearance. 
 
14ab A  15ab A  16ab A  18ab A 
14ab C  15ab A' 16ab A' 18ab A' 
14ab D  15ab C  16ab C  18ab B 
14ab F  15ab C' 16ab C' 18ab B' 
14b A  17b R 
14b C  17b R' 
14c A  16c A 
14c C  16c A' 
14c D  16c C 
14c F  16c C' 
20a A  34a A 
20a B  34a B 
20b B  36a A 
20c A  37b B 
20c A'  37c B 
20c B  37b E 
20c B'  37c E 
20c C  37b D 
20c C'  37c D 
21 A (120 h AED) 35b A 
21 A (192 h AED) 36b A 
21 B (192 h AED) 36b B 
24a A  37d B 
24a B  32 A  37d C 
24b A  37e B 
24b B  37e C 
25a A1  56 A (dmax assay) 
25a A2  56 B (dmax assay) 
25a B1  56 E (dmax assay) 
25a B2  56 F (dmax assay) 
32 B  34a C
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